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Abstract
Cobalt-Catalyzed Aerobic Oxidative Cyclization Reactions of Bisnucleophiles:
New Methodologies and the Role of Bisnucleophiles in O2 Activation
Jiaqi Liu
Over the past few decades, transition metals have found wide applications in the
development of selective oxidative transformations mediated by molecular oxygen. Due to the
benign nature of molecular oxygen as an oxidant and an increasing awareness of green chemistry
practice, tremendous progress has been made towards the development of Cu-and Pd-catalyzed
aerobic oxidation reactions. As a first-row transition metal alternative to copper, cobalt has been
employed in aerobic catalytic transformations for its cost-efficiency and earth abundance; however,
redox-active mediators such as benzoquinone (BQ), N-hydroxyphthalimide (NHPI) or salen-type
ligands are usually required. To date, reactions mediated by Co/O2 catalytic systems in the absence
of redox mediators are still limited. In this regard, we developed a highly efficient protocol
employing a Co/O2 catalytic system without acquiring external mediators to turn-over the cycle.
This dissertation offers a brief overview of advancements in cobalt-catalyzed aerobic
oxidative reactions in chapter 1, where three major classes of oxidation reactions mediated by
Co/O2 systems are particularly addressed. Chapterss 2 and 3 describe the development of a series
of new cobalt-catalyzed aerobic cyclization reactions of bis-nucleophiles. When isonitriles are
employed as coupling partners, a wide variety of functionalized 2-aminobenzoxazoles and 2aminobenzimidazoles are afforded as pharmaceutically valuable structures. These protocols are
additive-free, ligand-free, highly efficient, and require no external redox-active mediators.
Mechanistic studies point to the dual function of the bis-nucleophile as both a substrate and a
redox-active ligand, and its importance in activating molecular oxygen as the stoichiometric
oxidant. Additionally, the bis-nucleophile may act as a hydrogen atom donor capable of
participating in hydrogen atom transfer (HAT) reactions. Chapter 4 elucidates the synthesis and
characterization of two unprecedented CoII and CoIII complexes consisting of the N-unsubstituted
aminophenol ligand. As a continuous effort in deepening mechanistic investigations, these metal
complexes are regarded as potential active reaction intermediates and have demonstrated success
in enabling O2 activation thus mediating oxidative cyclization transformations afterward.
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Chapter 1. Cobalt-catalyzed Aerobic Oxidation Reactions: An Overview

1.1.

Transition-Metal Catalyzed Oxidation of Organic Substrates with O2
Oxidant
Molecular oxygen is a highly abundant, environmentally benign, and atom economical

oxidant, which makes it an ideal choice for oxidation reactions of organic substrates. However,
due to the high energy barrier associated with O2 activation, the incorporation of catalysts in the
reaction is usually necessary.1 With the increasing awareness of green chemistry practice in recent
decades, more efforts have been sought towards the development of the new catalytic oxidation
reactions to replace the conventional methods involving the use of stoichiometric quantities of
toxic inorganic oxidizing reagents, such as dichromate and permanganate.2 An ideal system for
“Green Oxidation” employs molecular oxygen as the primary oxidant together with recyclable
catalysts in a non-toxic solvent to minimize waste disposal. Thus, designing effective catalytic
systems that allow the activation of molecular oxygen at ambient conditions for selective oxidation
reactions is highly practical. A few applications have been translated to industrial processes and
have demonstrated great successes over the past decades (Scheme 1.1), such as the palladiumcatalyzed Wacker oxidation of alkenes to carbonyl compounds,3 “KA oil” production via radicalchain autoxidation of cyclohexane to a mixture of cyclohexanone and cyclohexanol, and the
synthesis of terephthalic acid from p-xylene in the presence of manganese and cobalt salt, using
molecular oxygen as the terminal oxidant.2
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Scheme 1.1. Industry Radical Autoxidation Process Employing Transition-Metals and Molecular
Oxygen.

Metalloenzymes that catalyze selective aerobic oxidation reactions have provided valuable
frameworks for the design of new catalysts over the century. These enzymes are characterized into
two major classes based on the fate of oxygen atom from the molecular oxygen, oxygenase, and
oxidase. Oxygenases provide oxygen atom transfer from the molecular oxygen to the substrates,
affording the oxygen-incorporated products, while oxidases just use molecular oxygen as the
electron or proton acceptor during the oxidation of substrates.4 The simplified mechanistic
elucidation of these two main categories of metalloenzyme is shown in Scheme 1.2.

Scheme 1.2. Simplified Mechanism of Metalloenzyme-Catalyzed Aerobic Oxidation. (a)
Oxygenase Pathway Featuring Oxygen Atom Transfer from O2 to Substrate. (b) Oxidase Pathway
Featuring O2 as a 2H+/2e- Acceptor in Substrate Oxidations.
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Studies on these natural oxidation processes have offered lots of insights and inspirations
for chemists aiming to utilize O2 for selective oxidation reactions. “Oxygenase-type” oxidation
reactions have demonstrated great successes in asymmetric catalysis, such as Sharpless
asymmetric epoxidation, where molecular oxygen or dioxygen surrogates such as amine N-oxides,
alkyl peroxides, or hydrogen peroxide are employed.4 The “oxidase-type” oxidation reactions
allow any oxidation reaction to being coupled to O2 reduction when the catalyst can mediate both
redox cycles of substrate oxidation by the oxidized catalyst and re-oxidation of the reduced catalyst
by O2. Over the course of seeking effective catalytic oxidation systems, a broad scope of oxidative
transformations has been developed using molecular oxygen as the terminal oxidant, catalyzed by
a vast range of transition metals.2, 5-9 These transformations include but are not limited to alcohol
oxidations, alkene epoxidation, alkene oxidation to alcohols and ketones, benzylic and allylic
oxidation, aromatic C-H oxidation, sulfoxidation, and Baeyer-Villiger oxidation. While numerous
contributions have been made toward this field of study, this chapter will mainly focus on three
major categories of aerobic oxidative transformation mediated by cobalt-catalysts, including
perspectives from both “oxygenase-type” and “oxidase-type” reactions.

1.2.

Historic Overview of Co/O2 Catalysis

1.2.1. Mukaiyama Olefin Oxygenation and Oxidative Cyclization of Alkenols
In the late 80s of the last century, Mukaiyama and co-workers had uncovered a few efficient
methods for introducing dioxygen functionality to the carbon-carbon double bond under mild
reaction conditions.10 The development of these methods made a significant contribution to the
selective oxygenation of olefins with molecular oxygen paired with cobalt salts, rather than
employing cobalt complexes consisting of Schiff-base ligands or porphyrin ligands. These
discoveries built foundations to their later reported olefin activation study, with O2 as the oxidant
and EtSiH3 as the reducing agent, the corresponding triethylsilyl peroxide was generated by using
a CoII catalyst at room temperature.11 They also found that the variation of silane agents could
produce the alcohol directly from the olefin. When phenyl silane was used in place of triethyl
silane, hydration of the olefin proceeded smoothly at room temperature with high efficiency
(Scheme 1.3).10
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Scheme 1.3. Mukaiyama Olefin Oxygenation with Co/O2 Catalytic System

In 1990, Mukaiyama reported a CoII-catalyzed oxidative cyclization of 5-hydroxy-1-alkene
for the preparation of trans-2-hydroxymethyltetrahydrofurans with molecular oxygen as the
oxidant.12 Employing a Co(modp)2 catalyst, various 2-hydroxymethyl-tetrahydrofurans were
attained with extremely high trans-selectivity (Scheme 1.4a). Though three decades have passed
since the discovery of this oxidative cyclization of alkenols, this reaction still interests a lot of
researchers as the diastereoselective synthesis of functionalized cyclic ethers is of significant
importance. Tetrahydrofurans (THFs) are key structural elements that are naturally occurring in
many substances with potent biological activities.13 The Mukaiyama oxidation usually proceeds
in excellent diastereoselectivity (>99:1 dr) and moderate to good yields, however, the catalyst can
be extremely difficult to remove from the THF products when modp ligand is employed,
introducing unnecessary challenges to the NMR characterization of the desired product. Also, the
difficulties associated with the purification of the products counterbalanced the synthetic
advantage of this cobalt catalyst. Later on, Pagenkopf and co-workers developed the second
generation of water-soluble cobalt catalyst for Mukaiyama oxidative cyclization reactions.14 This
catalyst was equipped with a piperazine unit, which was believed to help with the solubility of the
cobalt catalyst when the acidic workup is used (Scheme 1.4b). This method retained the efficiency
of the Mukaiyama oxidative cyclization while also providing significantly increased polarity of
the cobalt catalyst, and was expected to find applications in total synthesis.
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Scheme 1.4. First and Second Generations of Cobalt Catalysts in Mukaiyama Oxidative
Cyclization.

Hartung and co-workers further developed a few methods to expand the existing
Mukaiyama oxidative cyclization (Scheme 1.5a).15 With the retention of the extraordinary
diastereoselectivity (> 99:1 dr) of the original oxidative cyclization of alkenols, heterocycles with
different functionality can be obtained employing Co catalyst {4-[3,5-bis(trifluoromethyl)phenyl]-4-oxybut-3-en-2-one}-cobalt(II) (CoL2) under an O2 atmosphere. In their study, they
provided evidence that the intermediates generated during catalysis are free carbon radicals, which
can be converted into synthetically valuable functional groups with various chemical reagents
(Scheme 1.5b). In this way, they developed methods for reductive and brominative termination of
the aerobic oxidative cyclization of alkenols, with the right choice of the reductant and brominating
agents. They later expanded the scope to a broader range of acceptor molecules,16 such as monosubstituted olefins including methyl acrylate and acrylonitrile; 1,2-disubstituted olefins involving
dimethyl fumarate and N-phenylmaleic imide. The protocol can also tolerate ester-substituted
alkynes, giving rise to a diastereomerically pure bis-tetrahydrofuran, which was initiated by a
cascade process consisting of two aerobic oxidations, an alkyne addition, followed by a hydrogen
atom transfer (HAT).
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Scheme 1.5. Extension of Mukaiyama Oxidative Cyclization: Reductive and Brominative Alkenol
Cyclization.

1.2.2.

Co/NHPI-Catalyzed Aerobic Oxidative Reactions

While the discovery of Mukaiyama oxidative cyclization reactions has been a milestone in
the cobalt-catalyzed oxidations employing O2 as the stoichiometric oxidant, it has limited scope to
the oxy-functionality of alkenols to generate diastereomerically pure tetrahydrofurans (THFs). A
few years later, a practical method had been introduced by Ishii and co-workers to convert alkanes
and alkylbenzenes into the corresponding ketones and carboxylic acids using a combined system
consisting of N-hydroxyphthalimide (NHPI) and Co(II) (Scheme 1.6a).17-19 This co-catalytic
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system was primarily employed in the C-H oxidation of the methylene compounds at ambient
pressure. The generalized mechanism shown in Scheme 1.6b suggested the in-situ generated
phthalimide-N-oxyl radical (PINO) plays a critical role in the catalytic cycle to abstract a hydrogen
atom from the substrate. The resulting carbon-centered radical will participate in the oxygenation
with O2, giving rise to the corresponding ketone or carboxylic acid products. Among other
transition-metals being investigated, cobalt had shown to be the key promoter to generate the PINO
intermediate, other metals demonstrated less efficiency in this aerobic C-H oxidation reaction.6, 18

Scheme 1.6. Pioneering Work by Ishii on Aerobic C-H Oxidation Using the Combined Catalytic
System of Co and NHPI.

Following these pioneering works, Patil and co-workers later developed a solvent-free,
sustainable, and selective reaction for the C-H oxidation of alkylbenzenes by Co/NHPI under
phase-transfer conditions (PTC).20 Although NHPI was proved to be highly efficient and versatile
in the aerobic oxidation reactions, it has inherited limitations that prevented translation to the
industrial process. For example, there are no proper methods for the reuse and recovery of catalysts;
NHPI presented poor solubility in non-polar organic phases, and instability of both NHPI and its
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intermediate PINO at the temperature above 80 ºC.21, 22 The design of this oxidation system aimed
at transcending the existing limitations and had demonstrated some success in the preparation of
gram scale acetophenone when DDAB (Di-n-decyl-di-methyl ammonium bromide) was used as
the phase transfer agent (Scheme 1.7). In this work, a light microscope image demonstrated that
the multi-lamellar vesicles (MLVs) structures associated with DDAB protected NHPI at high
temperatures. Thus, they speculated an efficient recovery and reuse of this ternary catalytic system
(Co-NHPI/DDAB) is practical. However, this method only demonstrated excellent tolerance to
ethylbenzene and indane, it didn’t show much efficiency for tetralin substrates.

Scheme 1.7. Solvent-Free Aerobic Oxidation of Alkylbenzenes Catalyzed by Co/DDAB/NHPI

In 2017, Stahl and co-workers explored Co/NHPI-catalyzed benzylic oxygenation of
heterocyclic substrates including benzimidazoles, thiophenes, and pyridines.23 This protocol
generated benzylic ketones with good to excellent yields, including a gram-scale synthesis of a
pharmacologically active compound from its di(hetero) arylmethane precursor with a modified
procedure that comprised the use of 500 psi of a mixture (O2:N2 9:91) to maintain the limit
concentration allowance of molecular oxygen in the solvent BuOAc (Scheme 1.8). It was also
suggested in this study that radical oxygen reactions would be inhibited with the presence of certain
heterocyclic moieties. They attributed the inhibition of the chelation of heterocycles with the metal
catalyst, which can be circumvented by an alternative procedure of a cobalt-free, electrochemical
NHPI-mediated method they devised at the same time.
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Scheme 1.8. Oxygenation of Heteroarenes by Co/NHPI Catalytic System (Stahl).

Co/NHPI-catalyzed oxygenation not only established great success in the simple
oxygenation of the methylene functionalities, but it also proved to be tolerant with oxygenmediated chain-reactions. The Shia group developed a legitimate protocol of Co/NHPI-catalyzed
aerobic oxidation of terminal-capped alkynyl α‑cyano alkanone systems.24 With this method, aryl-,
silyl-, and alkyl-capped alkynyl α-cyano alkanone systems can be converted to the corresponding
highly functionalized bicyclic products in an effective manner (Scheme 1.9). It was also revealed
that the substituent capped on the terminal acetylene is structurally variable, although the
trialkylsilyl group may play an extraordinary role in inducing the radical chain reaction. According
to the proposed mechanism, the chain reaction is initiated by a hydrogen atom abstraction (HAA)
at the position α to the cyano group by the in-situ generated phthalimide (PINO) radical, followed
by an immediate 5-exo-dig addition to produce a vinyl radical species. Molecular oxygen is then
captured by the vinyl radical intermediate to generate a vinyl peroxide species, which undergoes a
second hydrogen atom abstraction (HAA) process by NHPI and a 1,4-dehydration to yield the
desired product as a highly functionalized bicyclic compound.
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Scheme 1.9. Autoxidation of Aryl-Capped Alkynyl α-Cyano Alkanones by CoII/NHPI Catalytic
System.

1.2.3.

Cobalt Schiff Base Complexes in Aerobic Oxidation Reactions
The tetradentate, square-planar Schiff base cobalt complex is well known for its O2

activation behavior. It was first discovered in the 1930s by Tsumaki that solid CoII(salen) ([N, N′
-bis-(salicylidene)-ethane-1,2-diaminato]cobalt) can reversibly bind molecular oxygen.25 This
finding spiked tremendous interest among researchers in the oxygen-carrying properties of cobalt
complexes with Schiff base ligands.
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The Co(salen) complex adapts a square planar geometry. Upon the coordination of
molecular oxygen, it adapts an octahedral geometry with the O2 occupying the axial position.26
The other axial position is usually occupied by a base, which is believed to help enhance the
binding affinity of molecular oxygen to Co(salen) species.27, 28 Co(salen) complexes typically form
either a mononuclear superoxo-complex or a dinuclear complex with a µ-peroxo bridge with
molecular oxygen; however, the superoxo complex is assumed to be a radical species and is
responsible for aerobic catalytic transformations (Scheme 1.10).

Scheme 1.10. Two Forms of Co(salen) Complexes with Molecular Oxygen. Mononuclear
Superoxo Species (Left) and Dinuclear µ-peroxo Species (Right).

Cobalt Schiff base catalysts operate under mild reaction conditions and allow the
stoichiometric use of molecular oxygen paired with earth-abundant transition metals. Over the past
few decades, it was extensively applied in the phenol oxidations.27, 29, 30 More recently, this aerobic
catalytic system has been translated to the deconstruction of lignin biomass and for the conversion
to higher value structures such as quinones and aldehydes. The general mechanism of Co(salen)catalyzed oxidation is illustrated in Scheme 1.11 with the p-hydroxyphenol lignin model as a
substrate.31, 32 A CoIII-superoxide adduct is formed upon activation of molecular oxygen, which
readily abstracts a phenolic hydrogen from the substrate to form a phenoxyl radical. This
intermediate interacts with the second equivalent of the CoIII-superoxide, giving rise to a peroxo
species which immediately undergoes a rearrangement to produce quinone and formaldehyde.
Alternatively, the same intermediate could also generate an aldehyde upon hydrogen atom
abstraction (HAT) from the CoIII. The presence of a base such as a pyridine at the axial position of
Co(salen) complex has been proved to facilitate the CoIII-superoxide formation by increasing the
binding affinity of dioxygen species to the metal center.
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Scheme 1.11. Generalized Mechanism of Co(salen)-Catalyzed Aerobic Oxidation of Lignin-like
Phenols to Form Quinones and Aldehydes.

These precedented studies concluded that cobalt Schiff base-catalyzed aerobic phenol
oxidations all involve the formation of CoIII−hydroxide and CoIII−hydroperoxide intermediates. In
one of the works published,32 the proposed CoIII-OH intermediate is able to regenerate catalytically
active CoII species. Upon hydrogen atom transfer (HAT) from phenol to cobalt hydroxy group, the
H2O can dissociate from the metal center and release the Co(salen) complex to complete the cycle.
In 2016, the Stahl group further investigated the Co(salophen)-catalyzed aerobic oxidation of phydroquinone (Figure 1.1 left).33 The mechanism of this catalytic oxidation was examined with a
combination of spectroscopy, kinetic measurements, and density functional theory (DFT)
calculations. The study suggested that the catalyst resting-state consists of an equilibrium between
a CoII(salophen) complex, a CoIII-superoxide adduct, and a hydrogen-bonded adduct between the
hydroquinone and the CoIII−O2 intermediate (Figure 1.1 right). The key processes involve a
hydrogen atom transfer (HAT) from the p-hydroquinone to the CoIII-superoxide species and a
proton-coupled electron transfer (PCET) between a semiquinone and CoIII−hydroperoxo
intermediate (Figure 1.1 left bottom). The latter is identified as the turn-over limiting step by
combined kinetic experiments and DFT calculations. Subsequently, a coordinated H2O2
intermediate of CoIII will participate in the oxidation of the second equivalent of p-hydroquinone
and regenerate the CoII catalyst in the cycle.
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Figure 1.1. Proposed Mechanism for the Co(salophen)-Catalyzed Aerobic Oxidation of pHydroquinone.

The well-established cycle for aerobic p-hydroquinone oxidation by cobalt Schiff base
complexes has been widely found in bimetallic-mediated “oxidase” type transformations. These
systems all consist of a coupled redox cycle, one cycle for the oxidation of the substrate by the
oxidized catalyst, and one cycle for re-oxidation of the reduced catalyst by O2. Particularly featured
in palladium-catalyzed oxidations,4 benzoquinones and macrocyclic cobalt complexes are usually
used as co-catalytic systems in a wide scope of oxidation reactions, such as allylic acetoxylation,34
Wacker-type oxidation of the alkenes35, and oxidative C-C cross-coupling reactions.36 Amongst
these impressive findings, Co(salophen) is the most commonly employed co-catalyst in the aerobic
oxidative transformations mediated by palladium37 and ruthenium.38 Scheme 1.12 illustrated an
example of Pd-catalyzed acetoxylation with a combined redox cycle employing Co(salophen) and
hydroquinone as a co-catalyst system. In this system, Co(salophen) and p-hydroquinone operate
synergistically to generate the active benzoquinone as a co-catalyst meanwhile mediate the
electron-transfer to the Pd-catalyzed oxidative C-H functionalization.
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Scheme 1.12. Simplified Mechanism for the Coupled Redox Cycles Employing Co(salophen)
and Hydroquinone Co-Catalyst in Pd-Catalyzed Allylic Acetoxylation.

Because of the high efficiency of Co(salen) in the bimetallic systems to function as an
electron-transfer mediator when it is paired with a benzoquinone co-catalyst, it has found its
application in the selective aerobic oxidative cross-coupling reactions. In 2019, the Pappo group
reported a waste-free, selectivity-driven oxidative coupling of phenols employing Co(salen) and
air in a recyclable 1,1,1,3,3,3-hexafluoropropan-2-ol (HFIP) solvent (Scheme 1.13).39 This
protocol offered a sustainable entry to the synthesis of nonsymmetric biphenols from the readily
oxidized phenols and 2-naphthols. A combination of control experiments and kinetic studies
pointed to the mechanism shown in Scheme 1.13 (bottom). The catalytic cycle starts with the
formation of a dinuclear µ-peroxo species of CoIII, which is in equilibrium with the active CoIIIsuperoxide (a). A ligated intermediate with CoIII-superoxide (b) is formed when the substituted
naphthol was introduced, which readily undergoes a hydrogen atom abstraction from a phenol
substrate to generate a CoIII-hydrogen peroxide (c) meanwhile liberating a phenoxyl radical. The
subsequent steps were kinetically invisible in the proposed cycle, the author suggested a rapid
consecutive proton-coupled electron transfer (PCET) from the naphthol to the ligated CoIIIhydrogen peroxide, which released a CoII-ligated napthoxyl radical intermediate (d). At this stage,
the two radical species underwent a coupling reaction and afford biphenol as the product. The
14

chemo-selectivity observed in this reaction thus can be attributed to the distinct roles of two
phenols during the HAT and PCET processes. Except for aerobic oxidative coupling reactions,
Co(salen) has also

been used for the

aerobic oxidative polymerization of 2,3-

dihydroxynaphthalene40 and polyphenol oxidation.41 These studies will not be discussed in this
chapter.

Scheme 1.13. Co(salen)-Catalyzed Aerobic Oxidative Cross-Coupling of Phenols in the WasteFree System.
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1.3.

Conclusion

This chapter highlights the significance of developing transition-metal catalyzed oxidative
reactions employing molecular oxygen as the stoichiometric oxidant. Two types of metalloenzyme
mimic oxidation are introduced, which provide fundamental framework for a vast array of
developments of the “oxygenase-type” and “oxidase-type” reactions. Advancements of three
major classes of oxidative transformations mediated by Co/O2 over the past few decades were
especially addressed, the Mukaiyama oxidative cyclization, the aerobic oxidation catalyzed by
Co/NHPI co-catalyst system, and a variety of powerful transformations facilitated by Co(salen)/O2
system with and without a p-hydroquinone co-mediator. The ideas underlying these brilliant works
have inspired the methodology developments and related mechanistic investigations in the next
three chapters. A journey towards the development of cobalt-catalyzed aerobic oxidative
cyclization reactions with bis-nucleophiles will be uncovered, and the key concepts mentioned in
this chapter regarding O2 carrier chemistry, hydrogen atom transfer (HAT) strategies as well as the
role of redox-mediators in Co/O2-catalyzed oxidation will be well-reflected in the following works.
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Chapter 2. Cobalt-Catalyzed Aerobic Oxidative Cyclization of 2Aminophenols with Isonitriles: 2-Aminophenol Enabled O2 Activation
by Cobalt(II)

2.1. Introduction

The recent decade has witnessed tremendous advances in homogeneous transition-metalcatalyzed aerobic oxidation reactions due to the environmentally benign nature of molecular O2 as
oxidant. As an alternative of widely explored Pd42,

43

and Cu44,

45

catalysts in these aerobic

oxidation reactions, cobalt has received considerable attention being an earth-abundant first-row
transition metal. However, in the cobalt-mediated aerobic oxidative reactions, redox-active comediators, such as benzoquinone (BQ)33, N-hydroxyphthalimide (NHPI)23, 24 and salen ligands46,
47

are often employed to enable the activation of molecular oxygen as the terminal oxidant. There

are fewer examples of cobalt-catalyzed aerobic oxidation reactions that operate efficiently in the
absence of external redox-active co-mediators, despite a surge of studies in Co/O2-mediated
organic transformations.15, 48, 49
Achieving aerobic oxidative transformations without requiring external redox-comediators
may be particularly challenging as these mediators have been shown in a recent study to prevent
the accumulation of peroxide and superoxide intermediates which lead to the generation of
undesired oxygenation side products.

33

Inspired by O2 activation routes in oxidation reactions

mediated by Co/BQ and Co/NHPI systems (Scheme 2.1a,b), we hypothesized the dual
functionality of a substrate also acts as a hydrogen atom donor that is able to activate molecular
oxygen via hydrogen atom transfer (HAT) and therefore selectively oxidize the substrate (Scheme
2.1c). We chose 2-aminophenol as a coupling partner to test our hypothesis due to its relevance to
metalloenzymes. Cobalt-containing biomimetic catecholase with N,O donor Schiff-base ligands
enables oxidation of a catechol derivative to its corresponding quinone with concomitant reduction
of O2 to H2O.50-52 Related N,O-based scaffolds such as o-aminophenol derivatives are also
commonly explored in cobalt complexes as redox-active ligands.53 We propose a phenoxyl radical
generated in situ in the presence of cobalt catalyst and O2, which can be trapped efficiently with
the proper choice of a coupling partner. Because isonitriles are versatile chemical entities capable
17

of reacting as electrophiles and nucleophiles, directing this tunable reactivity with metal complexes
provides a rapid entry to a vast array of pharmaceutically valuable nitrogenous molecular
structures.54-56

The coupling of 2-aminophenols with isonitriles gives rise to a variety of

substituted 2-aminobenzoxazoles;57 however, the aerobic routes to access these medicinally and
biologically important structures are quite limited.58

Scheme 2.1. Redox-Active Mediators in Cobalt-Mediated Aerobic Oxidative Reactions in
Enabling O2 Activation in Prior Studies and This Work. (a) Hydroquinone (H2Q) as a RedoxActive Mediator. (b) N-Hydroxyphthalimide (NHPI) as a Redox-Active Mediator. (c) Hypothesis
of This Work: The Dual Functionality of 2-Aminophenol as Both a Redox-Active Mediator and a
Substrate.

2.2 Results
2.2.1. Condition Optimization for Cobalt-Catalyzed Oxidative Cyclization of 2-Aminophenol
with tert-Butyl Isonitrile

We began our studies by evaluating the coupling reaction of 2-aminophenol (1a) and tertbutyl isonitrile (2a) using air as the supply of the terminal oxidant. In our early studies, air
efficiently promoted the oxidative cyclization of these two coupling partners in THF solvent. Of
18

all Co(II) catalysts being examined, Co(OAc)2 gave the highest yield of the substituted
2-aminobenzoxazole product 3a. When the solvent is switched to CH3CN, 3a was achieved in 93%
yield. Shorter reaction times led to slightly reduced yields (entry 12 and 13). A variety of bases
were also screened in condition optimization. Though in some cases they afforded the target
benzoxazole in high yields they were proved to be a non-necessary component for this reaction
(See Table 2.5 in the experimental section). The final optimized reaction conditions featured a
simple but efficient combination of Co(OAc)2 as the catalyst, CH3CN as the solvent, and an air
balloon as the source of terminal oxidant. The reaction was carried out at 65 °C for 24 hours.
Control experiments were conducted in the absence of either air or Co(II) (Entry 14 and 15), which
afforded the desired product with 0% and 14% yields respectively, indicating the importance of
both molecular oxygen and the Co(II) source in this oxidative cyclization transformation.
Table 2.1. Optimization of Reaction Conditionsa

Entry

Co Source

Solvent

Time (h)

% Yieldb

1

Co(acac)2

THF

24

58c

2

Co(acac)2•H2O

THF

24

67c

3

CoCO3

THF

24

51

4

CoCO3•H2O

THF

24

Trace

5

CoCl2

THF

24

46

6

Co(OAc)2

THF

24

86

7

Co(OAc)2

1,4-dioxane

24

89

8

Co(OAc)2

2-Me-THF

24

54

9

Co(OAc)2

DMF

24

86

10

Co(OAc)2

DMSO

24

78

11

Co(OAc)2

CH3CN

24

93(90)c

12

Co(OAc)2

CH3CN

12

85

13

Co(OAc)2

CH3CN

6

79

14

-

CH3CN

24

0

19

15d

Co(OAc)2

CH3CN

24

14

a

Reaction Conditions: 1a (0.3 mmol), 2a (0.3 mmol), cobalt(II) catalysts (10 mol%), solvent (3
mL), at 65 °C with an air balloon for 24 h. bThe yield of 3a was determined by 1H NMR
spectroscopy with dimethylsulfone as internal standard (0.03 mmol). cIsolated yield. dThe reaction
was conducted under N2.

2.2.2 Substrate Scope of Substituted 2-Aminophenols and Isonitriles
With optimized reaction condition in hand, we next explored the scope of substituted 2aminophenol coupling partners (1, Table 2.2). This protocol showed good tolerance of a variety of
functional groups including both electron-rich (3d, 3e, 3h, and 3i) and electron-deficient
substituents (3f, 3g, and 3k). The influence of a methyl group in each of the four aromatic positions
(3b, 3d, 3i, and 3l) reveals only a small steric effect, as the yield of 3b bearing the 3-methyl group
showed a slightly decreased yield. The 4-, 5-, and 6-methyl aminophenols all resulted in high
yields of the corresponding 2-aminobenzoxazoles. Similarly, the large phenyl and tert-butyl
groups afforded the desired cyclized products in good yields (3c and 3h). Finally, the di-substituted
electron-deficient 5-nitro-4-chloro-2-aminophenol 1m afforded the desired benzoxazole product
in 64% yield.
Table 2.2. Scope of Substituted 2-Aminophenolsa

a

Isolated Yields. Reaction conditions: 1 (0.3 mmol), 2a (0.3 mmol), and Co(OAc)2 (10 mol%) in
3 mL CH3CN at 65 °C with an air balloon for 24 h.
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To further evaluate the performance of this cyclization reaction, we investigated the scope
of isonitriles (2, Table 2.3). While tert-butylisonitrile is the most commonly employed isonitrile in
related coupling protocols,54, 59 other bulky aliphatic isonitriles are also excellent coupling partners
under our reaction conditions furnishing the corresponding products in high yields (3n, 3o and 3p).
Surprisingly, the isopropyl- and cyclohexyl-substituted isonitriles also generated high yields of the
corresponding 2-aminobenzoxazole products (3p and 3q). These products are expected to contain
weak C-H bonds (BDE = ~86 kcal mol-1)60 and are plausible substrates for further oxidation. The
benzylic isonitrile 2u, however, did not undergo efficient coupling and instead resulted in only a
moderate yield of the coupling product (3u, 32%). Also observed was the 3-aminobenzoxazine
byproduct (16% yield) which results from insertion of 2 equivalents of isontrile.61 Surprisingly, no
oxygenation byproducts were observed in this reaction, despite the weak C-H bond (~72
kcal·mol-1)62 and the precedent for Co/O2 enabled benzylic oxygenation.63 Finally, aryl isonitriles
also underwent coupling to yield the corresponding 2-aminobenzoxazole products, with the bulkier
aromatic ring of 1t resulting in the highest product yield.
Table 2.3. Scope of Substituted Isonitrilesa

a

Isolated Yields. Reaction conditions: 1a (0.3 mmol), 2 (0.3 mmol), and Co(OAc)2 (10 mol%) in
3 mL MeCN at 65 °C with an air balloon for 24 h.
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Although a wide variety of functional groups on the 2-aminophenol and isonitrile coupling
partners are well tolerated, we observed challenging substrates through our study for which
products could not be generated cleanly under the reported reaction conditions (Chart 2.1). This
protocol didn’t work efficiently for 2-aminophenol substrates bearing a halide in the 5-position.
5-bromo-2-aminophenol and 5-fluoro-2-aminophenol consistently gave the substituted 2aminobenzoxazole isomers with 5:1 ratio.

p-Toluenesulfonylmethyl isocyanide underwent

competitive oxidation reactions in the presence of O2 probably due to the liable C-H bond in
combination with the active sulfonyl group, and multiple products were generated. This protocol
was also not compatible with isonitriles bearing fused-ring systems. Both 1H-indol-5-yl
isocyanide and protected indol-5-yl isocyanide went through multiple reaction pathways. Similar
challenges were observed when 2-naphthyl isocyanide was subjected to the standard reaction
system which resulted in multiple unrecognizable products.

Chart 2.1. Products That Were Not Generated Cleanly Under the Reported Conditions

Reaction conditions: 1 (0.3 mmol), 2a (0.3 mmol), and Co(OAc)2 (10 mol%) in 3 mL CH3CN at
65 °C with an air balloon for 24 h.

2.2.3 Preliminary Mechanistic Investigations
2.2.3.1. Testing the Presence of Trappable Radical Intermediates
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The efficient coupling of isonitriles bearing weak C-H bonds suggested that a free-radical
intermediate is unlikely. To test our hypothesis, we sought to trap the free-radical intermediates by
a careful selection of radical scavengers. The three commonly used radical scavenger (2,2,6,6tetramethylpiperidin-1-yl)oxyl (TEMPO), 9,10-dihydroanthracene and 1,1-diphenylethylene
showed no evidence of trappable intermediates. Instead, high yields of 3a were still observed when
these reagents were included under the standard reaction conditions (Scheme 2.2a),64 which were
consistent with our hypothesis. When the same reactions are conducted in the absence of isonitrile,
oxidative dimerization of 2-aminophenol occurs to form 2-aminophenoxazine-3-one both in the
presence and absence of TEMPO (43% and 10% yields, respectively) (Scheme 2.2b),65 consistent
with the presence of aminophenol radicals.52, 66, 67 The elevated yield in the presence of TEMPO
could be a result of a TEMPO-mediated H-atom abstraction pathway to form the aminophenol
radical,68 where TEMPO was acting as a radical initiator rather than a radical-trapping agent.

Scheme 2.2. Aerobic Oxidative Cyclization Conducted in the Presence of Radical Trapping
Reagents.
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2.2.3.2. The Importance of O2 in Oxidative Cyclization and a Plausible Path for O2 Activation

We attribute the absence of a trappable intermediate to the possibility of a stabilized ligand
radical intermediate. A large series of CoII complexes of aminophenol-, aminothiophenol- and
phenylenediamine-derived ligands have been characterized.53, 55, 69-72 Wieghardt and coworkers
have shown aerobic oxidation of these species would form stabilized iminobenzosemiquinonatotype species bearing π-radical ligands (APSQ).70 In all of above mentioned cases highly-substituted
aminophenols are employed to avoid ligand dimerization and at the same time enable the formation
of stable oxidized complexes for isolation purpose. In our case, we believe a similar stabilized
ligand radical maybe formed under our reaction conditions from CoII catalyst, O2 and 2aminophenol. When isonitrile (CNR) is present, it is a sufficient trap for aminophenol radical while
in the absence of isonitrile, dimerization of 2-aminophenol occured and gave rise to 2aminophenoxazinone.
Then we conducted a series of control experiments in the absence of O2 to evaluate if O2 is
required for the formation of cyclized benzoxazole products or simply it is responsible for the
regeneration of CoII after the product formation (Scheme 2.3). When the standard reaction is
conducted with stoichiometric amount of Co(OAc)2 under inert atmosphere, only 10% of product
3a is obtained, suggesting the need for molecular oxygen to efficiently form the cyclized product.
The same reaction was conducted with stoichiometric amount of CoIII salt, Co(acac)3 under N2
atmosphere to test if CoIII species an active intermediate for this transformation. This time the
cyclized product was formed in 63% yield. The reduced yield obtained with Co(acac)3 related to
the standard catalytic conditions was attributed to the slow exchange of the acac ligand. To make
a parallel comparison, we set up a control experiment with CoII salt but the same acac ligand.
Consistent with our hypothesis, when the standard reaction was conducted with catalytic amount
of Co(acac)2 under aerobic atmosphere, 58% of 3a was obtained. These data combined suggested
that O2 is responsible for the oxidation of CoII to generate an active CoIII intermediate or a CoIIAPSQ
species with oxidized semiquinonato ligands.
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Scheme 2.3. Oxidative Cyclization of 2-Aminophenol and tert-Butyl Isonitrile Mediated by Cobalt
Under N2.

Given the importance of oxidation for product formation, we sought to better understand
the aerobic oxidation step of this transformation. The oxidation of CoII by molecular oxygen is
usually proposed to generate a CoIII-superoxide intermediate as demonstrated in a recent study by
Stahl, Hammes-Schiffer, and cowokers.33 In this study, molecular oxygen is activated by a
salophen-ligated CoII complex to form a CoIII-superoxide intermediate. This superoxide species is
responsible for H-atom transfer (HAT) from p-hydroquinone to generate a CoIII-hydroperoxide
intermediate. A second HAT sequence then followed to produce p-quinone with concomitant
release of H2O2 and regeneration of CoII(salophen). Under these reaction conditions, H2O2
underwent disproportionation to form H2O and O2 (Scheme 2.4a). Comparatively, the re-oxidation
of N-hydroxyphthalimide (NHPI) was proposed to go through an analogous HAT sequence.73 Thus
we imagined that a resembling CoIII-superoxide species may be responsible for HAT from 2aminophenol under our oxidative cyclization conditions (Scheme 2.4b). We proposed the
molecular oxygen activation by a CoII complex with coordination of two equivalents of
2-aminophenol ligands, which leads to the formation of the corresponding CoIII-superoxide as
suggested above. H2O2 is released after two stepwise HAT sequences from 2-aminophenol ligands
to peroxide, giving rise to the active CoIIAPSQ intermediate with two oxidized semiquinonato
ligands. Consequently, cyclized benzoxazole product is expected in the presence of isonitrile under
the aerobic oxidative reaction condition.
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Scheme 2.4. (a) Proposed Pathway for Co-Catalyzed Aerobic Oxidation of Catechol in Literature
and (b) Proposed Pathway for Aerobic 2-Aminophenol Oxidation in This Work.

2.2.3.3 Probing the Reaction Mechanism Through UV-Visible Studies

We conducted a series of UV-visible experiments to probe the oxidation step and
particularly the ligand environment that enables aerobic oxidation. Three parallel experiments
were set up with identical concentration of Co(acac)2 in acetonitrile to investigate potential
combination of reaction components that allows the activation of molecular oxygen. Due to the
limited solubility of Co(OAc)2 in CH3CN, Co(acac)2 was employed for these studies which also
showed catalytic competency in previous condition optimization. When Co(acac)2 was exposed to
air for 24 hours no changes in the absorption spectrum were observed (Figure 2.1a and Figure 2.5
in the Experimental section). Similarly, a mixture of 1:2 equivalents of Co(acac)2 and CNtBu in
CH3CN showed no significant changes in the spectroscopic features after exposure to air (Figure
2.1a and Figure 2.6 in the Experimental section). The mixture of Co(acac)2/CNtBu showed
identical maximum absorption with Co(acac)2 in CH3CN because the absorption of CNtBu can
only be detected in the vacuum UV region (λmax~140 nm). In contrast, when a solution of 1:2 ratio
of Co(acac)2 and 2-aminophenol was exposed to air a rapid color change was observed from light
pink to orange-brown within minutes. This rapid color change was accompanied by an increase in
the absorption around 260 nm (Figure 2.1b and Figure 2.7 in the Experimental section). This set
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of preliminary data suggested the activation of molecular oxygen only happen in an environment
with 2-aminophenol coordination.

(a)

(b)

Figure 2.1. (a) Absorption spectrum of Co(acac)2 only and Co(acac)2 with CNtBu in CH3CN under
N2 and after exposed to air overnight. (b) Absorption spectrum of Co(acac)2 and 2-aminophenol
under N2 and after exposed to air overnight. These experiments were conducted at 5.05×10-5M
concentration in CH3CN.

Based on the above observations, we ruled out the possibility of efficient O2 activation
mediated by CoII only or CoII/CNtBu. We next investigated if the prolonged exposure of CoII and
2-aminophenol mixture under air led to the formation of a CoIII intermediate. To test our hypothesis,
another set of parallel control experiments were conducted. If the absorption maxima of CoII/2aminphenol mixture are analogous to those of CoIII/2-aminophenol mixture in the presence of O2,
a CoIII intermediate may exist in our related catalytic system. In the first experiment, the spectrum
of the mixture of 1:3 ratio of Co(acac)2 and 2-aminophenol was taken under anaerobic atmosphere,
no spectroscopic changes were observed with extended period of time. When the same solution
was exposed to air, we observed a trend of color change comparable to 1:2 ratio mixture and a
band around 260 nm on the absorption spectrum was appeared (Figure 2.2). This spectroscopic
feature is similar to that observed when Co(acac)3 is combined with 2-aminophenol (λmax= 233 nm,
Figure 2.2, Figure 2.8 and Figure 2.9 in the Experimental section). In a related Co system bearing
catechol ligands, the semiquinonato species can be obtained when CoIII starting materials are
treated with catechol.74, 75 A related redox-equilibrium to access CoII(APSQ) from CoIII may be
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operative in these aminophenol systems. The absorption band around 410~430 nm of final trace
spectrum

of

Co(acac)3 and

2-aminphenol

mixture

demonstrated

the

presence

of

2-aminophenoxazine-3-one, the dimerized product of 2-aminophenol under aerobic condition we
had observed in the previous control experiment (Scheme 2.2b). This again might be attributed to
the slow exchange of the acac ligand and the rate of aminophenol oxidation exceeded the rate of
ligand exchange. Overall, these spectroscopic changes suggest aerobic oxidation of CoII is
facilitated by the presence of 2-aminophenol.

Figure 2.2. Absorption spectrum of Co(acac)2 with 2-aminophenol in CH3CN under N2 and after
exposed to air overnight stacked with the final trace spectrum of Co(acac)3 with 2-aminophenol
under air exposure. These experiments were conducted at 5.05×10-5 M concentration in CH3CN.

2.2.3.4. Other Considerations
In related Pd-catalyzed cyclization reactions of aminophenols with isonitriles, the C−N
bond-forming step is proposed to proceed via the migratory insertion of the CNR ligand. 61 Based
on our spectroscopic studies and related literature precedence, we have proposed a plausible
intermediate resulting from the O2 activation upon the coordination of 2-aminophenol to cobalt
center. Although our work here has focused on the step of aerobic oxidation of CoII, we consider
the subsequent coupling of the oxidized intermediate with isonitrile may also interest some
researchers. Though the investigation of this particular step is not our primary intention, we expect
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a radical-based addition to CNR may be operative given the presence of the proposed semiquinoate
radical intermediates; 54, 59however, future endeavors are required to gain a deeper insight into this
step of interest.

2.3. Conclusive Summary
In summary, we have developed a convenient and atom efficient route towards the
synthesis of 2-aminobenxazoles utilizing an additive free cobalt catalyst system under aerobic
conditions. A broad scope of substituted 2-aminophenols and isonitriles are well tolerated. Finally,
the importance of 2-aminophenol acting as a ligand to facilitate the aerobic oxidation of Co II was
confirmed with a series of UV-visible studies. Future work is directed toward the isolation and
characterization of the relevant aminophenol ligated cobalt intermediates.

2.4. Experimental Section
2.4.1. General Considerations
All synthetic reactions were performed on the benchtop unless otherwise noted. All proteo
solvents were taken from a Glass Contours solvent system, in which the solvent is passed through
a column of activated alumina with a pressure of Argon. All other commercial reagents and NMR
solvents were used without further purification unless otherwise stated.
1

H and 13C{1H} NMR spectra were recorded on an Agilent 400 MHz spectrometer, JEOL

400 MHz spectrometer, or a Varian INOVA 600 MHz spectrometer at room temperature, unless
otherwise noted. Chemical shifts (δ) are given in parts per million and referenced to the residual
solvent signal76 and all coupling constants (J) are reported in Hz. IR spectra were recorded on a
Perkin Elmer (Spectrum 100) FT-IR spectrometer. UV-visible spectra were recorded on a Stellar
Net Inc. Black Comet Concave Grating Spectrometer with a SL5 Deuterium/Halogen combination
lamp and dip probe or Shimadzu UV 1800. High resolution mass spectra were obtained on a
Thermofisher Scientific Q Exactive Mass Spectrometer.
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2.4.2 Procedure for Screening of the Reaction Conditions
2-Aminophenol (32.7 mg, 0.300 mmol) and cobalt (II) acetate (5.31 mg, 0.0300 mmol)
were combined in a 6-inch test tube in a N2 filled glovebox, and CH3CN (3.00 mL) and
tert-butylisonitrile (35.2 L, 0.300 mmol) were added. The test tube was then sealed with a septum,
removed the glovebox, and fitted with an air balloon attached to a needle inserted through the
septum. The reaction mixture was then stirred at 65 °C for 24 h. Upon completion, the mixture was
cooled to room temperature and filtered through a Pasteur pipette silica gel plug. Ethyl acetate (15
mL) was then passed through the plug and the resulting filtrate was concentrated by rotary
evaporation to yield a solid. Dimethylsulfone (3.00 mg, 0.0318 mmol), used as a 1H NMR standard,
was added to the solid residue and the crude mixture was dissolved in CDCl3 for 1H NMR analysis.
All of the optimization reactions in Tables 2.4, 2.5, and 2.6 were conducted following the standard
procedure except for those employing Co(acac)2 or Co(acac)2·H2O. In these cases, the percent
yield of the product was determined by column purification (gradient elution from pure hexane to
ethyl acetate: hexanes = 1:3) due to the difficulties in removing cobalt from the crude mixture.

Table 2.4. Optimization of the reaction temperature and base in the oxidative cyclization of 2aminophenol and tert-butylisonitrile. a

Entry

Temp (oC)

Base

% Yieldb

65
1
NaOAc
98
80
2
NaOAc
98
65
3
Na2CO3
78
80
4
Na2CO3
>99
65
5
93
80
6
91
a
Reaction conditions: 1a (0.300 mmol), 2a (0.300 mmol), Co(OAc)2 (0.0300 mmol), and base
(0.0600 mmol) in CH3CN (3.00 mL) with an air balloon at 65 °C for 24 h. bThe yield of 3a was
determined by 1H NMR spectroscopy with dimethylsulfone as internal standard (0.03 mmol).
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Table 2.5. Optimization of the base in the oxidative cyclization of 2-aminophenol and
tert-butylisonitrile.a

Entry

Base

% Yieldb

1
Na2CO3
78
2
NaOAc
98
3
LiOAc
84
4
Li2CO3
87
5
KOAc
82
6
K2CO3
31
7
None
86
a
Reaction conditions: 1a (0.300 mmol), 2a (0.300 mmol), Co(OAc)2 (0.0300 mmol), and base
(0.0600 mmol) in CH3CN (3.00 mL) with an air balloon at 65 °C for 24 h. bThe yield of 3a was
determined by 1H NMR spectroscopy with dimethylsulfone as internal standard (0.03 mmol).
Base was not incorporated in the final catalytic system because base-free reactions gave
comparable yields, while enabling a more straight-forward and reliable workup procedure.

Table 2.6. Optimization of the catalyst loading and reaction time in the oxidative cyclization of
2-aminophenol and tert-butylisonitrile.a

Co loading
Time (h)
% Yieldb
(mol%)
6
1
10
79
12
2
10
85
24
3
10
93
24
4
5
78
a
Reaction conditions: 1a (0.300 mmol), 2a (0.300 mmol) and Co(OAc)2 (0.0300 mmol) in CH3CN
(3.00 mL) with an air balloon at 65 °C for 24 h. bThe yield of 3a was determined by 1H NMR
spectroscopy with dimethylsulfone as internal standard (0.03 mmol).
Entry
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2.4.3. Synthesis and Characterization of the 2-Aminobenzoxazoles

Representative procedure for the synthesis of 2-aminobenzoxazoles
2-(tert-butylamino) benzoxazole (3a). 2-aminophenol (32.7 mg, 0.300 mmol) and cobalt(II)
acetate (5.31 mg, 0.0300 mmol) were combined in a 6-inch test tube inside a N2 filled glovebox,
and dissolved in dry CH3CN (3 mL). tert-Butyl isocyanide (35.2 L, 0.300 mmol) was added to
the same test tube before it was sealed with a septum and removed from the glovebox. The reaction
mixture was then stirred in an oil bath at 65 °C for 24 hours with an air balloon attached to a syringe
with a needle inserted through the septum. Upon completion, the reaction mixture was cooled to
room temperature and filtered through a Pasteur pipette silica gel plug and washed with ethyl
acetate (~15 mL). The resulting filtrate was concentrated by rotary evaporation and the resulting
solid was purified by silica column flash chromatography (gradient elution from the pure hexanes
to 25% ethyl acetate in hexanes, Rf = 0.5 in 3:1 hexanes : ethyl acetate), to give the title compound
as a brown solid in 90 % yield (51.3 mg, 0.270 mmol). All 2-aminobenzoxazoles were prepared
according the standard procedure unless otherwise noted.

2-(tert-butylamino) benzoxazole (3a). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (25% ethyl acetate in hexane,
Rf = 0.5 in 3:1 hexanes : ethyl acetate) to yield 51.25 mg (0.27 mmol, 90%) of the title product as
a brown solid. 1H NMR (400 MHz, CDCl3) δ = 7.37 (dd, 1H), 7.25 (dd, 1H), 7.16 (td, J = 7.7, 1.1
Hz, 1H), 7.02 (td, J = 7.8, 1.1 Hz, 1H), 5.75 (s, 1H), 1.51 (s, 9H). 13C NMR (100 MHz, CDCl3): δ
= 161.43, 148.25, 143.04, 123.75, 120.47, 116.12, 108.62, 52.09, 29.37. The spectral data are
consistent with those reported in the literature. 77, 78
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4-methyl-2-(tert-butylamino)benzoxazole (3b). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (25% ethyl acetate in
hexane, Rf = 0.7 in 3:1 hexanes : ethyl acetate) to yield 27.5 mg (0.13 mmol, 45%) of the title
compound as a yellow solid. 1H NMR (400 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.10 (dd,
J = 7.7, 0.6 Hz, 1H), 6.95 (ddd, J = 24.5, 8.2, 4.1 Hz, 2H), 4.94 (s, 1H), 2.48 (s, 3H), 1.49 (s, 9H).
C-NMR (100 MHz, CDCl3): δ = 160.60, 147.97, 141.58, 126.49, 124.61, 120.32, 106.14, 52.20,
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29.36, 16.37. HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H16N2O 205.1263; found 205.1336. The
spectral data are consistent with those reported in the literature.58

5-phenyl-2-(tert-butylamino)benzoxazole. (3c) The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (20% ethyl acetate in
hexane, Rf = 0.3 in 3:1 hexanes: ethyl acetate) to yield 75.9 mg (0.28 mmol, 95%) of the title
compound as an off-white solid (m.p. 129-131 °C). 1H NMR (400 MHz, CDCl3): δ = 7.61 (d, J =
7.7 Hz, 3H), 7.44 (t, J = 7.6 Hz, 2H), 7.29 (dt, J = 18.5, 8.0 Hz, 3H), 5.63 (s, 1H), 1.52 (s, 9H). 13C
NMR (400 MHz, CDCl3): δ = 161.56, 147.90, 143.88, 141.84, 137.60, 128.80, 127.40, 126.92,
120.04, 115.08, 108.58, 52.21, 29.35. HRMS (ESI-MS, m/z) [M+H]+ calcd for C17H18N2O
267.1419; found 267.1492. The spectral data are consistent with those reported in the literature.79

5-methyl-2-(tert-butylamino)benzoxazole (3d). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (25% ethyl acetate in
hexane, Rf = 0.6 in 3:1 hexanes : ethyl acetate) to yield 52.7 mg (0.26 mmol, 86%) of the title
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compound as a yellow solid. 1H NMR (400 MHz, CDCl3): δ = 7.18 (d, J = 0.6 Hz, 1H), 7.11 (d, J
= 8.1 Hz, 1H), 6.84 – 6.79 (m, 1H), 5.24 (s, 1H), 2.39 (s, 3H), 1.49 (s, 9H). 13C NMR (100 MHz,
CDCl3): δ = 161.20, 146.42, 143.37, 133.43, 121.32, 116.86, 108.00, 52.12, 29.36, 21.62. HRMS
(ESI-MS, m/z) [M+H]+ calcd for C12H16N2O 205.1263; found 205.1337. The spectral data are
consistent with those reported in the literature.61

-methoxy-2-(tert-butylamino)benzoxazole (3e). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (gradient elution from
pure hexanes to hexanes : ethyl acetate = 3:1, Rf = 0.4 in 3:1 hexanes : ethyl acetate) to yield 58.0
mg (0.263 mmol, 74%) of the title compound as a brown solid (m.p.= 111-113 °C) . 1H NMR (400
MHz, CDCl3): δ = 7.10 (d, J = 8.7 Hz, 1H), 6.94 (d, J = 2.4 Hz, 1H), 6.57 (dd, J = 8.6, 2.5 Hz,
1H), 5.32 (s, 1H), 3.80 (s, 3H), 1.48 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 161.82, 156.95,
144.21, 142.77, 108.45, 107.20, 101.56, 56.02, 52.12, 29.33. HRMS (ESI-MS, m/z) [M+H]+ calcd
for C12H16N2O2 221.1212; found 221.1249. The spectral data are consistent with those reported in
the literature.61

5-nitro-2-(tert-butylamino)benzoxazole (3f). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (gradient elution from pure
hexanes to 3:1 hexanes: ethyl acetate, Rf = 0.55 in 3:1 hexanes: ethyl acetate) to yield 56.5 mg
(0.240 mmol, 80 %) of the title compound as a yellow solid. 1H NMR (400 MHz, CDCl3): δ =
8.17 (d, J = 2.2 Hz, 1H), 7.97 (dd, J = 8.7, 2.3 Hz, 1H), 7.25 (d, J = 8.8 Hz, 1H), 5.36 (s, 1H),
1.50 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 162.57, 152.26, 145.02, 144.26, 117.31, 111.86,
108.23, 52.76, 29.08. HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H13N3O3 236.0957; found
236.1030. The spectral data are consistent with those reported in the literature.58
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5-bromo-2-(tert-butylamino)benzoxazole (3g). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (20% ethyl acetate in
hexane, Rf = 0.7 in 3:1 hexanes: ethyl acetate) to yield 72.6 mg (0.27 mmol, 90%) of the title
compound as a yellow solid (mp = 102-104 °C). 1H NMR (400 MHz, CDCl3) δ = 7.46 (s, 1H),
7.16 – 7.03 (m, 2H), 5.57 (s, 1H), 1.49 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 162.50,
147.87, 145.43, 123.30, 119.46, 116.41, 109.72, 52.42, 29.34. IR (ATR, cm-1): 162.50, 147.87,
145.43, 123.30, 119.46, 116.41, 109.72, 52.42, 29.34. HRMS (ESI-MS, m/z) [M+H]+ calcd for
C11H13BrN2O 269.0211; found 269.0287. The spectral data are consistent with those reported in
the literature.61

5-tert-butyl-2-(tert-butylamino)benzoxazole (3h). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (20% ethyl
acetate in hexane, Rf = 0.7 in 3:1 hexanes: ethyl acetate) to yield 69.0 mg (0.28 mol, 93%) of the
title compound as a pink solid (mp =121-123 °C). 1H NMR (400 MHz, CDCl3) δ = 7.44 (d, J = 1.6
Hz, 1H), 7.13 (d, J = 8.4 Hz, 1H), 7.04 (dd, J = 8.4, 1.9 Hz, 1H), 5.07 (s, 1H), 1.48 (s, 9H), 1.33
(s, 9H). 13C NMR (150 MHz, CDCl3): δ = 161.09, 147.18, 146.0, 143.05, 117.87, 113.57, 107.69,
52.04, 34.90, 31.94, 29.26. IR (ATR, cm-1): 3248 (w), 2964 (m), 1640 (s), 1582 (s), 1428 (m),
1480 (m), 1216 (s), 912 (w), 801 (m), 653 (m). HRMS (ESI-MS, m/z) [M+H]+ calcd for C15H22N2O
247.1732; found 247.1805.
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6-methyl-2-(tert-butylamino)benzoxazole (3i). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (25% ethyl acetate in hexane,
Rf = 0.7 in 3:1 hexanes : ethyl acetate) to yield 51.0 mg (0.25 mmol, 83%) of the title compound
as a yellow solid (mp = 104-106 °C). 1H NMR (400 MHz, CDCl3): δ = 7.23 (d, J = 7.9 Hz, 1H),
7.06 (s, 1H), 6.95 (dd, J = 7.9, 0.8 Hz, 1H), 5.44 (s, 1H), 2.38 (s, 3H), 1.47 (s, 9H). 13C NMR (100
MHz, CDCl3): δ = 160.87, 148.44, 140.76, 130.58, 124.44, 115.71, 109.24, 52.04, 29.36, 21.53.
HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H16N2O 205.1263; found 205.1335. The spectral data
are consistent with those reported in the literature.80

6-methoxy-2-(tert-butylamino) benzoxazole (3j). The title compound was synthesized according
to the standard procedure on a larger scale. 2-amino-5-methoxyphenol (83.5 mg, 0.600 mmol) and
cobalt(II) acetate (10.6 mg, 0.0600 mmol) were combined in a 6-inch test tube inside a N2 filled
glovebox, and dissolved in dry CH3CN (5 mL). tert-Butyl isocyanide (70.4 L, 0.600 mmol) was
added to the test tube before it was sealed with a septum and removed from the glovebox. The
reaction mixture was then stirred in an oil bath at 65 °C for 24 hours with an air balloon attached
to a syringe and needle inserted through the septum. Upon completion, the reaction mixture was
cooled to room temperature and was filtered through a pad of celite. The resulting filtrate was
stirred with saturated EDTA solution (100 mL) for three hours, extracted with ethyl acetate (50
mL) and the layers were separated. The aqueous layer was extracted twice with ethyl acetate (2 x
30 mL) and the combined organic layers were washed with saturated sodium chloride solution (80
mL), separated, dried over anhydrous sodium sulfate and concentrated by rotary evaporation to 3
mL. The concentrated crude mixture was passed through a silica gel pipette column, which was
then washed with ethyl acetate (10 mL). This step removes any remaining cobalt from the crude
mixture. The resulting filtrate was concentrated by rotary evaporation and the resulting solid was
purified by silica column flash chromatography (gradient elution from the pure hexanes to hexanes:
ethyl acetate = 8:1, Rf = 0.3 in 4:1 hexanes : ethyl acetate), to give the title compound as a light
brown solid in 31 % yield (40.9 mg, 0.186 mmol). m.p. = 82-84 °C. 1H NMR (400 MHz, CDCl3):
δ 7.23 (d, J = 8.5 Hz, 1H), 6.86 (s, 1H), 6.73 (dd, J = 8.4, 1.8 Hz, 1H), 5.18 (s, 1H), 3.79 (s, 3H),
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1.47 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 160.34, 155.20, 148.71, 136.88, 116.18, 109.97,
95.85, 56.21, 52.09, 29.30. IR (ATR, cm-1): 3197 (w), 2966 (m), 2834 (w), 1640 (s), 1584 (s),
1486 (s), 1441 (m), 1362 (m), 1270 (m), 1202 (s), 1138 (s), 1027 (m), 996 (m), 863 (w), 803(w).
HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H16N2O2 221.1285; found 221.1276.

6-nitro-2-(tert-butylamino)benzoxazole (3k). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (25% ethyl acetate in hexane,
Rf = 0.5 in 3:1 hexanes : ethyl acetate) to yield 51.4 mg (0.22 mmol, 73%) of the title compound
as a yellow solid. 1H NMR (400 MHz, CDCl3): δ = 8.21 – 8.07 (m, 2H), 7.33 (d, J = 8.7 Hz, 1H),
5.77 (s, 1H), 1.53 (s, 9H). 13C NMR (100MHz, CDCl3): δ = 163.96 150.03, 147.32, 141.50, 121.28,
114.95, 104.99, 53.02, 29.13. HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H13N3O3 236.0957;
found 236.1029. The spectral data are consistent with those reported in the literature.80

7-methyl-2-(tert-butylamino)benzoxazole (3l). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (20% ethyl acetate in hexane,
Rf = 0.7 in 3:1 hexanes : ethyl acetate) to yield 47.7 mg (0.23 mmol, 78%) of the title compound
as a yellow solid. 1H NMR (400 MHz, CDCl3): δ = 7.10 (d, J = 8.7 Hz, 1H), 6.94 (d, J = 2.4 Hz,
1H), 6.57 (dd, J = 8.6, 2.5 Hz, 1H), 5.32 (s, 1H), 3.80 (s, 3H), 1.48 (s, 9H). 13C NMR (100 MHz,
CDCl3): δ = 160.96, 147.25, 142.78, 123.63, 122.14, 118.98, 113.85, 52.08, 29.39, 15.04. IR
(ATR, cm-1): 3359 (w), 2977 (w), 1740 (s), 1642 (s), 1580 (s), 1459 (w), 1370 (w), 1270 (m), 1239
(s), 1046 (m), 775 (m), 740 (m). HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H16N2O 205.1263;
found 205.1336.
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6-nitro-5-chloro-2-(tert-butylamino)benzoxazole (3m). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (gradient
elution from pure hexanes to 1:1 hexanes: ethyl acetate, Rf = 0.5 in 3:1 hexanes : ethyl acetate) to
yield 51.8 mg (0.192 mmol, 64%) of the title compound as a fluffy yellow solid (m.p. = 165167 °C). 1H NMR (400 MHz, CDCl3): δ = 7.90 (s, 1H), 7.37 (s, 1H), 5.80 (s, 1H), 1.52 (s, 9H).
C NMR (100MHz, CDCl3): δ = 164.44, 149.04, 145.97, 140.20, 124.61, 118.00, 106.94, 53.23,

13

29.05. IR (ATR, cm-1): 3203 (w), 2980 (w), 1655 (s), 1575 (s), 1454 (s), 1313 (s), 1263 (s), 1213
(s), 1011 (m), 906 (m), 872 (m), 832 (m), 729 (m), 669 (w). HRMS (ESI-MS, m/z) [M+H]+ calcd
for C11H12ClN3O3 270.0567; found 270.0640.

2-(cyclohexylamino)benzoxazole (3n). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (20% ethyl acetate in hexane,
Rf = 0.3 in hexanes: ethyl acetate) to yield 47.3 mg (0.22 mmol, 73%) of the title compound as a
white solid. 1H NMR (600 MHz, CDCl3) δ = 7.35 (d, J = 7.7 Hz, 1H), 7.23 (d, J=7.7Hz, 1H), 7.15
(td, J = 7.7, 0.9 Hz, 1H), 7.01 (t, J = 7.7 Hz, 1H), 5.14 (s, 1H), 3.76 (s, 1H), 2.13 (dd, J = 12.4, 3.1
Hz, 2H), 1.85 – 1.71 (m, 2H), 1.70 – 1.60 (m, 1H), 1.51 – 1.38 (m, 2H), 1.26 (dddd, J = 24.9, 15.5,
9.9, 3.4 Hz, 3H). 13C NMR (150 MHz, CDCl3): δ = 161.50, 148.47, 143.08, 123.98, 120.81, 116.29,
108.76, 52.17, 33.57, 25.63, 24.87. HRMS (ESI-MS, m/z) [M+H]+ calcd for C13H16N2O 217.1263;
found 217.1335. The spectral data are consistent with those reported in the literature.81
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2-(1-admantylamino)benzoxazole (3o). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (25% ethyl acetate in hexanes,
Rf = 0.7 in 3:1 hexanes: ethyl acetate) to yield 78.9 mg (0.29 mmol, 98.0 %) of the title compound
as a pink solid (m.p. = 160-162 °C). 1H NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 7.8 Hz, 1H),
7.26 – 7.21 (d, J = 7.8Hz, 1H), 7.14 (t, J = 7.7 Hz, 1H), 7.01 (t, J = 7.7 Hz, 1H), 5.20 (s, 1H), 2.13
(d, J = 21.4 Hz, 9H), 1.79 – 1.67 (m, 6H).

13

C NMR (100 MHz, CDCl3): δ = 160.67, 148.15,

143.21, 123.78, 120.65, 116.34, 108.60, 52.47, 42.18, 36.29, 29.63. IR (ATR, cm-1): 3243 (w),
2903 (m), 2851 (w), 1635 (s), 1576 (s), 1460 (m), 1357 (w), 1233 (m), 1011 (w), 813 (w), 740 (m).
HRMS (ESI-MS, m/z) [M+H]+ calcd for C17H20N2O 269.1576; found 269.1648.

2-(1,1,3,3-tetramethylbutylamino)benzoxazole (3p). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (gradient
elution from pure hexanes to 4:1 hexanes: ethyl acetate, Rf = 0.30 in 3:1 hexanes : ethyl acetate) to
yield 62.8 mg (0.255 mmol, 85 %) of the title compound as a light yellow solid (m.p.=109-110 o
C). 1H NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 7.7 Hz, 1H), 7.23 (d, J = 8.0 Hz, 1H), 7.14 (td, J
= 7.7, 1.0 Hz, 1H), 7.00 (td, J = 7.7, 1.1 Hz, 1H), 5.54 (s, 1H), 1.84 (s, 2H), 1.53 (s, 6H), 1.00 (s,
9H). 13C NMR (100 MHz, CDCl3): δ = 160.99, 148.21, 143.33, 123.76, 120.48, 116.30, 108.59,
55.81, 51.90, 31.82, 31.59, 28.85. IR (ATR, cm-1): 3239 (w), 2950 (m), 1655 (s), 1640 (s), 1579
(s), 1459 (s), 1149 (w), 1009 (w), 927 (w), 847 (w), 754 (m), 740 (s). HRMS (ESI-MS, m/z)
[M+H]+ calcd for C15H22N2O 247.1732; found 247.1806.

2-(isopropylamino)benzoxazole (3q). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (gradient elution from pure
hexanes to 4:1 hexanes : ethyl acetate, Rf = 0.30 in 3:1 hexanes : ethyl acetate) to yield 41.7 mg
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(0.237 mmol, 79 %) of the title compound as a light yellow solid. 1H NMR (400 MHz, CDCl3): δ
= 7.35 (d, J = 7.8 Hz, 1H), 7.28 – 7.20 (m, 1H), 7.15 (dd, J = 11.3, 4.0 Hz, 1H), 7.06 – 6.97 (m,
1H), 5.44 (s, 1H), 4.08 (s, 1H) 1.33 (d, J = 6.5 Hz, 7H). 13C NMR (100 MHz, CDCl3): δ = 161.63,
148.47, 143.09, 123.95, 120.73, 116.19, 108.78, 45.45, 23.25. HRMS (ESI-MS, m/z) [M+H]+
calcd for C10H12N2O 177.0950; found 177.1023. The spectral data are consistent with those
reported in the literature.82

2-(4-methoxyphenylamino)benzoxazole (3r). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (gradient elution from pure
hexanes to 1:1 hexanes: ethyl acetate, Rf = 0.55 in 3:1 hexanes : ethyl acetate) to yield 25.6 mg
(0.107 mmol, 36 %) of the title compound as a light yellow solid (m.p.= 137-139 o C). 1H NMR
(400 MHz, CDCl3): δ = 8.77 (s, 1H), 7.52 – 7.45 (m, 2H), 7.40 (d, J = 7.8 Hz, 1H), 7.31 (d, J =
8.0 Hz, 1H), 7.20 (td, J = 7.7, 1.0 Hz, 1H), 7.08 (td, J = 7.8, 1.1 Hz, 1H), 6.96 – 6.89 (m, 2H), 3.80
(s, 3H). 13C NMR (100 MHz, CDCl3): δ = 156.26, 142.36, 131.16, 124.4, 121.55, 121.19, 116.73,
114.72, 109.21, 55.70. HRMS (ESI-MS, m/z) [M+H]+ calcd for C14H12N2O2 241.0972; found
241.0965. The spectral data are consistent with those reported in the literature.83

2-(6-chloro-2-methylphenylamino)benzoxazole (3s). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (gradient
elution from pure hexanes to 4:1 hexanes : ethyl acetate , Rf = 0.40 in 3:1 hexanes : ethyl acetate)
to yield 28.5 mg (0.110 mmol, 37 %) of the title compound as a light yellow solid (m.p.=166168 °C). 1H NMR (600 MHz, CDCl3): δ = 7.83 (s, 1H), 7.34 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 6.9
Hz, 1H), 7.26 – 7.13 (m, 3H), 7.07 (t, J = 7.7 Hz, 1H), 2.39 (s, 3H). 13C NMR (100 MHz, CDCl3):
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δ = 138.14, 133.21, 132.00, 129.82, 129.63, 128.08, 127.63, 124.24, 121.70, 117.16, 109.33, 19.01.
IR (ATR, cm-1): 2984 (w), 1639 (m), 1582 (m), 1460 (m), 1372 (m), 1238 (s), 1045 (s), 938 (w),
847 (w), 744 (w), 672 (w). HRMS (ESI-MS, m/z) [M+H]+ calcd for C14H11ClN2O 259.0560; found
259.0632.

2-(2,6-dimethylphenylamino)benzoxazole (3t). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (gradient elution from
pure hexanes to 4:1 hexanes: ethyl acetate, Rf = 0.40 in 3:1 hexanes : ethyl acetate) to yield 58.9
mg (0.247 mmol, 82 %) of the title compound as a light yellow solid. 1H NMR (400 MHz, CDCl3):
δ = 8.78 (s, 1H), 7.28 – 7.21 (m, 2H), 7.20 – 7.10 (m, 4H), 7.03 (dd, J = 11.3, 4.2 Hz, 1H), 2.36 (s,
6H). 13C NMR (400 MHz, CDCl3): δ = 161.12, 148.49, 142.57, 136.05, 134.33, 128.56, 127.45,
124.03, 120.88, 116.20, 109.09, 18.44. HRMS (ESI-MS, m/z) [M+H]+ calcd for C15H14N2O
239.1106; found 239.1177. The spectral data are consistent with those reported in the literature.58

N-(phenylmethyl)-2-benzoxazolamine (3u). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (gradient elution from pure
hexanes to 4:1 hexanes : ethyl acetate, Rf = 0.3 in 3:1 hexanes : ethyl acetate) to yield 21.8 mg
(0.0972 mmol, 32.4%) of the title compound as a light yellow solid (m.p.= 122-124 °C). 1H NMR
(400 MHz, CDCl3): δ = 7.43 – 7.33 (m, 4H), 7.32 – 7.27 (m, 2H), 7.28 – 7.21 (m, 1H), 7.16 (t, J
= 7.6 Hz, 1H), 7.03 (t, J = 7.7 Hz, 1H), 5.63 (s, 1H), 4.68 (s, 2H). 13C NMR (100 MHz, CDCl3): δ
= 162.09, 148.75, 143.04, 137.83, 128.98, 128.01, 127.77, 124.09, 121.14, 116.67, 108.96, 47.29.
HRMS (ESI-MS, m/z) [M+H]+ calcd for C14H12N2O 225.1022; found 225.1013. The spectral data
are consistent with those reported in the literature.83
41

2-(4-fluorophenylamino)benzoxazole (3v) The title compound was synthesized according to the
standard procedure on a doubled scale. Cobalt (II) acetate (10.6 mg, 0.0600 mmol), 2-aminophenol
(65.4 mg, 0.600 mmol) and 4-fluorophenyl isocyanide (72.7 mg, 0.600 mmol) were combined in
a 6-inch test tube inside a N2 filled glovebox and dissolved in dry CH3CN (5 mL). The test tube
was sealed with a septum and removed from the glovebox. The reaction mixture was then stirred
in an oil bath at 65 °C for 24 hours with an air balloon attached to a syringe and needle inserted
through the septum. Upon completion, the reaction mixture was cooled to room temperature and
filtered through a Pasteur pipette silica gel plug and washed with ethyl acetate (~15 mL). The
resulting filtrate was concentrated by rotary evaporation and the solid was purified by silica
column chromatography (gradient elution from pure hexanes to 10:1 hexanes : ethyl acetate, Rf =
0.65 in 3:1 hexanes : ethyl acetate) to yield 26.8 mg (0.180 mmol, 19.6%) of the title compound
as a yellow solid (m.p.= 167-169 °C). 1H NMR (400 MHz, CDCl3): δ = 7.80 (s, 1H), δ 7.63 – 7.53
(m, 2H), 7.47 (d, J = 7.8 Hz, 1H), 7.35 (d, J = 8.0 Hz, 1H), 7.27 – 7.21 (m, 2H), 7.17 – 7.05 (m,
3H). 13C NMR (100 MHz, CDCl3): δ = 159.97 (s), 158.36 (s), 147.99 (s), 142.31 (s), 133.94 (d, J
= 2.7 Hz), 124.49 (s), 122.14 (s), 120.43 (d, J = 7.9 Hz), 117.32 (s), 116.19 (d, J = 22.9 Hz), 109.27
(s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C13H9FN2O 229.0699; found 229.0772. The spectral
data are consistent with those reported in the literature.84
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2.4.4 Procedures for Control Experiments

2.4.4.1. Control Experiments under a Nitrogen Atmosphere

Scheme 2.5. (a) The standard reaction conditions and control experiments with (b) 10 mol%
Co(OAc)2 and (c) 1 equiv Co(OAc)2 conducted under a nitrogen atmosphere. Yields are
determined by 1H NMR spectroscopy using dimethylsulfone internal standard.

2-Aminophenol (32.7 mg, 0.300 mmol) and cobalt (II) acetate (either 5.31 mg, 0.0300
mmol or 53.1mg, 0.300 mmol) were combined in a 25 mL Schlenk tube in a N2 filled glovebox.
CH3CN (3.00 mL) and tert-butylisonitrile (35.2 L, 0.300 mmol) were then added. The Schlenk
tube was then sealed with a septum, removed from the glovebox, connected to a Schlenk line and
the mixture stirred under N2 for 24 hours at 65 °C. At the end of this period, the reaction mixture
was cooled to room temperature and filtered through a Pasteur pipette silica gel plug. Ethyl acetate
(15 mL) was then passed through the plug and the resulting filtrate was concentrated by rotary
evaporation to yield a dark brown solid. Dimethylsulfone (3.00 mg, 0.0318 mmol), used as a 1H
NMR standard, was added to the solid residue and the crude mixture was dissolved in CDCl 3 for
1

H NMR analysis.
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2.4.4.2. Control Experiment with a Cobalt(III) Source

Scheme 2.6. Control experiment with (a) Co(acac)3 as a cobalt(III) source and (b) the
corresponding catalytic reaction with Co(acac)2. aIsolated yield. b Yield determined by 1H NMR
spectroscopy using dimethylsulfone as internal standard.

Procedure for Stoichiometric CoIII (acac)3 Control Experiment:
2-Aminophenol (32.7 mg, 0.300 mmol) and cobalt(III) acetylacetonate (106.8 mg, 0.3000 mmol)
were combined in a 25 mL Schlenk tube in a N2 filled glovebox, and CH3CN (3 mL) and tert-butyl
isonitrile (35.2 L, 0.300 mmol) were added. The Schlenk tube was then sealed with a septum,
removed from the glovebox and stirred under N2 on a Schlenk line for 24 hours in a 65 °C oil bath.
Upon completion, the reaction mixture was cooled to room temperature and filtered through a pad
of Celite via vacuum filtration. The filtrate was then concentrated by rotary evaporation to yield
the crude product as a dark brown solid. The crude material was then purified by silica column
chromatography (6:1 hexanes: ethyl acetate, Rf = 0.3 in 5:1 hexanes : ethyl acetate) to generate
35.9 mg (0.189mmol, 63%) of the desired product as brown solid.
Procedure for Catalytic CoII(acac)2 Control Experiment:
2-Aminophenol (32.7 mg, 0.300 mmol) and cobalt(II) acetylacetonate (7.71 mg, 0.0300 mmol)
were combined in a 25 mL Schlenk tube in a N2 filled glovebox, and CH3CN (3 mL) and tert-butyl
isonitrile (35.2 L, 0.300 mmol) were added. The Schlenk tube was then sealed with a septum,
removed from the glovebox, fitted with an air balloon attached to a needle inserted through the
septum and stirred under this aerobic atmosphere for 24 hours in a 65 °C oil bath. Upon completion,
the reaction mixture was cooled to room temperature and filtered through a pad of Celite via
vacuum filtration. The filtrate was then concentrated by rotary evaporation to yield the crude
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product as a dark brown solid. The crude material was then purified by silica column
chromatography (6:1 hexanes: ethyl acetate, Rf = 0.3 in 5:1 hexanes : ethyl acetate) to generate
33.1 mg (0.174 mmol, 58%) of the desired product as brown solid.

2.4.4.3. Control Experiment with a Peroxide Oxidant

Scheme 2.7. Control experiment with di-tert-butyl peroxide as the oxidant. Yield determined by
1
H NMR spectroscopy using dimethylsulfone as internal standard.

2-Aminophenol (32.7 mg, 0.300 mmol), di-tert-butyl peroxide (87.7 mg, 0.600 mmol) and
cobalt (II) acetate (5.31 mg, 0.0300 mmol) were combined in a 25 mL Schlenk tube in a N2 filled
glovebox. CH3CN (3 mL) and tert-butyl isonitrile (35.2 L, 0.300mmol) were added. The Schlenk
tube was then sealed with a septum, removed from the glovebox and the reaction stirred under N2
on a Schlenk line for 24 hours at 65 °C. Upon completion, the reaction mixture was cooled to room
temperature and filtered through a Pasteur pipette silica gel plug. Ethyl acetate (15 mL) was passed
through the silica plug and the resulting filtrate was concentrated via rotary evaporation to yield
the crude product as a dark brown solid. The yield of the reaction was determined by 1H NMR
spectroscopy with dimethylsulfone (3.00 mg, 0.0318 mmol) as the internal standard.
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2.4.4.4. Control Experiments with Radical Trapping Reagents

Scheme 2.8. Control experiment with (a) TEMPO, (b) 9,10-dihydroanthracene (DHA), and (c)
1,1-diphenylethylene included as radical trapping agents. Yields determined by 1H NMR
spectroscopy using dimethylsulfone as internal standard.

Standard procedure for radical trap experiments. 2-Aminophenol (32.7 mg, 0.300 mmol),
radical scavengers (0.6 mmol), and cobalt (II) acetate (5.31 mg, 0.0300 mmol) were combined in
a 6 inch test tube in a N2 filled glovebox, CH3CN (3 mL) and tert-butylisonitrile (35.2 L, 0.300
mmol) were added. The test tube was then sealed with a septum, removed from the glovebox, and
fitted with an air balloon attached to a needle inserted through the septum. The reaction mixture
was stirred in an oil bath at 65 °C for 24 hours.
Work up method for control experiment with TEMPO as the radical scavenger. Upon
completion of the reaction, the reaction mixture was cooled to room temperature and was diluted
with ethyl acetate (20 mL). The resulting mixture was extracted with a saturated solution of
Na2S2O3 (3 x 20 mL) until the organic layer changed from dark red to light yellow. The organic
layer was then washed with saturated sodium chloride solution, separated, dried over anhydrous
magnesium sulfate, filtered, and finally concentrated via rotary evaporation to ~3 mL then passed
through a Pasteur pipette silica gel plug to remove residue cobalt. The filter plug was flushed with
extra 10 mL of ethyl acetate and further concentrated by rotary evaporation to provide the crude
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product as a brownish-red solid. The crude yield was determined by 1H NMR spectroscopy with
dimethylsulfone (0.0300 mg, 0.0318 mmol) as the internal standard.
Work up method for control experiment with all other radical scavengers. Upon completion,
the reaction mixture was cooled to room temperature, filtered through a pad of silica gel with ethyl
acetate (20 mL) by vacuum filtration, and the resulting filtrate was concentrated by rotary
evaporation to ~3 mL then passed through a Pasteur pipette silica gel plug (to further remove any
remaining cobalt). The filter plug was flushed with an extra 10 mL of ethyl acetate and eventually,
the solvent was removed by rotary evaporation to generate the crude product as a brownish solid.
The crude yield was determined by 1H NMR spectroscopy with dimethylsulfone (0.03 mg, 0.0318
mmol) as the internal standard.

2.4.4.5. Control Experiments in the Absence of Isonitrile

Scheme 2.9. Control experiments conducted in the absence of isonitrile both (a) without and (b)
with TEMPO. Yields determined by 1H NMR spectroscopy using a dimethylsulfone internal
standard.

Procedure for (a): 2-Aminophenol (32.7 mg, 0.300 mmol) and cobalt(II) acetate (5.31 mg, 0.0300
mmol) were combined in a 25 mL Schlenk tube, and the tube was evacuated and back-filled with
air three times. CH3CN (3.00 mL) was added and the reaction mixture was stirred at 65 °C for 24
h. Upon completion, the reaction mixture was cooled to room temperature, filtered through Celite,
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and washed with excess amount of ethyl acetate (50 mL). The filtrate was then concentrated to 3
mL by a rotary evaporation and the resulting mixture was filtered through a silica gel plug to
further remove cobalt residues. Then, the plug was rinsed with ethyl acetate (10 mL) and the
combined filtrate was concentrated under vacuum to yield the crude product as a brownish solid.
Dimethylsulfone (3.00 mg, 0.0318 mmol), used as a 1H NMR standard, was added to the solid
residue and the crude mixture was dissolved in DMSO-d6 for 1H NMR analysis.
Procedure for (b): 2-Aminophenol (32.7 mg, 0.300 mmol), TEMPO (93.4 mg, 0.6 mmol) and
cobalt(II) acetate (5.31 mg, 0.0300 mmol) were combined in a 25 mL Schlenk tube, and the tube
was evacuated and back-filled with air three times. CH3CN (3.00 mL) was added and the reaction
mixture was stirred at 65 °C for 24 h. Upon completion, the reaction mixture was cooled to room
temperature, filtered through Celite, and washed with ethyl acetate (~50 mL). The filtrate was then
extracted with a saturated solution of Na2S2O3 (3 x 20 mL) until the organic layer changed from
dark red to light yellow. This step removes any remaining TEMPO. The organic layer was then
washed with saturated sodium chloride solution, dried over anhydrous magnesium sulfate, filtered,
and finally concentrated via rotary evaporation to ~3 mL. The resulting mixture was filtered
through a silica gel plug to further remove cobalt residues. Then, the plug was rinsed with ethyl
acetate (10 mL) and the combined filtrate was concentrated under vacuum to yield the crude
product as a brownish solid. Dimethylsulfone (3.00 mg, 0.0318 mmol), used as a 1H NMR standard,
was added to the solid residue and the crude mixture was dissolved in DMSO-d6 for 1H NMR
analysis.
In both cases, the reaction yields were determined by

1

H NMR spectroscopy with a

dimethylsulfone (0.0300 mg, 0.0318 mmol) internal standard. The assignment of the product as 2aminophenoxazin-3-one was confirmed by both literature evidence85 as well as comparison with
the standard purchased from Asta Tech (95% pure). 1H-NMR (400 MHz, DMSO-d6) δ 7.70 (d, J
= 7.7 Hz, 1H), 7.47 (dd, J = 18.8, 8.0 Hz, 2H), 7.38 (t, J = 7.2 Hz, 1H), 6.80 (s, 2H), 6.36 (d, J =
2.6 Hz, 2H).
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Figure 2.3. 1H NMR spectrum of the crude reaction mixture of the Co-catalyzed, TEMPOmediated dimerization of 2-aminophenol for the synthesis of 2-aminophenoxazin-3-one (reaction
b in Scheme 2.9) in DMSO-d6 at 400 MHz.
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Figure 2.4. 1H NMR spectrum of standard 2-aminophenozaxin-3-one purchased from AstaTech
(95% pure) in DMSO-d6 at 400 MHz.

2.4.4.6. Experimental Procedures for UV-Visible Experiments
The following three experiments (A-C) were conducted with a Stellar Net UV-Vis dip probe.
All cobalt salt and 2-aminphenol solutions for these experiments were prepared by serial dilution
under nitrogen using standard Schlenk techniques. The general procedure for preparing
CoII(acac)2 and 2-aminophenol solutions in acetonitrile are described below:
Preparation of CoII(acac)2 solution in CH3CN:
To a 25 mL Schlenk tube equipped with a stir bar and a dip probe inserted through the septum,
was added CoII (acac)2 (1.3 mg, 5.05×10-3 mmol). The tube was evacuated and backfilled with N2
three times via the side arm and dry acetonitrile (10 mL) was added by syringe. For dilution
purposes, 9 mL of the resulting 10 mL solution was removed. To the remaining 1 mL of solution,
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was added an additional 9 mL of fresh dry acetonitrile to yield a final 10 mL solution with a
concentration of 5.05×10-5 M.
Preparation of 2-aminophenol solution in CH3CN:
To a 25 mL Schlenk tube equipped with a stir bar and septum, 2-aminophenol (6.5mg, 0.060 mmol)
was added and the tube was evacuated and backfilled with N2 three times via the side arm. Dry
acetonitrile (3 mL) was added to yield a final solution with a concentration of 2.0 ×10-2 M.
A. CoII(acac)2 control experiment under N2 and air atmosphere
During the experiment, the standard spectrum of CoII(acac)2 (5.05×10-2 mM in 10 mL MeCN) was
taken first under the protection of N2 atmosphere, then the headspace was exposed to air by
inserting an air balloon through the septum. The spectroscopic changes were monitored overnight
with stirring. No significant changes were observed upon exposure to air and the spectrum of the
cobalt species showed two absorbance maxima at 202 nm and 272 nm under both aerobic and
anaerobic conditions (Figure 2.5 below).

Figure 2.5. UV-visible spectra of CoII(acac)2 (5.05×10-2 mM in MeCN) prepared under N2 (orange
trace), and then exposed to air and monitored over the course of 12 h at room temperature (blue
trace).

B. CoII(acac)2 control experiment with tBuNC
The standard spectrum of CoII(acac)2 in acetonitrile (5.05×10-2 mM in 10 mL MeCN) was taken
first under a N2 atmosphere, then tert-butylisonitrile (5 L, 3.65 mg, 0.044 mmol, 8 equiv) was
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added by syringe. The mixture was then exposed to air by inserting an air balloon through the
septum and the reaction mixture was stirred under the air atmosphere overnight. No new band were
observed and instead only the two absorbance maxima characteristic of CoII(acac)2 were present
(202 nm and 272 nm, Figure S4 below).

Figure 2.6. UV-Visible spectra of (a) CoII(acac)2 (5.05×10-2 mM in MeCN) prepared under N2
(red trace), and then tert-butylisonitrile (8 equiv) was added (green trace), and final, exposed to
air overnight (dark blue trace).

C. CoII(acac)2 control experiment with 2 equivalents of 2-aminophenol
First, a UV-visible spectrum of CoII (acac)2 (5.05×10-2 mM in 10 mL MeCN) was taken under a
N2 atmosphere. Then 2-aminophenol was added by syringe in 1 equivalent increments (25 L of
the 2.0 ×10-2 M aminophenol stock solution in MeCN, described above) until a total of 2
equivalents had been added. Spectra were recorded after each addition. The mixture was then
stirred under an inert atmosphere for 2.5 h, then exposed to air by inserting an air balloon through
the septum. The resulting mixture was stirred in the closed aerobic system overnight. UV-visible
spectra were taken throughout the reaction. Under anaerobic condition, CoII(acac)2 showed
absorbance maxima at 202 and 272 nm. Upon the injection of the 2-aminophenol solution in MeCN,
accumulation of 2-aminophneol was observed. Changes of absorbance maxima were observed
only when the mixture was exposed to air, which was observed as the slow growth of the peak
around 270 nm (Figure 2.7, below).
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(a)

(b)

Figure 2.7. UV-visible spectra of (a) CoII(acac)2 (5.05×10-2 mM in MeCN) prepared under N2
(yellow trace), and then treated with 2-aminophenol to reach a total of 2 equiv added (deep blue
trace), and (b) CoII(acac)2 (5.05×10-2 mM in MeCN) and 2-aminophenol (2 equiv, purple trace)
exposed to air and monitored over the course of 12 h at room temperature (orange trace).

The following two experiments (D and E) were conducted with a Shimadzu UV 1800
instrument
All cobalt salt and 2-aminophenol solutions for these experiments were prepared by serial dilution
in a nitrogen-filled glovebox or using standard Schlenk techniques. The general procedure for
preparing CoII(acac)2 and 2-aminophenol solutions in acetonitrile are described below:
General procedure for preparing CoII(acac)2 solution:
To a 20 mL scintillation vial inside the glovebox, Co(acac)2 (1.3 mg, 5.0×10-3 mmol) was first
dissolved in dry CH3CN (10 mL). For dilution purposes, 1 mL of the resulting 10 mL solution was
transferred to a new clean 20 mL scintillation vial. To this 1 mL of solution was added 19 mL of
fresh CH3CN to yield a final 20 mL solution with concentration of 2.5×10-5 M.
General procedure for preparing CoIII(acac)3 solution:
To a 20 mL scintillation vial inside the glovebox, Co(acac)3 (1.8 mg, 2.5×10-3 mmol) was first
dissolved in dry CH3CN (10 mL). For dilution purposes, 1 mL of the resulting 10 mL solution was
transferred to a new clean 20 mL scintillation vial. To this 1 mL of solution was added 19 mL of
fresh CH3CN to yield a final 20 mL solution with concentration of 2.5×10-5 M.
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General procedure for preparing 2-aminophenol solution
To a 25 mL Schlenk tube equipped with a stir bar and septum, 2-aminophenol (8.2 mg, 0.075
mmol) was added and the tube was evacuated and backfilled with N2 three times. Dry acetonitrile
(3 mL) was added via syringe to make a final solution with a concentration of 2.5 ×10-2 M.

D. CoII(acac)2 control experiment with 3 equivalents of 2-aminophenol
Inside a N2 filled glovebox, a 3 mL aliquot of the standard solution of Co(acac)2 (2.5×10-5M,
described above) was transferred to a cuvette. The cuvette was then sealed, removed from the
glovebox and an initial spectrum recorded. Then 2-aminophenol was added by syringe in 1
equivalent increments (3 L of the 2.5 ×10-2 M aminophenol stock solution in CH3CN, described
above) until a total of 3 equivalents had been added. Spectra were recorded after each addition and
for 1 hour further under N2. Under a N2 atmosphere, no significant changes in the spectra were
observed upon addition of 2-aminophenol except for the accumulation of 2-aminophenol in the
mixture. Air was then bubbled into the mixture for 3 min by inserting an air balloon through the
septum of the cuvette and UV-visible spectra were recorded under this aerobic atmosphere for over
12 hours. Upon exposure of the mixture to air, spectral changes were seen with a rapid growth of
the absorbance around 260 nm. (Figure 2.8, below).

(a)

(b)

Figure 2.8. (a) Co(acac)2 (5.0×10-5M) in MeCN under N2 (red trace) with the addition of 3 equiv
of 2-aminophenol (yellow trace), and (b) Co(acac)2 and 2-aminophenol (3 equiv, yellow trace)
exposed to air overnight (deep blue trace).

54

E. CoIII(acac)3 control experiment with 3 equivalents of 2-aminophenol
Inside a N2 filled glovebox, a 3 mL aliquot of the standard solution of Co(acac)3 (2.5×10-5M,
described above) was transferred to a cuvette. The cuvette was then sealed, removed from the
glovebox and an initial spectrum recorded. Then 2-aminophenol was added by syringe in 1
equivalent increments (3 L of the 2.5 ×10-2 M aminophenol stock solution in CH3CN, described
above) until a total of 3 equivalents had been added. Spectra were recorded after each addition and
for 2 hours further under N2. Air was then bubbled into the mixture by inserting an air balloon
through the septum of the cuvette and UV-visible spectra were recorded under this aerobic
atmosphere for over 12 hours (Figure 2.9 below).

(a)

(b)

Figure 2.9. (a) Co(acac)3 (2.5×10-5 M) in MeCN under N2 (blue trace) with the addition of 3 equiv
of 2-aminophenol (yellow trace) and (b) Co(acac)3 (2.5×10-5 M) and 2-aminophenol (3 equiv, red
trace) exposed to air overnight (blue trace).
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Chapter 3. Cobalt-Catalyzed Aerobic Oxidative Cyclization of
2-Aminoanilines with Isonitriles: Facile Access to Substituted
2-Aminobenzimidazoles
3.1 Introduction

Benzimidazoles are structurally important heterocyclic compounds that are key targets or
the intermediates in the synthesis of pharmaceutically valuable and biologically active
molecules.86-90 Specifically, the 2-aminobenzimidazole scaffold is a common substructure in this
category that existing widely in a variety of antihistamines (norastemizole and astemizole),91
antihelmitics (mebendazole),92 kinase inhibitors,93,

94

and integrin ανβ3 antagonists.95 These

structures have also demonstrated anticancer96 and antimalarial97 activities among others in related
research (Chart 3.1).98, 99

Chart 3.1. Selected biologically active small molecules containing 2-aminobenzimidazole
substructure.
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One of the most conventional routes to access these heterocyclic structures relies on the
desulfurization of a preformed thiourea that can be prepared from either the reduction of the
appropriate ortho-nitroaryl thiourea100-104 or the coupling of ortho-phenylenediamine with the
corresponding isothiocyanate81,

105-111

(Scheme 3.1 Route a). Unfortunately, the pre-

functionalization of these starting materials has disadvantages like low yields, poor atom efficiency
and the reduction of nitro-group was not always efficient. Also, these reactions require the use of
super stoichiometric mercury salts for the ring-closure of thiourea derivatives and toxic/or
hazardous desulfurizing agents such as MeI among others.81, 112 Alternatively, TsCl has been
employed under basic conditions113 and coupling agents such as 1,3-diisopropylcarbodiimde (DIC)
or

N-(3-dimethylaminopropyl)-N’-ethylcarbodiimide

hydrochloride

(EDC)

or

dicyclohexylcarbodiimide (DCC) have also been shown to be efficient in this category of
transformations.102, 114 Whilst effective, these methods suffer from low atom economy and the
employment of toxic reagents renders a doubtful feasibility for large scale synthesis and limited
industrial applications. Furthermore, the 1,2-diamine substitutions on the arene substrates prior to
desulfurization often require a fresh preparation due to the poor stability of these compounds.115

Scheme 3.1. Selected conventional routes for the synthesis of 2-aminobenzimidazoles. Reaction
Conditions: (Route a) desulfurization agents such as HgO, carbodiimide or Cu catalyst and base.
(Route b) Cu catalyst and O2. (Route c) reflux at high temperature or Pd catalyst. (Route d) Cu
catalyst and base.

More recently, transition metal-catalyzed cyclization reactions have provided attractive
alternatives

to

access

2-(N-substituted)-aminobenzimidazoles.

The

copper-catalyzed

intramolecular cyclization reactions of thioureas116 or guanidines (Scheme 3.1 Route b)115 help
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eliminate the requirement of stoichiometric desulfurizing agents. Other approaches enable
arylamination of 2-chlorobenzimidazole either by Pd catalysis117,

118

or SNAr transformation

mediated either by high temperature119, 120 or high pressure (Scheme 3.1 Route c).121 Cyclization
of dihaloarenes with substituted guanidines mediated by a Cu catalyst also provided an alternative
path to achieve 2-aminobenzimidazoles (Scheme 3.1 Route d),122, 123 however, this protocol is
restricted by its inherent limitation that only dihaloarenes can be used and availability of
guanidines is another challenge. Finally, transition-metal-free cyclization reactions using I2110, 111
or hypervalent iodine-based oxidants124 have also been developed. To circumvent additional nontrivial synthetic challenges that most methodologies suffer, the ability to utilize readily available
coupling partners in combination with environmentally benign oxidants, such as O2 and air, and
abundant first-row transition-metal catalysts would represent a significant advance toward the
facile synthesis of substituted 2-aminobenzimidazoles.57 A variety of cobalt-catalyzed cyclization
reactions of isonitriles have been developed. Specifically, Wang and coworkers have reported
cyclization reactions with bisnucleophiles employing persulfate-based oxidants125 and in the last
chapter we have revealed an aerobic cobalt-catalyzed oxidative cyclization of aminophenols and
isonitriles to generate substituted 2-aminobenzoxazoles.126 Thus, we wondered if we can expand
our aerobic cobalt catalyst system to the efficient synthesis of other heterocycles. In this chapter,
we will disclose the cobalt-catalyzed aerobic oxidative cyclization reactions of orthophenylenediamines with isonitriles to generate substituted 2-aminobenzimidazoles (Scheme 3.2).
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Scheme 3.2. 2-aminobenzimidazole synthesis via transition-metal catalyzed oxidative cyclization
of bisnucleophiles with isonitriles. (a) Pd/O2 mediated oxidative cyclization reactions. (b)
Oxidative cyclization reactions mediated by Co catalyst pairing with a persulfate oxidant. (c)
Approach of our work in this chapter.

3.2 Results

3.2.1. Condition Optimization of Cobalt-Catalyzed Aerobic Oxidative Cyclization of oPhenylenediamine with tert-Butyl Isonitrile

We started our condition optimization with the model coupling reaction of orthophenylenediamine (4a) and tert-butyl isonitrile (2a) under the aerobic cobalt-catalyzed conditions.
Of all cobalt salts investigated, Co(OAc)2 was found to provide the highest yield of 5a in 69% of
yield when CH3CN was employed as a solvent at 65 °C (entries 1-5). Reactions run in CH3CN
provided higher yields of 5a than other commonly utilized solvents such as dioxane, THF and
DMF (entries 5-9). The incorporation of base additives improved the reaction yield, with two
equivalents of K2CO3 showing the greatest improvement of product in 85% of yield (entries 10-15).
Finally, we have found that the increase of the reaction temperature plays a critical role in this
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aerobic oxidative cyclization reaction. The yield of 5a was increased to 95% when the reaction
temperature was raised to 80 °C (entry 16). Thus, the optimized reaction conditions employ 10
mol% of Co(OAc)2 with two equivalents of K2CO3 and an air balloon in CH3CN at 80 °C for 24
hours.
Table 3.1 Optimization of Reaction Conditionsa

Entry

Co Source

Solvent

Base

% Yieldb

1

CoCO3

CH3CN

--

Trace

2

CoCO3·H2O

CH3CN

--

Trace

3

CoCl2

CH3CN

--

Trace

4

Co(acac)2

CH3CN

--

41

5

Co(OAc)2

CH3CN

--

69

6

Co(OAc)2

1,4-dioxane

--

61

7

Co(OAc)2

2-Me-THF

--

69

8

Co(OAc)2

THF

--

54

9

Co(OAc)2

DMF

--

23

10

Co(OAc)2

CH3CN

K2CO3

85

11

Co(OAc)2

CH3CN

Na2CO3

79

12

Co(OAc)2

CH3CN

Li2CO3

67

13

Co(OAc)2

CH3CN

KOAc

82

14

Co(OAc)2

CH3CN

NaOAc

62

15

Co(OAc)2

CH3CN

LiOAc

65

16[c]

Co(OAc)2

CH3CN

K2CO3

95

a

Reaction Conditions: 4a (0.3 mmol), 2a (0.3 mmol), cobalt(II) catalysts (10 mol%), solvent (3
mL), at 65 °C with an air balloon for 24 h. bThe yield of 5a was determined by 1H NMR
spectroscopy with dimethylsulfone as internal standard (0.03 mmol).cThe reaction was conducted
at 80 °C.
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Last year Glorious and co-workers developed an user-friendly assessment tool that
enabled the sensitivity to different variants of a protocol to be rapidly assessed.127 This tool delivers
a straightforward overview of the sensitivity of reactions to key parameters by the standardized
presentation of the results in a radar diagram. This diagram provides a direct visualization of the
general sensitivity of a reaction based on the shape of the black line generated. The round shape
around the “0% deviation line” indicates low sensitivity, while any section deflecting from that to
the red zone refers to high sensitivity. Specifically, the sharp “arrow-like” deflections immediately
demonstrate the most influential parameters. As we aimed to develop a highly efficient but simple
transformation delivering the scaffolds of critical pharmaceutical importance, we applied this tool
to our standard cobalt-catalyzed aerobic cyclization reaction to test the robustness of the condition
screening and reproducibility of this protocol.
In this assessment, O2 concentration, base stoichiometry, catalyst loading, concentration of
reaction mixture and reaction temperature were chosen as key parameters in the standard
cyclization reaction. These parameters were evaluated by carefully setting up five sets of
experiments with single variation for each, following the systematic four-step procedure reported
by Glorious (experimentation, data analysis, calculation and data plotting) (Figure 3.1a). From
the radar diagram generated upon using this methodology, we realized the almost neglectable
influence of reaction mixture concentration and small impact of catalyst loading on the overall
performance of this transformation. Also confirmed was the strong dependence of this reaction on
the base loading as well as the reaction temperature and O2 concentration, as indicated by the black
“arrow-like” deflections shown in the diagram (Figure 3.1b) (See the details of reaction set up
and results of these assessment experiments in the Experimental Section 3.4.3/Tables 3.8 &
3.9/Figures 3.2-3.4). By knowing the highly sensitive parameters associated with a chemical
transformation, the implementation of this condition-based assessment in our cobalt aerobic
cyclization system could help us facilitate higher reproducibility in the later stage substrate scope
investigations, and allow the fast application of the new developed protocol in further structural
functionalization.
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Figure 3.1. Condition-based sensitivity assessment experiment. (a) Four steps involved in
sensitivity assessment procedure (b) Sensitivity assessment of key parameters in Co-catalyzed
aerobic oxidative cyclization of o-phenylenediamine with tert-butyl isonitrile.

3.2.2 Substrate Scope of o-Phenylenediamines and Isonitriles

With the optimized reaction conditions, we move on to investigate a variety of substituted
ortho-phenylenediamine coupling partners (4, Table 3.2). This protocol is broadly tolerant of a
wide range functional groups including both electron-rich and electron-deficient substrates. Of the
ortho-phenylenediamines being explored, the reaction didn’t show preference for either electronMHYHHHHdonating or withdrawing substituents. Electron-withdrawing (4e-4j), electron-neutral
H(4a, 4b) and electron-donating (4c and 4d) groups all leads to high yields of the benzimidazole
products. Similarly, steric influences on the reaction yield are minimal. For example, high yields
of benzimidazoles are obtained in the presence of methyl-substitution in both the 3- and 4positions of ortho-phenylenediamine. Furthermore, functional groups such as a 4-tert-butyl (4c)
or naphthalene (4m) are also well tolerated.
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Table 3.2. Scope of ortho-Phenylenediamine and Isonitrile Coupling Partnersa

a

Isolated Yields. Reaction conditions: 4 (0.3 mmol), 5 (0.3 mmol), K2CO3 (0.6 mmol), Co(OAc)2
(10 mol%) in MeCN (3 mL), at 80 °C with an air balloon for 24 h. bYield in parentheses determined
by 1H NMR spectroscopy.
In addition to substituted ortho-phenylenediamine coupling partners, various isonitirle
coupling partners (2) were also explored. Bulky aliphatic substituents, such as tert-butyl,
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neopenthyl and admantyl groups delivered the most efficient product formation (5a, 5n. 5o). In
contrast, less bulky n-pentyl isonitirle undergoes multiple isonitrile insertion steps to generate the
corresponding diamino quinoxazoline product (6) in 25% yield (Scheme 3.3).

Scheme 3.3. Synthesis of N-subsittuted diamino quinoxazoline.

A similar behavior was observed when 2,6-di-methyl phenyl isonitrile was employed as a
coupling partner. Different from the case above where the product was generated exclusively from
double insertion of isonitrile in this reaction, a complicated compound resulting from tripleinsertion of the isonitrile was also found to be one of the major products (Table 3.3c). We also
explored other isonitrile and diamine coupling partners for this chemical transformation (Table
3.3). Isonitirles that had proceeded smoothly with ortho-aminophenol coupling partners in our
previous study unfortunately revealed to be ineffective in this aerobic cyclization reaction. For
example, the oxidative cyclization product was not observed when isopropyl isonitrile was
employed as the coupling partner. Interestingly, a product resulting from benzylic oxidation was
detected as the major product in the reaction where benzyl isonitirle was used; however, this
oxygenation was not observed in the aerobic oxidative cyclization of ortho-aminophenol with
benzyl isonitrile, indicating the reaction might be operating via a distinct oxidation pathway (Table
3.3c). Additionally, we also included a fused-ring system and a heteroaromatic ring in our substrate
scope investigation. Unfortunately we found that our system is not tolerant of the fused 2-naphthyl
isocyanide. Heterocyclic-based diamines were also shown to be unsuccessful in delievering the
desired products in our aerobic system. Both 2,3-diamopyridine and 3,4-diaminopyridine didn’t
undergo oxidative cyclization with tert-butyl isonitrile under our standard reaction conditions
(Table 3.3b), probably due to the irreversible binding of pyridine substrates to the cobalt catalyst,
leading to catalyst deactivation.
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Table 3.3. Unsuccesful Isonitrile and Diamine Coupling Partners

We also explored the reactivity of N-substituted ortho-phenylenediamine coupling partners,
the reaction of N-methyl- and N-phenyl-substituted ortho-phenylenediamines (5q and 5r) allow
access to the corresponding N-subsituted 2-aminobenzimidazoles in moderate yields (Scheme 3.4).

Scheme 3.4. Synthesis of N-substituted 2-aminobenzimidazoles.

3.2.3. Application of the Cobalt-Catalyzed Oxidative Cyclization of o-Phenylenediamines
with Isonitriles

Next, we sought to explore the utilization of this cobalt-catalyzed method to access the
unsubstituted 2-aminobenzimidazoles. These compounds are convenient precursors to access a
65

variety of substituted benzimidazoles readily available as synthetic intermediates or
pharmaceutically important drug targets. For example, studies have shown this compound to be an
intermediate in the synthesis of biologically active small molecules such as mebendazole (Scheme
3.5a)128 and enviroxime (Scheme 3.5b).129 It also allows access to unique fused heterocyclic
structures when treated with aryl sulfonyl chlorides (Scheme 3.5c)130 or oximes (Scheme 3.5d).131
Finally, treating unsubstituted 2-aminobenzimidazole with triphenylphosphine dibromide
generates iminophosphoranes, a versatile structure for heterocyclic synthesis (Scheme 3.5e).132

Scheme 3.5. Application of unsubstituted 2-aminobenzimidazoles in pharmaceutical-related
synthesis. (a) methyl chloroformate and base128 (b) isopropylsulfonyl chloride, base and reflux132
(c) sulfonyl chloride/Cu catalyst then Pd catalyst130 (d) hydroximoyl chloride and reflux131 (e)
Ph3PBr2 and base132

Thus, we sought to enable the efficient access to the unsubstituted 2-aminobenzimidazole
5s. Researchers in other groups have shown the N-tert-butyl benzimidazole to undergo selective
dealkylation upon treatment with a strong acid.57 Based on this precedent, we designed a
convenient sequence for facile access to 2-aminobenzimidazole from ortho-phenylenediamine and
the readily available tert-butyl isonitrile. Upon accomplishment of the reaction under standard
condition, the resulting crude product 5a was treated directly with a strong acid under reflux
conditions, giving rise to the unsubstituted 2-aminobenzimidazole 5s in 82% yield (Scheme 3.6).
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Scheme 3.6. Synthesis of the unsubstituted 2-aminobenzimidazoles 5s and 5t via acid-promoted
dealkylation.

Finally, we applied this sequence to the synthesis of 5t (Scheme 3.6), an important
precursor for accessing antiparasitic small molecule mebendazole and antivirus drug enviroxime.
Our method allows access to 5t in a convenient two-step synthesis from orthodiaminobenzophenone and tert-butyl isonitrile in 70% yield. Then we attempted to convert this
intermediate to mebendazole by selective acylation of amino group. However, the journey towards
this small molecule synthesis led to unexpected challenges. When 5t was treated with dimethyl
dicarbonate and triethylamine under the conventional amino group protection conditions, we
didn’t observe the generation of mebendazole resulting from the NH2-functionalization (Scheme
3.7). We also attempted the Cu-mediated cross-coupling reaction between 2-amino-5-benzoyl
benzimidazole and methyl-chloroformate,133 and no desired product was detected under the
referred reaction condition. More interestingly, when chloroformate was acting as a coupling
partner under varied reaction conditions,134 it consistently generated a mixture of compounds from
two distinct N-substitutions (For more details regarding this reaction, see the Experimental
Section 3.4.8), demonstrating these structural isomers are more thermodynamically favorable
under these reaction conditions.
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Scheme 3.7. Attempted synthesis of mebendazole from 2-amino-5-benzoyl-1H-benzimidazole 5t
under varied reaction conditions.
More endeavors have been made towards a forced base-promoted rearrangement for
mebendazole synthesis from the mixture of the structural isomers; however, only starting materials
were recovered under the reflux condition for a few hours, suggesting mebendazole isomers are
thermodynamically stable and harsher reaction conditions might be required. To track the poor
regioselectivity of this transformation, we found support from the literature that the transformation
of 2-amino-5-benzoyl benzimidazole to mebendazole can be quite complicated (Scheme 3.8).128
The reaction effectiveness is highly dependent on the choice of solvent and pH value of the reaction
mixture. With methyl chloroformate as a coupling partner, the reaction generated exclusively
mono-acylated or di-acylated product when acetone or chloroform were employed as a solvent.
When the reaction was performed in pH 7.8 environment, a distinct di-acylated product was
formed. Although it is suggested mebendazole could be eventually generated through
methanolysis (for di-acylated regio-isomer) or base promoted rearrangement (for mono-acylated
isomer), we unfortunately didn’t generate mebendazole successfully following these protocols.
However, we are optimistic that through a thorough tuning of reaction conditions or broad
screening, an ideal regioselectivity could be expected, and our protocol of generating
2-aminobenzimidazoles though two-step sequence will provide access to a variety of other
2-aminobenzimidazole substructures that are biologically important.
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Scheme 3.8. Synthesis of mebendazole from the 2-amino-5-benzoyl benzimidazole in literature.

3.2.4. Radical Trapping Experiments for the Standard Reaction
In our previous studies on the oxidative cyclization of ortho-aminophenols with
isonitriles,126 we found the reaction to proceed through a pathway involving initial oxidation of an
aminophenol-coordinated cobalt(II) species by O2 to generate a semiquinoato-type intermediate.70
Due to the ligand stabilization, these radical intermediates were not trappable with common radical
trapping agents. In this study, similarly, no trappable free radicals are observed under the current
reaction conditions. When the standard reaction was conducted in the presence of TEMPO, no
radical trapped products were obtained, and we observed no significant decrease in the yield of
benzimidazole product. Similarly, the incorporation of 1,1-diphenylethylene into the reaction
system led to no observation of the radical trapped intermediates. Except for 24% recovery of the
starting material, there was no drastic changes in the yield of benzimidazole (Scheme 3.9).
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Scheme 3.9. Control experiments with TEMPO and 1,1-diphenylethylene as radical trapping
agents.

3.3 Conclusive Summary
In summary, we have described a new cobalt-catalyzed oxidative cyclization of orthophenylenediamines with isonitriles to generate the substituted 2-aminobenzimidazoles. This
catalytic reaction is efficient under simple and mild ligand-free conditions. It also provides access
to the unsubstituted 2-aminobenzimidazoles from an acid-promoted dealkylation of the 2-(tertbutylamino)-benzimidazoles. This route affords structures that can serve as important
intermediates in the synthesis of pharmaceutically valuable small molecules.

3.4. Experimental Section
3.4.1. General Considerations
1

H, and 13C{1H} NMR spectra were recorded on an Agilent 400 MHz spectrometer or a

JEOL 400 MHz spectrometer. Chemical shifts are given in parts per million and referenced to the
residual solvent signal;135 all coupling constants are reported in Hz. High resolution mass spectra
were obtained on a Thermo Finnigan Linear Trapping Quadrupole mass spectrometer. IR spectra
were recorded on a PerkinElmer (Spectrum 100) FT-IR spectrometer. Column chromatography
was performed using Silicycle SiliaFlash P60 silica gel.
Dry solvents were taken from a solvent system which passes the solvent through a column
of activated molecular sieves. All deuterated solvents were purchased from Cambridge Isotope
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Laboratories. All other chemicals were purchased from commercial sources and used without
further purification unless otherwise noted. Air to fill air balloons was obtained from a house
compressed air system. O2 used in control reactions was purchased from Airgas. Both air and O2
sources were used as received without drying tubes or additional precautions to remove trace water.

3.4.2. Optimization of the Reaction Condition

General Procedure for Screening of Reaction Conditions. ortho-Phenylenediamine (32.4 mg,
0.300 mmol) and a cobalt(II) source (0.03 mmol, 10 mol %) were combined in a 6-inch test tube
in a N2 filled glovebox. A base (2 equiv, 0.6 mmol) was added in some instances. Solvent (3 mL)
and tert-butylisonitrile (35.2 L, 0.3 mmol) were added and the test tube was sealed with a septum
before being removed from the glovebox. Upon removal, an air balloon attached to a needle was
inserted through the septum and the reaction mixture was then stirred for 24 hours at 65 or 80 °C
in an oil bath. Upon completion, the reaction mixture was cooled to room temperature and passed
through a pad of Celite via vacuum filtration. The resulting Celite cake was washed with ethyl
acetate (~ 50 mL), the filtrate was collected and concentrated by rotary evaporation to 3 mL, then
passed through a silica gel plug Pasteur pipette and rinsed with ethyl acetate (~10 mL). The filtrate
was collected and the solvent was removed by rotary evaporation. Dimethyl sulfone (3.00 mg,
0.0318 mmol) was added as an internal standard and the crude mixture was dissolved in DMSOd6 for 1H NMR analysis. The reaction yield was determined by 1H NMR spectroscopy.
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Table 3.4. Optimization of the cobalt source in the oxidative cyclization of orthophenylenediamine and tert-butylisonitrile.a

Entry

Co Catalyst

% Yield

1
CoCO3
<5
2
Co(acac)2
41
3
Co(OAc)2
69
4
CoCl2
<5
5
CoCO3·H2O
<5
a
Reaction conditions: 4a (0.300 mmol), 2a (0.300 mmol), cobalt catalyst (0.030 mmol), CH3CN
(3.00 mL), with an air balloon at 65 °C for 24 h. The yields of 5a were determined by 1H NMR
spectroscopy with dimethyl sulfone as internal standard (0.0300 mmol).

Table 3.5. Optimization of the solvent in the oxidative cyclization of ortho-phenylenediamine
and tert-butylisonitrile.a

Entry

Solvent

% Yield

1
CH3CN
69
2
1,4-dioxane
61
3
Me-THF
69
4
THF
54
5
DMF
23
a
Reaction conditions: 4a (0.300 mmol), 2a (0.300 mmol), Co(OAc)2 (0.030 mmol), solvent (3.00
mL), with an air balloon at 65 °C for 24 h. The yields of 5a were determined by 1H NMR
spectroscopy with dimethyl sulfone as internal standard (0.0300 mmol).

72

Table 3.6. Optimization of the base in the oxidative cyclization of ortho-phenylenediamine and
tert-butylisonitrile.a

Entry

Base

% Yield

1
LiOAc
65
2
NaOAc
62
3
KOAc
82
4
Li2CO3
67
5
Na2CO3
79
6
K2CO3
85
a
Reaction conditions: 4a (0.300 mmol), 2a (0.300 mmol), Co(OAc)2 (0.030 mmol), CH3CN (3.00
mL), base (0.600 mmol) with an air balloon at 65 °C for 24 h. The yields of 5a were determined
by 1H NMR spectroscopy with dimethyl sulfone as internal standard (0.0300 mmol).

Table 3.7. Optimization of the temperature in the oxidative cyclization of ortho-phenylenediamine
and tert-butylisonitrile.a

Entry

Temp (oC)

Solvent

% Yield

65
1
CH3CN
85
80
2
CH3CN
95
80
3
Me-THF
78
a
Reaction conditions: 4a (0.300 mmol), 2a (0.300 mmol), Co(OAc)2 (0.030 mmol), solvent (3.00
mL), K2CO3 (2 equiv) with an air balloon at 65 °C or 80 °C for 24 h. The yields of 5a were
determined by 1H NMR spectroscopy with dimethyl sulfone as internal standard (0.0300 mmol).

73

3.4.3. Reaction Parameter Assessment
To assess the sensitivity of the reaction to different parameters, a set of control experiments
were conducted according to the work reported by Glorius and coworkers. 127 In each experiment
only a single parameter is varied while all others are held constant. In our study, the following
parameters were varied: oxygen concentration, base loading, catalyst loading, reaction
concentration and reaction temperature as described in Table 3.8 below. Each reaction was
conducted according to the standard procedure described below with the exception of the
parameter being tested. For each reaction the yield of 5a was quantified by 1H NMR spectroscopy.
The deviation from the standard conditions was calculated in order to provide the visual colorcoded radar diagram shown in Figure 3.4. For a given parameter, the proximity of the line to the
perimeter indicates the significance of the parameter, or the reactions sensitivity to the parameter.

Conditions for reaction parameter assessment. o-phenylenediamine (0.3 mmol), tert-butyl
isocyanide (0.3 mmol), Co(OAc)2 (0.03 mmol), K2CO3 (0.6 mmol), MeCN (3 mL), 80 °C, 24
hours. Due to the limited solubility of Co(OAc)2 and K2CO3 in MeCN, and volatility of the
isonitrile, stock solutions were not prepared. All components of the reaction mixtures with varied
parameters were independently weighed. All experiments were set up according to the standard
procedure unless otherwise indicated.
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Table 3.8. Conditions used for reaction parameter assessment.

Entry
1
2
3
4
5
6
7
8
9
10
11

Evaluated Parameter
Reaction prep and setup
inert atmosphere
N2 atmosphere1
O2 content
pure O2 atmosphere
O2 balloon2
base free
0 equiv of base
base
high base loading
4 equiv of base
low catalyst loading
5 mol% of Co(OAc)2
catalyst
high catalyst loading
20 mol% of Co(OAc)2
low concentration
with 6.0 mL MeCN
concentration
high concentration
with 1.5 mL MeCN
low heating temperature
65 °C
temperature
room temperature
room temperature
control
standard reaction conditions

1

The reaction was set up in a 25 mL Schlenk tube with Schlenk line technique. See the inert atmosphere
procedure below for the detailed description. 2The reaction was set up in a 25 mL Schlenk tube with an O2
balloon attached to a needle inserted through the septum. See the O2 atmosphere procedure below for the
detailed description.

Procedure for reaction parameter assessment ortho-Phenylenediamine (32.4 mg, 0.300 mmol)
and a cobalt(II) acetate (5 mol%, 10 mol % or 20 mol%) were combined in a 6-inch test tube in a
N2 filled glovebox. K2CO3 (0 equiv, 2 equiv, or 4 equiv) was added to the same test tube. CH3CN
(1.5 mL, 3 mL or 6 mL) and tert-butylisonitrile (35.2 L, 0.300 mmol) were added and the test
tube was sealed with a septum before being removed from the glovebox. Upon removal, an air
balloon attached to a needle was inserted through the septum and the reaction mixture was then
stirred for 24 hours at room temperature, 65 or 80 °C in an oil bath. Upon completion, the reaction
mixture was cooled to room temperature and passed through a pad of Celite via vacuum filtration.
The resulting Celite cake was washed with ethyl acetate (~ 50 mL), the filtrate was collected and
concentrated by rotary evaporation to 3 mL, then passed through a silica gel plug Pasteur pipette
and rinsed with ethyl acetate (~10 mL). The filtrate was collected and the solvent was removed by
rotary evaporation. Dimethyl sulfone (3.00 mg, 0.0318 mmol) was added as an internal standard
and the crude mixture was dissolved in DMSO-d6 for 1H NMR analysis. The reaction yield was
determined by 1H NMR spectroscopy.
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(a)
(b)
Figure 3.2. Reaction set up for parameter assessment studies. (a) Preparation of the reaction
mixture inside the glovebox. (b) Final reaction setup inside a fume hood with an air balloon.

Procedure for inert atmosphere reaction (Entry 1 in Table 3.8). To a 25 mL Schlenk tube
equipped with a stir bar, ortho-phenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31mg,
0.0300 mmol), K2CO3 (82.9 mg, 0.600 mmol) were combined. The tube was then evacuated and
backfilled with N2 three times. Dry CH3CN (3 mL) and tert-butylisonitrile (35.2 L, 0.300 mmol)
were added under N2 atmosphere and the reaction mixture was stirred in a 80 °C oil bath for 24
hours. Upon completion, the reaction mixture was cooled to room temperature and passed through
a pad of Celite via vacuum filtration. The resulting Celite cake was washed with ethyl acetate (~
50 mL), the filtrate was collected and concentrated by rotary evaporation to 3 mL, then passed
through a silica gel plug Pasteur pipette and rinsed with ethyl acetate (~10 mL). The filtrate was
collected and the solvent was removed by rotary evaporation. Dimethyl sulfone (3.00 mg, 0.0318
mmol) was added as an internal standard and the crude mixture was dissolved in DMSO-d6 for 1H
NMR analysis. The reaction yield was determined by 1H NMR spectroscopy.
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Procedure for the O2 atmosphere reaction (Entry 2 in Table 3.8). To a 25 mL Schlenk tube
equipped with a stir bar, ortho-phenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31mg,
0.0300 mmol), K2CO3 (82.9 mg, 0.600 mmol) were combined. The tube was then evacuated and
backfilled with O2 three times using a O2 balloon. The side arm of the Schlenk tube was sealed
and an O2 balloon attached to a needled was balloon inserted through the septum. Dry CH3CN (3
mL) and tert-butylisonitrile (35.2 L, 0.300 mmol) were then added and the reaction mixture was
stirred in an 80 °C oil bath for 24 hours. Upon completion, the reaction mixture was cooled to
room temperature and passed through a pad of Celite via vacuum filtration. The resulting Celite
cake was washed with ethyl acetate (~ 50 mL), the filtrate was collected and concentrated by rotary
evaporation to 3 mL, then passed through a silica gel plug Pasteur pipette and rinsed with ethyl
acetate (~10 mL). The filtrate was collected and the solvent was removed by rotary evaporation.
Dimethyl sulfone (3.00 mg, 0.0318 mmol) was added as an internal standard and the crude mixture
was dissolved in DMSO-d6 for 1H NMR analysis. The reaction yield was determined by 1H NMR
spectroscopy.

Figure 3.3. Reaction setup under N2 atmosphere (left side) and O2 atmosphere (right side,
stopcocks are closed).
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Table 3.9. Results of Parameter Assessment of the Standard Reaction.
Entry
1
2
3
4
5
6
7
8
9

Evaluated Parameter
O2 content
base
catalyst
concentration
temperature

10
11

control

inert atmosphere
pure O2 atmosphere
Base free
high base loading
low catalyst loading
high catalyst loading
low concentration
high concentration
low heating
temperature
room temperature
standard reaction
condition

Run 1
(%)
9
94
67
92
67
92
86
93

Run 2
(%)
11
97
67
90
66
92
87
89

Average
% Yield
10
96
67
91
67
92
87
91

%
Deviation
-89
1
-29
-4
-29
-3
-8
-4

83

86

85

-11

37

37

37

-62

95

95

95

0

Figure 3.4. Radar diagram generated from parameter assessment data shown in Table 3.9.

The radar diagram indicates the high sensitivity of the standard reaction to an inert
atmosphere. Base loading and reaction temperature are also critical factors in influencing the yield
of the product 5a.
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3.4.4. Alternative Reaction Setups

Our parameter assessment studies revealed that the standard reaction proceeds efficiently
in the presence of a sufficient supply of oxygen. For example, with air as the source of oxygen the
reaction yields 95% of 5a, while with an O2 balloon 96% yield of 5a is obtained. Thus, it is possible
that the transformation proceeds smoothly in the absence of an air balloon with a headspace filled
with air. To test the efficacy of this protocol, we used a sealed 125 mL pressure tube as the vessel
for the reaction instead of using our standard 6-inch test tube fitted with an air balloon.
Sealed Reaction Vessel. To a 125 mL pressure tube equipped with a stir bar, orthophenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31mg, 0.0300 mmol), K2CO3 (82.9 mg,
0.600 mmol) were combined in the open air. Dry CH3CN (3 mL) and tert-butylisonitrile (35.2 L,
0.300 mmol) were added, the pressure tube was sealed and the reaction mixture was stirred in an
80 °C oil bath for 24 hours. Upon completion, the reaction mixture was cooled to room temperature
and passed through a pad of Celite via vacuum filtration. The resulting Celite cake was washed
with ethyl acetate (~ 50 mL), the filtrate was collected and concentrated by rotary evaporation to
3 mL, then passed through a silica gel plug Pasteur pipette and rinsed with ethyl acetate (~10 mL).
The filtrate was collected, and the solvent was removed by rotary evaporation. Dimethyl sulfone
(3.00 mg, 0.0318 mmol) was added as an internal standard and the crude mixture was dissolved in
DMSO-d6 for 1H NMR analysis. The reaction gave 95.9% of the desired product indicating the
efficiency of the transformation in a sealed vessel with only a headspace of air.
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Figure 3.5. Reaction setup using a pressure tube with a headspace filled with air.
The reaction also proceeds smoothly using standard Schlenk technique with reagents
stores in a benchtop dessicator without need for a glovebox.

Benchtop Procedure. To an oven-dried 25 mL Schlenk tube equipped with a stir bar, orthophenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31mg, 0.0300 mmol), K2CO3 (82.9 mg,
0.600 mmol) were combined. The tube was connected to the Schlenk line via the sidearm and was
evacuated and backfilled with an air balloon three times. The side arm valve was then closed and
an air balloon attached to a needle was inserted through the septum. Dry CH3CN (3 mL) and tertbutylisonitrile (35.2 mL, 0.300 mmol) were added and the reaction mixture was stirred in an 80 °C
oil bath for 24 hours. Upon completion, the reaction mixture was cooled to room temperature and
passed through a pad of Celite via vacuum filtration. The resulting Celite cake was washed with
ethyl acetate (~ 50 mL), the filtrate was collected and concentrated by rotary evaporation to 3 mL,
then passed through a silica gel plug Pasteur pipette and rinsed with ethyl acetate (~10 mL). The
filtrate was collected and the solvent was removed by rotary evaporation. Dimethyl sulfone (3.00
mg, 0.0318 mmol) was added as an internal standard and the crude mixture was dissolved in
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DMSO-d6 for 1H NMR analysis. The reaction yield was determined by 1H NMR spectroscopy to
be 95.9% (average of two independent reaction yields).
3.4.5. Synthesis and Characterization of 2-Aminobenzimidazoles (5) and Other Reaction
Products (6)

Representative Procedure for the Synthesis of 2-Aminobenzimidazoles (5)
Ortho-phenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31 mg, 0.0300 mmol, 10
mol %), and K2CO3 (82.9 mg, 0.600 mmol) were combined in a 6-inch test tube in an N2 filled
glovebox. CH3CN (3 mL) and tert-butylisonitrile (34.2 mL, 0.300 mmol) were added and the test
tube was sealed with a septum before being removed from the glovebox. Upon removal, an air
balloon attached to a needle was inserted through the septum and the reaction mixture was then
stirred for 24 hours at 65 or 80 °C in an oil bath. Upon completion, the reaction mixture was cooled
to room temperature and passed through a pad of Celite via vacuum filtration. The resulting Celite
cake was washed with ethyl acetate (~ 50 mL), the filtrate was collected and concentrated by rotary
evaporation to 3 mL, then passed through a silica gel plug Pasteur pipette and rinsed with ethyl
acetate (~10 mL). The solvent was removed by rotary evaporation again. The residue was purified
by silica column chromatography (98:2 EtOAc:MeOH). All 2-aminobenzimidazole compounds (5)
were prepared following the standard procedure unless otherwise noted.

2-(tert-butylamino)-benzimidazole (5a). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (98:2 EtOAc: MeOH, Rf = 0.20
in 80:15:5 CHCl3: EtOAc: MeOH) to yield 52.6 mg (0.278 mmol, 92.8 % yield) of the title
compound as a light-yellow solid (mp = 217-220 ºC). 1H NMR (400 MHz, DMSO-d6): δ = 10.19
(s, 1H), 7.15 (dd, J = 5.7, 3.2 Hz, 2H), 6.85 (dd, J = 5.7, 3.2 Hz, 2H), 6.18 (s, 1H), 1.42 (s, 9H).
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C NMR (100 MHz, DMSO-d6): δ = 154.11, 119.05, 111.77, 50.69, 29.09. FTIR (ATR, cm-1):

13

3428 (w), 3058 (w), 2960 (w), 2868 (w), 2673 (w), 1554 (s), 1481 (m), 1465 (m), 1455 (m), 1414
(m), 1391 (m), 1362 (m), 1265 (m), 1204 (s), 1069 (m), 1008 (m), 923 (m), 865 (m), 839 (m), 760
(m), 734 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H16N3 190.1337; found 190.1339. The
spectral data are consistent with those reported in the literature.57
1.0 Gram Scale Reaction. Upon scaling the reaction, the product yield is reduced, likely due to
inefficient gas-liquid mixing. Due to the limited solubility of Co(OAc)2 in CH3CN under the large
scale reaction conditions, a mixed solvent system was used to enhance the solubility of Co(OAc)2.
To an oven-dried 250 mL round-bottom flask equipped with a stir bar, o-phenylenediamine (1.00g,
9.25 mmol), Co(OAc)2 (163.7mg, 0.925 mmol) and K2CO3 (2.56g, 18.5 mmol) were combined.
The flask was sealed with a septum under air atmosphere. 125 mL 1:1 ratio of mixed solvent H2O:
CH3CN was added. With stirring, tert-butyl isocyanide (1.05 mL, 9.25 mmol) was added dropwise.
The reaction mixture was allowed to stir in an 80 °C oil bath for 48 hours under aerobic atmosphere
with two air balloons inserted through the septum. Upon completion of the reaction, the reaction
mixture was cooled down to room temperature and CH3CN were removed via rotary evaporation.
The remaining mixture was partitioned in 100 mL ethyl acetate and stirred with 3 M EDTA (100
mL) up to 12 hours. The aqueous layer was separated and extracted with ethyl acetate (2 × 50 mL).
The combined organic phase was washed with brine, separated, dried over anhydrous MgSO4,
filtered and concentrated via rotary evaporation to generate the crude product as a dark brown solid.
The product was purified by column chromatography (gradient elution from pure chloroform to
97:3 CHCl3: MeOH) to yield 377 mg (1.99 mmol, 21.5%) of the desired product as a brown solid.

2-(tert-butylamino)-5-methylbenzimidazole (5b). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (97:1:2 CHCl3:
MeOH: Et3N, Rf = 0.2 in the same solvent) to yield 58.8 mg (0.289 mmol, 96.4 % yield) of the
title compound as a brown oil. 1H NMR (400 MHz, CDCl3): δ = 10.64 (s, 1H), 7.17 (d, J = 7.9 Hz,
1H), 7.10 (s, 1H), 6.84 (d, J = 7.9 Hz, 1H), 5.64 (s, 1H), 2.35 (s, 3H), 1.37 (s, 9H). 13C NMR (100

82

MHz, CDCl3): δ = 153.81, 136.91, 134.85, 130.50, 121.82, 112.40, 111.75, 51.78, 29.58, 21.61.
FTIR (ATR, cm-1): 3277 (w), 2969 (w), 1634 (m), 1596 (m), 1568 (s), 1488 (m), 1459 (m), 1392
(m), 1364 (m), 1273 (m), 1215 (s), 1143 (w), 1034 (w), 956 (w), 938 (w), 861 (w), 802 (m), 750
(s), 665 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H18N3 204.1494; found 204.1495. The
spectral data are consistent with those reported in the literature.57

2-(tert-butylamino)-5-tert-butylbenzimidazole (5c). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (95:2:3 EtOAc:
MeOH: Et3N, Rf = 0.5 in 98:2 EtOAc: MeOH) to yield 68.3 mg (0.278 mmol, 92.6 % yield) of the
title compound as a dark brown oil. 1H NMR (400 MHz, CDCl3): δ = 8.76 (s, 1H), 7.35 (s, 1H),
7.22 (d, J = 7.9 Hz, 1H), 7.08 (d, J = 7.4 Hz, 1H), 5.29 (s, 1H), 1.40 (s, 9H), 1.32 (s, 9H).13C NMR
(100 MHz, CDCl3): δ = 154.57, 143.75, 137.61, 135.61, 117.80, 111.45, 109.01, 51.51, 34.68,
32.01, 29.61. FTIR (ATR, cm-1): 3393 (w), 3310 (w), 3086 (w), 2961 (m), 2867 (m), 1636 (m),
1596 (m), 1567 (s), 1486 (m), 1435 (m), 1391 (m), 1273 (m), 1216 (s), 1134 (w), 1086 (w), 1050
(w), 1024 (m), 934 (w), 870 (w), 811 (m), 752 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for
C15H24N3 246.1964; found 246.1965.

2-(tert-butylamino)-5-methoxybenzimidazole (5d). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (100:20:10
CHCl3: EtOAc: MeOH, Rf = 0.15 in the same solvent system) to yield 41.3 mg (0.188 mmol, 62.8%
yield) of the title compound as a brown oil. 1H NMR (400 MHz, CDCl3): δ = 8.85 (s, 1H), 7.16 (d,
J = 7.7 Hz, 1H), 6.87 (s, 1H), 6.63 (d, J = 7.6 Hz, 1H), 6.17 (s, 1H), 3.72 (s, 3H), 1.39 (s, 9H). 13C
NMR (100 MHz, CDCl3): δ = 155.58, 153.08, 136.61, 129.61, 112.09, 108.63, 97.69, 56.03, 52.06,
29.52. FTIR (ATR, cm-1): 3299 (w), 3085 (w), 2964 (m), 1636 (m), 1601 (m), 1567 (s), 1486 (s),
1446 (s), 1391 (m), 1364 (m), 1302 (m), 1261 (m), 1194 (s), 1152 (s), 1024 (s), 958 (m), 788 (s).

83

HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H18N3O 220.1443; found 220.1444. The spectral data
are consistent with those reported in the literature.57

2-(tert-butylamino)-5-bromobenzimidazole (5e). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (95:2:3 EtOAc: MeOH: Et3N, Rf = 0.7
in 98:2 EtOAc: MeOH) to yield 63.0 mg (0.226 mmol, 75.4 % yield) of the title compound as a yellow
brown solid (mp = 152-155 °C). 1H NMR (400 MHz, CDCl3): δ = 8.73 (s, 1H), 7.37 (s, 1H), 7.08 (s, 2H),
5.26 (s, 1H), 1.41 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 154.72, 139.63, 136.62, 123.07, 115.24, 112.95,
51.71, 29.55. FTIR (ATR, cm-1): 3322 (w), 3073 (w), 2967 (m), 1630 (m), 1592 (m), 1565 (s), 1462 (s),
1392 (m), 1365 (m), 1341 (w), 1267 (m), 1215 (s), 1048 (m), 1023 (m), 1006 (m), 950 (m), 908 (m), 852
(w), 801 (m), 753 (m), 677 (m). HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H15N3Br 268.0452; found
268.0444. The spectral data are consistent with those reported in the literature. 57

2-(tert-butylamino)-5-chlorobenzimidazole (5f). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (98:2:0.3 CHCl3: MeOH:
Et3N, Rf = 0.5 in 96:4:0.3 CHCl3: MeOH: Et3N) to yield 54.5 mg (0.244 mmol, 81.2 % yield) of
the title compound as a dark yellow solid (mp = 178-181 °C). 1H NMR (400 MHz, DMSO-d6): δ
= 7.17 (s, 1H), 7.12 (d, J = 8.2 Hz, 1H), 6.85 (d, J = 8.1 Hz, 1H), 6.47 (s, 1H), 1.40 (s, 9H). 13C
NMR (100 MHz, DMSO-d6): δ =154.92, 123.30, 118.63, 111.90, 50.77, 28.94. FTIR (ATR, cm1

): 3441 (w), 3074 (w), 2975 (w), 1634 (m), 1595 (s), 1567 (s), 1467 (s), 1441 (s), 1392 (m), 1364

(m), 1269 (m), 1213 (s), 1060 (s), 953 (m), 924 (m), 859 (m), 792 (s), 696 (s). HRMS (ESI-MS,
m/z) [M+H]+ calcd for C11H15ClN3 226.0920, found 226.0922. The spectral data are consistent
with those reported in the literature.57
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2-(tert-butylamino)-5-fluorobenzimidazole (5g). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (98:2:0.3 CHCl3: MeOH:
Et3N, Rf = 0.5 in 96:4:0.3 CHCl3: MeOH: Et3N) to yield 50.0 mg (0.241 mmol, 80.4 % yield) of
the title compound as a beige solid (mp = 203-205 °C). 1H NMR (400 MHz, DMSO-d6): δ = 7.05
(dd, J = 8.2, 5.0 Hz, 1H), 6.92 (d, J = 9.8 Hz, 1H), 6.61 (t, J = 9.2 Hz, 1H), 6.39 (s, 1H), 1.37 (s,
9H). 13C NMR (100 MHz, DMSO-d6): δ =158.55, 156.26, 155.03, 110.65, 105.47, 105.23, 99.36,
50.75, 28.97. 19F NMR (376 MHz, DMSO-d6): δ = -124.51 (s, 1F). FTIR (ATR, cm-1): 3439 (w),
3066 (w), 2979 (w), 2928 (w), 2856 (w), 1637 (m), 1581 (s), 1562 (s), 1486 (s), 1452 (s), 1403 (s),
1284 (m), 1254 (m), 1206 (s), 1139 (s), 1105 (m), 1068 (m), 968 (m), 947 (m), 836 (s), 791 (s),
714 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H15FN3 209.1278, found 209.1273. The
spectral data are consistent with those reported in the literature.57

2-(tert-butylamino)-5-trifluoromethylbenzimidazole (5h). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (98:2:0.3
CHCl3: MeOH: Et3N, Rf = 0.4 in 96:4:0.3 CHCl3: MeOH: Et3N) to yield 40.2 mg (0.156 mmol,
52.1 % yield) of the title compound as a dark yellow solid (mp = 166-168 °C). 1H NMR (400 MHz,
CD3OD ): δ = 7.44 (s, 1H), 7.27 (d, J = 8.2 Hz, 1H), 7.21 (d, J = 8.3 Hz, 1H), 1.45 (s, 9H). 13C
NMR (100 MHz, Methanol-d4): δ =156.85, 126.79 (q, J = 269 Hz), 123.14 (q, J = 32 Hz), 118.18
(q, J =4.0 Hz), 115.71, 112.38, 109.77, 52.15, 29.52. 19F NMR (376 MHz, Methanol-d4): δ = 61.82 (s, 3F). FTIR (ATR, cm-1): 3405 (w), 3082 (w), 2974 (w), 2936 (w), 1637 (m), 1575 (s),
1447 (m), 1366 (m), 1325 (s), 1217 (m), 1159 (m), 1112 (s), 1051 (m), 953 (w), 929 (w), 873 (w),
815 (w), 729 w), 666 (w). HRMS (ESI-MS, m/z) [M+H]+ calcd for C12H15F3N3 calcd for 259.1246,
found 259.1239.
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2-(tert-butylamino)-5-nitrobenzimidazole (5i). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (96:4:0.3 CHCl3: MeOH:
Et3N, Rf = 0.10 in the same solvent system) to yield 47.1 mg (0.201 mmol, 67.0 % yield) of the
title compound as a bright yellow solid (mp = 147-149 °C). 1H NMR (400 MHz, CD3OD): δ =
8.05 (s, 1H), 7.98 – 7.90 (m, 1H), 7.88 (s, 1H), 7.24 (d, J = 8.7 Hz, 1H), 1.48 (s, 9H). 13C NMR
(100 MHz, CD3OD): δ = 158.24, 142.63, 118.12, 112.17, 107.87, 52.39, 29.42. FTIR (ATR, cm1

): 3362 (m), 2968 (m), 2214 (w), 1635 (s), 1602 (s), 1572 (s), 1504 (m), 1470 (s), 1437 (m), 1416

(m), 1392 (m), 1360 (m), 1280 (s), 1258 (s), 1211 (s), 1121 (s), 1048 (s), 932 (s), 871 (s), 809 (m),
729 (s), 687 (s), 662 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H15N4O2 235.1191; found
235.1190. The spectral data are consistent with those reported in the literature.57

2-(tert-butylamino)-5-cyanobenzimidazole (5j). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (100:2:0.3 CHCl3: MeOH:
Et3N, Rf = 0.1 in CHCl3: MeOH: Et3N= 96:4:0.3) to yield 22.1 mg (0.103 mmol, 34.3 % yield) of
the title compound as a light brown solid (mp = 185-188 °C). 1H NMR (400 MHz, CD3OD): δ =
7.50 (s, 1H), 7.31 (d, J = 0.8 Hz, 2H), 1.48 (s, 9H). 13C NMR (100 MHz, CD3OD): δ = 157.06,
143.21, 138.58, 125.91, 121.56, 115.93, 113.49, 103.08, 52.38, 29.43. FTIR (ATR, cm-1): 3331(m),
2969 (m), 2931 (m), 2216 (m), 1632 (s), 1591 (s), 1566 (s), 1467 (s), 1445 (s), 1392 (m), 1364 (m),
1281 (s), 1216 (s), 1120 (m), 1055 (m), 959 (m), 938 (m), 866 (m), 811 (s), 755 (m). HRMS (ESIMS, m/z) [M+H]+ calcd for C12H15N4 215.1292; found 215.1291. The spectral data are consistent
with those reported in the literature.57
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2-(tert-butylamino)-4-methylbenzimidazole (5k). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (97:1:2 CHCl3:
MeOH: Et3N, Rf = 0.15 in the same solvent system) to yield 45.7 mg (0.225 mmol, 74.9 % yield)
of the title compound as a dark brown solid (mp = 146-148 °C). 1H NMR (400 MHz, CDCl3): δ =
9.69 (s, 1H), 7.21 (d, J = 7.7 Hz, 1H), 6.95 (t, J = 7.6 Hz, 1H), 6.86 (d, J = 7.4 Hz, 1H), 5.38 (s,
1H), 2.41 (s, 3H), 1.40 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 154.02, 139.55, 134.15, 121.56,
120.87, 120.59, 111.28, 51.69, 29.73, 17.00. FTIR (ATR, cm-1): 3386 (w), 3060 (w), 2968 (m),
2163 (w), 2050 (w), 1981 (w), 1627 (s), 1610 (s), 1563 (s), 1491 (m), 1457 (s), 1391 (m), 1363 (s),
1273 (s), 1216 (s), 1160 (m), 1085 (m), 1033 (m), 948 (m), 866 (w), 776 (s), 739 (s). HRMS (ESIMS, m/z) [M+H]+ calcd for C12H18N3 204.1495; found 204.1495. The spectral data are consistent
with those reported in the literature.57

2-(tert-butylamino)-7-bromobenzimidazole (5l). The title compound was synthesized according
to the standard procedure and purified by silica column chromatography (96: 4: 0.3 CHCl3: MeOH:
Et3N, Rf = 0.15 in the same solvent system) to yield 70.3 mg (0.262 mmol, 87.4 % yield) of the
title compound as a dark brown solid (mp = 158-160 °C). 1H NMR (400 MHz, CDCl3): δ = 9.57
(s, 1H), 7.25 (d, J = 7.2 Hz, 1H), 7.16 (d, J = 7.8 Hz, 1H), 6.90 (t, J = 7.8 Hz, 1H), 5.22 (s, 1H),
1.40 (s, 9H). 13C NMR (100 MHz, CDCl3): δ = 154.11, 140.10, 135.88, 123.22, 121.93, 112.40,
103.94, 51.95, 29.78. FTIR (ATR, cm-1): 3394 (w), 2968 (m), 1628 (m), 1586 (s), 1565 (s), 1459
(m), 1433 (s), 1392 (m), 1364 (s), 1268 (s), 1214 (s), 1182 (s), 1138 (m), 1044 (m), 930 (m), 77
(s), 730 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C11H15N3Br 268.0448; found 268.0444.
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2-(tert-butylamino)-naphtho[2,3-d]imidazole (5m). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (80:15:5 CHCl3:
EtOAc: MeOH, Rf = 0.15 in the same solvent system) to yield 45.3 mg (0.189 mmol, 63.1% yield)
of the title compound as a dark brown solid (mp = 100-102 °C). 1H NMR (400 MHz, CDCl3): δ =
9.76 (s, 1H), 7.73 (d, J = 2.4 Hz, 2H), 7.63 (s, 2H), 7.29 (d, J = 2.9 Hz, 2H), 6.31 (s, 1H), 1.42 (s,
9H).

13

C NMR (100 MHz, CDCl3): δ = 155.83, 137.49, 130.04, 127.39, 123.54, 107.57, 52.10,

29.50. FTIR (ATR, cm-1): 3386 (w), 3054 (w), 2968 (m), 2930 (w), 1651 (m), 1601 (s), 1567 (s),
1463 (m), 1447 (s), 1425 (s), 1392 (m), 1334 (m), 1260 (s), 1207 (s), 1113 (m), 1058 (w), 1034
(w), 944 (m), 852 (s), 783 (m), 742 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C15H18N3
240.1494; found 240.1495.

2-(1,1,3,3-tetramethylbutylamino)benzimidazole (5n). The title compound was synthesized
according to the standard procedure and purified by silica column chromatography (96: 4: 0.3
CHCl3: MeOH: Et3N, Rf = 0.15 in the same solvent system to yield 61.8 mg (0.252 mmol, 84.0 %
yield) of the title compound as a dark brown solid (mp = 143-146 °C). 1H NMR (400 MHz, CDCl3):
δ = 10.71 = (s, 1H), 7.31 (s, 2H), 7.04 (s, 2H), 5.47 (s, 1H), 1.73 (s, 2H), 1.48 (s, 6H), 0.90 (s, 9H).
C NMR (100 MHz, CDCl3): δ = 153.61, 136.83, 120.85, 112.09, 55.66, 52.67, 31.69, 31.56,

13

29.82. FTIR (ATR, cm-1): 3394 (w), 3060 (w), 2951 (m), 1629 (m), 1599 (m), 1564 (s), 1462 (s),
1421 (m), 1386 (m), 1364 (m), 1271 (m), 1247 (m), 1222 (s), 1150 (m), 1060 (w), 1008 (m), 955
(w), 800 (w), 735 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C15H24N3 246.1964; found
246.1965.
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2-(1-admantylamino)benzimidazole (5o). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (95:2:3 EtOAc: MeOH: Et3N,
Rf = 0.4 in 98:2 EtOAc: MeOH) to yield 58.3 mg (0.235 mmol, 78.2% yield) of the title compound
as a dark reddish-maroon solid (mp = 220-222 °C). 1H NMR (400 MHz, DMSO-d6): δ = 10.13 (s,
1H), 7.13 (s, 2H), 6.83 (s, 2H), 6.05 (s, 1H), 2.07 (s, 9H), 1.66 (s, 6H).13C NMR (100 MHz, DMSO):
δ = 153.57, 118.97, 111.71, 50.82, 41.61, 36.09, 29.05. FTIR (ATR, cm-1): 3386 (w), 3059 (w),
2904 (s), 2850 (m), 1627 (m), 1600 (m), 1567 (s), 1462 (s), 1398 (w), 1358 (s), 1342 (m), 1264
(s), 1139 (m), 1049 (m), 935 (m), 815 (m), 756 (s), 665 (m). HRMS (ESI-MS, m/z) [M+H]+ calcd
for C17H22N3 268.1807; found 268.1808. The spectral data are consistent with those reported in
the literature.136

2-(cyclohexylamino)benzimidazole (5p). The title compound was synthesized according to the
standard procedure and purified by silica column chromatography (97:1:2 CHCl3: MeOH: Et3N,
Rf = 0.15 in the same solvent system) to yield 40.0 mg (0.186 mmol, 61.9 % yield) of the title
compound as a yellow oil. 1H NMR (400 MHz, DMSO-d6): δ = 10.62 (s, 1H), 7.10 (s, 2H), 6.84
(dd, J = 5.3, 2.9 Hz, 2H), 6.56 (d, J = 5.7 Hz, 1H), 3.51 (m, 1H), 1.94 (d, J = 11.1 Hz, 2H), 1.71
(d, J = 12.3 Hz, 2H), 1.59 (d, J = 12.6 Hz, 1H), 1.24 (qd, J = 23.6, 11.8 Hz, 5H). 13C NMR (100
MHz, DMSO-d6): δ = 154.58, 119.06, 111.38, 50.92, 32.96, 25.37, 24.73. FTIR (ATR, cm-1): 3265
(w), 3056 (w), 2926 (s), 2853 (m), 1665 (m), 1631 (s), 1602 (s), 1577 (s), 1464 (s), 1450 (s), 1402
(m), 1358 (m), 1266 (s), 1213 (m), 1148 (m), 1106 (m), 1024 (m), 890 (m), 810 (m), 738 (s).
HRMS (ESI-MS, m/z) [M+H]+ calcd for C13H18N3 216.1495; found 216.1495. The spectral data
are consistent with those reported in the literature.137
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Synthesis of N-Substituted 2-Aminobenzimidazoles (3q and 3r)

To a 6-inch test tube in an N2 filled glovebox, N-substituted ortho-phenylenediamine (0.300 mmol),
Co(OAc)2 (5.31mg, 0.0300 mmol), K2CO3 (82.9 mg, 0.600 mmol) were combined. CH3CN (3 mL)
and tert-butylisonitrile (35.2

L, 0.300 mmol) was added and the test tube was sealed with a

septum before being removed from the glovebox. The reaction mixture was then stirred for 24
hours in an 80 °C oil bath with an air balloon attached to a needle inserted through the septum.
Upon completion, the reaction mixture was cooled to room temperature, diluted with 10 mL ethyl
acetate and filtered through a pad of Celite. An additional 20 mL of ethyl acetate was used to flush
the Celite and the filtrate was concentrated to ~3 mL under vacuum. The resulting concentrate was
then passed through a silica gel plug Pasteur pipette and rinsed with ~10 mL ethyl acetate. The
solvent was removed by rotary evaporation to generate the crude product as a dark brown solid.
Dimethyl sulfone (2.90 mg, 0.03 mmol) was added as an internal standard and the crude mixture
was dissolved in DMSO-d6 for 1H NMR analysis.
N-tert-butyl-1-methyl-1H-benzimidazol-2-amine (5q). 1H NMR (400 MHz, DMSO-d6): δ =
7.22 (d, J = 7.4 Hz, 1H), 7.11 (d, J = 7.4 Hz, 1H), 6.91 (p, J = 7.5 Hz, 2H), 5.90 (s, 1H), 3.48 (s,
3H), 1.46 (s, 9H). The spectral data is consistent with those reported in the literature.80
N-tert-butyl-1-phenyl-1H-benzimidazol-2-amine (5r). 1H NMR (400 MHz, CDCl3): δ = 7.65 –
7.46 (m, 4H), 7.41 (d, J = 7.9 Hz, 2H), 7.13 (t, J = 7.6 Hz, 1H), 6.98 (t, J = 7.6 Hz, 1H), 6.91 (d, J
= 7.8 Hz, 1H), 4.15 (s, 1H), 1.50 (s, 9H). The spectral data are consistent with those reported in
the literature.138
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N2,N3-dipentylquinoxaline-2,3-diamine (6). The title compound was synthesized according to
the standard procedure and purified by silica column chromatography (gradient elution from pure
hexanes to 6:1 hexanes: ethyl acetate, Rf = 0.55 in 6:1 hexanes: ethyl acetate) to yield 11.5 mg
(0.0383 mmol, 25.5% yield) of the title compound as a light brown oil. 1H NMR (400 MHz,
CDCl3): δ = 7.67 (dd, J = 5.9, 3.5 Hz, 2H), 7.30 (dd, J = 6.1, 3.5 Hz, 2H), 4.91 (s, 2H), 3.56 (t, J
= 7.2 Hz, 4H), 1.84 – 1.56 (m, 4H), 1.49 – 1.29 (m, 9H), 1.26 (s, 2H), 0.91 (t, J = 6.8 Hz, 7H),
0.07 (s, 2H). 13C NMR (100 MHz, CDCl3): δ = 144.45, 136.46, 125.35, 124.90, 42.80, 29.49, 29.13,
22.61, 14.15. FTIR (ATR, cm-1): 3341(w), 2956 (m), 2928 (m), 2858 (m), 1649 (w), 1598 (m),
1556 (s), 1505 (s), 1460 (s), 1352 (m), 1330 (m), 1259 (m), 1259 (m), 1214 (s), 1144 (m), 1022
(m), 936 (w), 801 (m), 750 (s), 666 (m). HRMS (ESI-MS, m/z) [M+H]+ calcd for C18H29N4
301.2387; found 301.2384.

3.4.6. Synthesis of 2-Aminobenzimidazoles (5s and 5t)

2-aminobenzimidazole (5s). ortho-phenylenediamine (32.4 mg, 0.300 mmol), Co(OAc)2 (5.31mg,
0.0300 mmol), K2CO3 (82.9 mg, 0.600 mmol) were combined in a 6-inch test tube in an N2 filled
glovebox. CH3CN (3 mL) and tert-butylisonitrile (35.2

L, 0.300 mmol) were added and the test

tube was sealed with a septum before being removed from the glovebox. The reaction mixture was
then stirred for 24 hours in an 80 °C oil bath with an air balloon attached to a needled inserted
through the septum. Upon completion, the reaction mixture was cooled to room temperature,
diluted with ethyl acetate (10 mL) and filtered through a pad of Celite. Additional ethyl acetate
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(20 mL) was used to flush the Celite and the resulting filtrate was transferred in a 100 mL twoneck flask and the solvent was removed by rotary evaporation. The flask was then connected to
the Schlenk line and evacuated and backfilled with nitrogen three times. Under a N2 atmosphere,
dry toluene (20 mL) was added by syringe followed by a solution of concentrated HCl (1 mL) in
toluene (5 mL). The resulting reaction mixture was placed in a 120 °C oil bath and allowed to
reflux overnight. Upon completion, the reaction mixture was cooled to room temperature, basified
with 3M NaOH until the aqueous layer reached a pH of ~13 (monitored by pH paper) and turned
from a black goo to a dark brown suspension. The aqueous layer was extracted with ethyl acetate
(3 x 50 mL) and the combined organic layers were washed with brine (50 mL), separated, dried
over anhydrous sodium sulfate, filtered, and the solvent removed under vacuum to yield the crude
product as a light yellow solid. Dimethyl sulfone (3.00 mg, 0.0318 mmol) was added as an internal
standard and the crude mixture was dissolved in DMSO-d6 for 1H NMR analysis. The reaction
yield was determined by 1H NMR spectroscopy to be 82%.
1

H NMR (400 MHz, DMSO-d6): δ = 7.09 (s, 2H), 6.84 (s, 2H), 6.18 (s, 2H). The spectral data are

consistent with those reported in the literature.57

2-Amino-5-benzoyl-1H-benzimidazole (5t). In a N2-filled glovebox, a 6-inch test tube equipped
with a stir bar was loaded with 3,4-diaminobenzophenone (63.7 mg, 0.300 mmol), Co(OAc)2 (5.31
mg, 0.0300 mmol), and K2CO3 (82.9 mg, 0.600 mmol). Dry CH3CN (5 mL) was added to the test
tube followed by tert-butylisonitrile (34.2 mL, 0.300 mmol). The test tube was then removed from
the glovebox and the reaction mixture was stirred in an 80 °C oil bath for 24 hours. Upon
completion, the reaction mixture was cooled to room temperature, filtered through a pad of Celite,
and the Celite was rinsed with 30 mL of ethyl acetate. The filtrate was then transferred to a 100
mL two-neck flask and the solvent was removed under vacuum. The flask was then connected to
the Schlenk line, fitted with a water condenser and evacuated and backfilled with N2 three times.
Under a N2 atmosphere, dry toluene (20 mL) was added via syringe, followed by a mixture of
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concentrated HCl (1 mL) in toluene (5 mL). The reaction mixture was heated at 120 °C with
stirring overnight to enable complete dealkylation. Upon completion, the reaction mixture was
cooled to room temperature, basified with 3M NaOH until the aqueous layer reached a pH of ~13
(monitored by pH paper) and turned from a black goo to a dark brown suspension. The aqueous
layer was then extracted with ethyl acetate (3 x 50 mL) and the combined organic layers were
washed with brine, separated, dried over anhydrous sodium sulfate, filtered, and concentrated via
rotary evaporation to generate the crude product as a dark yellow solid. The product was purified
by silica column chromatography (EtOAc: MeOH: Et3N = 90:10:5, Rf = 0.1 in the same solvent
system) to yield the title compound. Due to the presence of triethylamine in the isolated compound,
an aqueous extraction was applied to remove remaining triethylamine. The isolated compound was
dissolved in 30 mL ethyl acetate and partitioned into 100 mL water. The water layer was extracted
ethyl acetate (2 x 20 mL) and the combined organic layers were washed with brine, dried over
anhydrous sodium sulfate, filtered, and concentrated via rotary evaporation to provide 49.9 mg of
the titled compound (0.210 mmol, 70.1 %) as a yellow solid (m.p.= 169-174 ºC). 1H NMR (400
MHz, DMSO-d6): δ = 7.71 – 7.64 (m, 2H), 7.64 – 7.48 (m, 4H), 7.40 (d, J = 1.7 Hz, 1H), 7.20 (d,
J = 8.2 Hz, 1H), 6.74 (s, 2H). 13C NMR (100 MHz, DMSO-d6): δ = 195.47, 157.68, 145.25, 139.03,
136.62, 131.51, 129.22, 128.32, 127.78, 123.56, 112.64, 111.92. FTIR (ATR, cm-1): 3320 (w),
3171 (w), 3060 (w), 2923 (w), 2853 (w), 1598 (s), 1565 (s), 1519 (s), 1466 (m), 1433 (s), 1344
(m), 1318 (s), 1283 (s), 1177 (w), 1071 (m), 1026 (m), 975 (w), 930 (w), 873 (m), 851 (m), 825
(m), 790 (s), 709 (s), 695 (s). HRMS (ESI-MS, m/z) [M+H]+ calcd for C14H12N3O 238.0975; found
238.0974.
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3.4.7. Procedures for Control Experiments with Radical Trapping Agents

Standard procedure for radical trap experiments. ortho-phenylenediamine (32.4 mg, 0.300
mmol), Co(OAc)2 (5.31 mg, 0.0300 mmol), K2CO3 (82.9 mg, 0.600 mmol) and radical scavenger
(2.0 equiv, 0.600 mmol) were combined in a 6-inch test tube in an N2 filled glovebox. CH3CN (3
mL) and tert-butylisonitrile (35.2 mL, 0.300 mmol) were added and the test tube was sealed with
a septum before being removed from the glovebox. The reaction mixture was then stirred for 24
hours in an 80 °C oil bath with an air balloon inserted through the septum.
Work up method for control experiment with 1,1-diphenylethylene as the radical scavenger.
Upon completion, the reaction mixture was cooled to room temperature, diluted with 10 mL ethyl
acetate and filtered through a pad of Celite. An additional 20 mL ethyl acetate was used to wash
the Celite and the resulting filtrate was concentrated to ~3 mL on the rotary evaporator. The
resulting solution was then passed through a silica gel Pasteur pipette to remove any remaining
cobalt and the pipette was flushed with additional 10 mL of ethyl acetate. The filtrate was collected
and the solvent was removed via rotary evaporation to generate the crude product. Dimethyl
sulfone (3.00 mg, 0.0318 mmol) was added as an internal standard and the crude mixture was
dissolved in DMSO-d6 for 1H NMR analysis. The reaction yield was determined by 1H NMR
spectroscopy.
Work up method for control experiment with TEMPO as the radical scavenger. After cooling
to room temperature, the reaction mixture was diluted with ethyl acetate (20 mL) and the resulting
mixture was extracted with a saturated solution of Na2S2O3 (3 x 20 mL) until the organic layer
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changed from dark red to light yellow. The organic layer was then washed with brine, and the
resulting organic layer was dried over anhydrous sodium sulfate, filtered, and finally concentrated
via rotary evaporation to ~3 mL. The concentrated sample was then passed through a Pasteur
pipette silica gel plug to remove any remaining cobalt and the pipette was flushed with additional
10 mL of ethyl acetate. The filtrate was collected and the solvent was removed via rotary
evaporation to generate the crude product as a brownish-red solid. Dimethyl sulfone (3.00 mg,
0.0318 mmol) was added as an internal standard and the crude mixture was dissolved in DMSOd6 for 1H NMR analysis. The reaction yield was determined by 1H NMR spectroscopy.

3.4.8. Attempts in the Synthesis of Mebendazole from 2-Amino-5-Benzoyl Benzimidazole
As we stated previously, the formation of mebendazole from 2-amino-5-benzoyl
benzimidazole (5t) was quite challenging due to the presence of exchangeable NH protons in the
starting material. Aside from the methodologies applied in Scheme 3.8 we especially extended our
exploration in this transformation using methyl chloroformate as a coupling partner, but with
varied reaction conditions (Scheme 3.10). We realized a fully conversion of the starting material
in these related reaction conditions; however, these transformations yielded almost 1:1 mixture of
mebendazole isomers exclusively regardless of the varied bases and reaction stoichiometry.
Suggesting a thermodynamic preference of the following structural isomers over mebendazole
under these reaction conditions.

95

Scheme 3.10. Attempts in the synthesis of mebendazole from 2-amino-5-benzoyl benzimidazole
and methyl chloroformate.

Structures of mebendazole isomers are elucidated by 1H-NMR using one of the model
reactions from Scheme 3.10, where NaHCO3 was employed as a base. Characteristic protons on
the benzimidazole ring are highlighted in each structure of the mebendazole isomers. Due to the
extreme similarity of the physical properties these two isomers presented, the isolation proved to
be impractical. Therefore the structure elucidation here is provided by the sample with mixed
isomers (Figure 3.6-3.9).
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Figure 3.6. Mixture of the two mebendazole structural isomers from the model transformation.

Figure 3.7. 1H NMR for structural elucidation of mebendazole isomer with 1-acylation.
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Figure 3.8. 1H NMR for Structural elucidation of mebendazole isomer with 3-acylation.

Figure 3.9. 13C NMR for the mixture of two mebendazole isomers.
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Chapter 4. Synthesis, Isolation and Characterization of the Well-Defined
CoII and CoIII Complexes bearing NH2-unsubstituted Aminophenol
Ligands and Their Reactivity Studies in the Aerobic Oxidative
Cyclization Reactions
4.1. Introduction

In transition metal catalysis, the property of a complex can be affected by the coordination
of ligand to the metal center. Redox non-innocent ligands, which can engage in a ping-pong
mechanism by easily being oxidized or reduced by one or more electrons, can have important
effects on the redox states of the transition metal center upon coordination. These ligands are
capable of stabilizing metal ions with unusual oxidation states through modification of the
electrochemical potentials, and act as an electron-reservoirs which allow the transition metal to
maintain its most common or stable oxidation state in multielectron transformations by donating
or accepting the electron densities. 139-141 O-aminophenol, an archetypal example of a redox noninnocent ligand, has been used widely paired with numerous transition-metal catalysts. This ligand
can accommodate three stable oxidation states once deprotonated, o-aminophenolate, oiminosemiquinoate and o-iminobenzoquinone as shown in Scheme 4.1. Metal complexes with one
and two electron reduced forms in o-aminophenol type ligands have been intensively reported by
multiple research groups.142-146

Scheme 4.1. Oxidation states of the bidentate o-aminophenol as a redox-active ligand
Among the types of redox non-innocent ligands, extensive studies have focused on 3,5-ditert-butyl substituted o-aminophenol ligands. The increased electron-donating property of tertbutyl groups enables the deprotonated ligand to stabilize the complex with high oxidation states
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efficiently. Also, these substituents play a critical role in facilitating the oxidation of the ligand
while suppressing its oxidative decomposition by lowering the oxidation potential of the ligand.147
With the increasing interest of pairing 3,5-di-tert-butyl-o-aminophenol with transition-metal
catalysts, great efforts have been made on the synthesis and studies of such complexes with a wide
range of transition metals, such as iron complexes,148 uranium complexes,149 platinum
complexes,150 and zirconium complexes.151
While the 2nd and 3rd row late transition metals have a well-established two-electron
oxidation state changes in catalysis, first-row base metals don’t necessarily undergo the same
transformations due to their preference for the single-electron redox changes, for example,
CoII/CoIII couples. In this regard, the combined behavior of a base metal and a redox non-innocent
ligand may facilitate 2e- transformations resembling those of noble metals without compromising
to the high energy redox-states for oxidizing the metal by two electrons.141 The Wieghardt group
has made significant contributions in elucidating the electronic structure and the coordination
chemistry of redox non-innocent ligands involving catechol, o-aminophenol and ophenylenediamine.

69, 70, 152-156

These works have provided valuable insights towards the

understanding of how the ligands bind to the metal center and interact with the metal in different
oxidation states. CoIII complexes consisting of 3,5-di-tert-butyl-o-aminophenol ligands were
amongst those of the most studied by this group. A few examples of these metal complexes are
illustrated in Figure 4.1. Regardless of the coordination environment of these structures, most of
the well-defined CoIII complexes exclusively contain o-aminophenol ligands with bulky aromatic
substitution on each NH moiety,

55, 70, 145

a comprehensive study on a cobalt complex bearing o-

aminophenol ligands with unsubstituted NH2 groups has yet to be reported.

Figure 4.1. Selected examples for cobalt complexes with 3,5-di-tert-butyl-o-aminophenols.
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In these extensively studied CoIII complexes the ligand radical anions were assigned. Upon
oxidation, the metal center remained CoIII while the ligands engaged in the redox changes when
coordinated to the metal, resembling the oxidative transformation mediated by noble metals. A
few decades prior to these findings, Gary and co-workers had demonstrated that square planner
cobalt and nickel complexes with dithiolene ligands were best described as metal (II) species with
two ligand radical anions, rather than the assumed metal with +4 oxidation states and ligands with
-2.157, 158 Due to the presence of the extended network of π bonds, these redox non-innocent ligands
not only allow themselves to stabilize the radical species but also promote reversible reactions
with the metal center, when the formation of radicals are involved.159 These carbon-centered ligand
radicals were not only determined in cobalt complexes, they were also frequently reported in the
structural elucidation of other metal complexes such as NiII,160 CuII,145, 156 PdII,145, 154 and FeIII 69,
155

when the same 3,5-di-tert-butyl-o-aminophenol ligand was employed.
Despite all the notable advances in assigning the true electronic structure of these transition

metal complexes involving redox non-innocent ligands, reactivity studies using these metal
complexes with radicals on the supporting ligands as catalysts are still underrepresented.
Wieghardt and co-workers reported the first examples where redox-active ligands in the metal
complexes effectively engaged in C-H bond activations.161 The work was inspired by enzymatic
reactions of galactose oxidase, which performs the two-electron oxidation of alcohols to aldehydes.
Using CuII and ZnII complexes of a tetradentate redox non-innocent ligand, primary alcohols could
effectively be oxidized to aldehydes with the reduction of O2 to H2O2 (Scheme 4.2). Under aerobic
conditions, the single electron oxidized complex (a) underwent a stoichiometric oxidation of the
primary alcohol and gave rise to complex (b). Through a rate-determining HAA step and electron
transfer, the corresponding aldehyde was generated along with the doubly protonated, singleelectron reduced species (d), which immediately regenerated complex (a) in the presence of
molecular oxygen to complete the cycle.
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Scheme 4.2. Proposed mechanism for the catalytic oxidation of primary alcohols by dioxygen
employing complexes of a tetradentate redox non-innocent ligand.

Although this revolutionary work had shed a lot of light on the later studies of the primary
alcohol oxidation reactions using well-characterized metal complexes bearing aminophenolderived redox non-innocent ligands,162, 163 implications for cobalt complexes containing redoxactive aminophenolate-type ligand in catalysis are still quite limited. To date, the only wellestablished work demonstrating the reactivity of cobalt aminophenolate complexes was reported
by the Soper group,71 where a square planner CoIII complex was capable of catalyzing a Negishilike cross-coupling reaction of an alkyl halide with an organozinc reagent (Scheme 4.3). The
starting CoIII complex had two bidentate amidophenolato ligands coordinating to the metal center
in the anionic aminophenolate form. This complex demonstrated a very unique reactivity to behave
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as a nucleophile and react towards the alkylhalide, affording the square pyramidal alkyl complex
in quantitative yield. While the cobalt remained the same oxidation state during the oxidative
addition, the electrons required for this transformation were provided by the amidophenolato
ligands, both of which were oxidized to o-iminosemiquinoate (sq-) oxidation state. Upon treatment
of the alkyl complex with zinc bromide, ethyl benzene was observed as a result of C-C bond
formation. The starting CoIII complex with square planer geometry was regenerated.

Scheme 4.3. Negishi-type cross-coupling reaction of alkyl halides with organozinc reagents by
CoIIIbis(o-amidophenolato) complex.

In this regard, the work in this chapter strives to deepen the understanding of cobalt
complexes bearing redox non-innocent aminophenolate ligands, especially their engagement in the
oxidative cyclization reactions with bis-nucleophiles through O2 activation. To date, the cobalt
complexes reported in this chapter are the first examples of well-characterized CoII and CoIII
species bearing redox-active 3,5-di-tert-butyl-o-aminophenol ligand without NH2 substitutions.
Notably, the bulky N-substitutions on the most commonly used aminophenol-derived ligands play
a critical role in stabilizing Co complexes in the presence of O2. The Paine research group recently
reported a biomimetic six-coordinate Fe(II) complex capable of oxidizing 2-amino-4-tertbutylphenol to picolinic acid in the presence of O2 (Scheme 4.4),164 which resembles the activity
of the dioxygenase metalloenzymes165 that are able to catalyze the ring cleavage of numerous
organic substrates. This finding suggests that to sustain the stability of carbon-centered ligand
radicals against oxidative ring opening reactions in the presence of O2, both N-substitutions and
protective tert-butyl groups at the backbone of aminophenol are necessary.
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Scheme 4.4. Proposed mechanism for oxidative ring cleavage of 2-amino-4-tert-butylphenol to
the picolinic acid in the presence of O2.

As a continuation of our previous mechanistic investigations on the oxidative cyclization
reactions with bis-nucleophiles, these extremely challenging complexes were further tested in the
model reaction developed in chapter 2 for their ability to effectively mediate aerobic oxidative
cyclization reactions as potential active intermediates. Beyond the above investigations, this work
expands on the currently limited understanding of first-row base metal species from the structure
elucidation to the implementation in the organic transformations.

4.2. Results
4.2.1. Synthesis of CoII complex bearing 2-amino-4,6-ditert-butyl phenol ligands CoII(2amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-butylphenol)2
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Initially, several attempts to isolate the cobalt complex containing the unsubstituted 2amino-4-nitrophenol ligands were unsuccessful. Mixtures of products were obtained due to the
solubility issues associated with the starting materials and the products. Consequently, the efficacy
of 2-amino-4,6-di-tertbutyl phenol was tested in the standard conditions for aerobic oxidative
cyclization developed in Chapter 2 (Scheme 4.5), where the desired product 3w was generated
with an isolated yield of 78%. Based on the positive results, the 2-amino-4,6-di-tertbutyl phenol
was selected as the ligand of choice to synthesize and isolate the cobalt complexes.

Scheme 4.5. Cobalt-catalyzed oxidative coupling of 2-amino-4,6-di-tert-butyl phenol and tertbutyl isonitrile under the standard reaction conditions.

The synthesis of the CoII complex was performed under a rigorously inert atmosphere using
acetonitrile as the solvent. Triethylamine was introduced as a base to deprotonate the ligand. CoCl2
was chosen as the cobalt source for its greater solubility compared to Co(OAc)2. When 2-amino4,6-di-tert-butylphenol was employed as a ligand, we were delightful to find that under the reaction
conditions shown in Scheme 4.6, a cobalt complex with a unique coordinating environment was
formed in acetonitrile, regardless of the ratio between the metal and the ligand. These results are
in contrast to the observations in most other studies, where the corresponding complexes were
formed based on the stoichiometry of the ligands introduced;70, 145 however, the ligands presented
in those studies all used bulky N-substitutions as detailed in the introduction, which may help to
stabilize the 1:2 and 1:3 complexes in solution. In this work, the monomeric cobalt complex was
obtained in optimal yield when a 1:4 metal to ligand ratio was employed. A microcrystalline solid
was generated with a golden sheen. Based on the extent of acetonitrile solvation, the color of the
solid varied from beige to faint greyish green in different batches of synthesis.
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Entry

M:L Ratio

% Yield

1
2
3
4

1:1
1:2
1:3
1:4

43
54
70
93

Scheme 4.6. Synthesis and condition optimization of CoII-APditBu complex CoII(2-amino-4,6-tertbutylphenolate)2(2-amino-4,6-tert-butylphenol)2 by varying metal to ligand ratio.

1

H-NMR spectroscopy could not confirm the structure of the CoII complex 7 due to its

paramagnetic nature. Single crystals, suitable for X-ray diffraction studies, were acquired by slow
evaporation of the mixture under anaerobic conditions upon reaction completion. X-ray
crystallography elucidation indicated the space group Im3̅ of the resulting cubic light-yellow
single crystal. A unique coordinating environment of the CoII complex is determined as shown in
Figure 4.2, which consists of two monodentate aminophenol ligands cis to each other and two
bidendate aminophenolate ligands, binding through the octahedral geometry.
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Figure 4.2. The structure of Co(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-butylphenol)2.
All non-hydrogen atoms are dawn as 40% thermal probability ellipsoids. All hydrogen atoms
except those on heteroatoms are omitted for clarity.

4.2.2. Synthesis of CoIII complex bearing 2-amino-4,6-di-tert-butyl phenol ligands Co2III(2amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-butylphenol)(μ-2-amido-4,6-tertbutylphenolate)2
The synthesis of the CoIII complex bearing the same 2-amino-4,6-di-tert-butyl phenol was
initially attempted by the homogenous aqueous synthesis employing air as the source of oxidant.
Under the ambient atmosphere, numerous trials led to the generation of a mixture of products,
which was difficult to purify due to the superior solubility of the products in most polar organic
solvents or the mixed solvents. In these experiments, CoCl2 was treated with two or three
equivalents of the 2-amino-4,6-di-tert-butylphenol ligands along with the same equivalents of
bases. The reactions were carried out under either room temperature or reflux conditions in the
presence of air, but no cobalt species shown in Scheme 4.7 were isolated as pure substances. The
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mixture of the products was extremely soluble in most organic solvents. The lack of bulky Nsubstitution on the aminophenolate ligand may also contribute to the instability of the formed
product in solution when the reactions were carried out under an aerobic atmosphere. These
observations were in accordance with similar discoveries by other research groups, that ligands
such as catecholate and diamines usually would be unstable in solution when they are bound to
metal centers, due to their distinctive ability to form radical species.159

Scheme 4.7. Attempted synthesis of CoIII-APditBu complex in the aqueous medium under ambient
atmosphere. Conditions: CoCl2 (1equiv), 2-amino-4,6-di-tert-butylphenol (2 or 3 equivs),
triethylamine (2 or 3 equivs), acetonitrile. These reactions were carried out under ambient
atmosphere either at room temperature or reflux conditions.

In one of Wieghart’s studies, it was disclosed that when a comparable type of redox-active
ligand 2-amino-4,6-di-tert-butyl thiophenol was employed in the synthesis of CoII complexes,
solid state oxidation was observed immediately upon the exposure of CoII complex to the air, as
indicated by the color change (Scheme 4.8). Inspired by this discovery, a small batch of CoIIAPditBu was taken out of the glovebox for testing of solid-state oxidation. An instant color change
was observed from light grey to shinny dark violet when the compound was exposed to air,
demonstrating the efficiency of solid-based oxidation to isolate the CoIII-aminophenolate
complexes in this study.

108

Scheme 4.8. Solid state oxidation observed by Wieghart group for the oxidation of the CoII
complex [CoII(LSAP)2]2·2CH3CN in the presence of air (LSAP= 2-amino-4,6-di-tertbutylthiophenol).

Subsequently, we concentrated our efforts on the characterization of this oxidized
compound. From our observations, the degree of solvation affected the rate at which oxidation of
the CoII-APditBu complex occurred. The presence of the solvent led to a slower rate of oxidation,
whereas, the oxidation occurred in a few hours in the solid state. Elemental analysis confirmed the
identity of the oxidized species to be a 3:1 ligand: metal complex, such as a monomeric complex
8a or 8b with three ligands coordinating to one cobalt center, as illustrated in the Scheme 4.9.

Scheme 4.9. Solid-state oxidation of metal complex CoII(2-amino-4,6-tert-butylphenolate)2(2amino-4,6-tert-butylphenol)2 under air.

A violet plate-shaped single crystal was able to be obtained by slow diffusion of pentane
into dichloromethane dissolved with CoIII-APditBu complex under the rigorously anaerobic
atmosphere and submitted to X-ray diffraction. The structure of the crystal was elucidated as a
dimeric metal complex with the space group P21/n. Each cobalt center possesses three
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aminophenol-derived ligands with distinct coordinating environments (Figure 4.3), a neutral
aminophenol ligand, a monoanionic aminophenolate ligand, and a bridging aminophenolate ligand
connecting two cobalt centers via the NH group. Although the structure of this CoIII-APditBu
complex revealed a dimeric species rather than monomeric as proposed, it is consistent with the
elemental analysis of the compound collected from the solid-state oxidation.

Figure 4.3. The structure of Co2(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tertbutylphenol)(μ-2-amido-4,6-tert-butylphenolate)2. All non-hydrogen atoms are drawn as 50%
thermal probability ellipsoids. All hydrogen atoms except those on heteroatoms are omitted for
clarity.
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4.2.3. Evaluations of the Electronic Properties of CoII-APditBu (7) and CoIII-APditBu (8)
Complexes

4.2.3.1. UV-Visible Spectroscopy
The electronic properties of both CoII-APditBu (7) and CoIII-APditBu (8) were evaluated by
UV-visible spectroscopy (Figure 4.4). The electronic spectrum of complex (7) measured in
CH2Cl2 displayed no intense absorption maxima above 450 nm, suggesting that the ligands
coordinated to the metal center are aromatic, in accordance with the X-ray structure. The electronic
spectrum of CoIII-APditBu (8) presented two intense absorption maxima in CH2Cl2 solution around
550 nm (ε = 3.6×103 M-1 cm-1) and 783 nm (ε = 7.5×102 M-1 cm-1), which were absent for the CoII
complex, indicating that a ligand to metal charge transfer may be involved. Although the X-ray
crystal structure of this CoIII compound showed aromatic coordinating ligands of 2-amino-4-6-ditert-butyl phenolate, in solution this compound may have radicals residing on the ligands, as
suggested by the structure of 8a. A series CoIII complexes reported by Weighardt and co-workers
consisting of N-substituted iminosemiquinoate (sq-) ligands70 presented the most intense
absorption maxima around 695 nm (ε = 1.87×104 M-1 cm-1) and 884 nm (ε = 1.03×104 M-1 cm-1).
Compared to these observations, the much weaker absorption maxima of our CoIII complex may
be attributed to the low concentration of the cobalt species involving the ligand centered radical.
Because our isolated species doesn’t contain the N-substitution for stabilization in solution, the
majority of these ligand-centered radicals are possibly delocalized and tautomerized and turn the
ligand into aromatic aminophenolate coordinating to the metal center.
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Figure 4.4. UV-visible spectroscopy of CoII-APditBu complex (7) and CoIII-APditBu complex (8).
Top: Spectrum for CoII-APditBu complex 7. Concentration: 1.1×10-4 M in CH2Cl2. Bottom left:
Spectrum for CoIII-APditBu complex 8. Concentration: 5.0×10-5 M in CH2Cl2. Bottom right:
Spectrum for CoIII-APditBu complex 8. Concentration: 5.0×10-4 M in CH2Cl2. All the above
measurements were completed under N2 atmosphere.

4.3.2.2. Cyclic Voltammetry
We further investigated both CoII-APditBu (7) and CoIII-APditBu (8) complexes by cyclic
voltammetry. CoII-APditBu complex 7 displayed a significant redox event at E1/2 = 0.145V. Based
on the |Epa − Epc| values with different scan rates in comparison to ferrocene, this redox process for
CoII complex is reversible. Additionally, the compound also exhibited a few irreversible oxidation
and reduction events around +1.0 V and -0.8 V. Compared to the CoII species, CoIII-APditBu

112

complex 8 presented a significant different behavior under anaerobic atmosphere. The oxidation
and reduction processes were completely irreversible when a higher potential (> 0 V) was applied
at the starting point. The complex showed a redox behavior highly similar to the Co II complex 7
with a lower applied potential, albeit a narrower window was observed. The redox events of this
CoIII species are quite different from those in the literature. In a study of a CoIII complex consisting
of tridentate benzoxazole amidophenoxide ligands,143 four redox couples were observed at E1/2 at
-0.67 V, -0.20 V, +0.28 V, and +0.84V respectively. As both oxidation and reduction of this CoIII
were suggested as ligand-centered behaviors, we speculate that an irreversible decomposition
occurred to our CoIII complex 8 due to a lack of stabilizing N-substitutions.

Figure 4.5. Cyclic voltammograms of CoII-APditBu (7) and CoIII-APditBu (8). Left: Voltammograms
of CoII-APditBu (7). Conditions: 10 mM complex, 0.10 M [nBu4N]+[PF6]-, scan rate 50, 100, 150,
200, 250 mV·s-1, DMSO solution, 298 K. Right: Voltammograms of CoIII-APditBu (8). Conditions:
10 mM complex, 0.10 M [nBu4N]+[PF6]-, scan rate 100 mV·s-1, DMSO solution, 298 K. All of
experiments were done under N2 atmosphere inside a glovebox.

4.2.3.3. EPR Measurements (New section added)
Both CoII-APditBu complex (7) and CoIII-APditBu complex (8) were submitted to EPR
measurements for the potential presence of ligand-centered radicals (Figure 4.6). Under N2
atmosphere, CoII exhibited no signals at 77 K. When air was introduced into the tube, the sample
was immediately sealed and frozen in liquid N2 for measurements. Intense signals were observed,
suggesting radicals were generated in situ followed air oxidation (Figure 4.6 left). The signal of
CoII complex upon air oxidation was calculated with a g value equals to 2.001. A radical coupled
to a nucleus was found with a nuclear spin of 7/2 and an isotropic hyperfine coupling constant of
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28.1 Gauss. This hyperfine coupling constant was in a good agreement with a phenoxyl radical
coupled to a cobalt ion previously reported from a CoIII salen intermediate generated upon
introducing the molecular oxygen.47 Our results combined with the literature precedence
highlighted that a phenoxyl radical, or a carbon-centered ligand radical may exist in our system as
a result of air oxidation. Compared to the species generated upon aerobic oxidation of CoII, the
signals observed for CoIII-APditBu complex (8) were a lot weaker and broader, probably due to the
slow rotation of a frozen sample (Figure 4.6 right). Similarly, a g value was calculated for these
signals as 2.001. The spectrum of this complex also featured a coupling to one nucleus with a
nuclear spin of 7/2 and an isotropic hyperfine coupling constant of 25.0 Gauss. The weak signals
may also be attributed to a partial existence of the ligand-centered radicals. We performed the
simulations for both CoII and CoIII complexes by employing the parameters mentioned above.
Simulating those parameters for CoII-APditBu complex (7) recapitulated the line positions very well.
As for CoII-APditBu complex (8), the simulation fit the positions of the main features of the
experimental spectrum very well especially on the low-field side (Simulated spectra not included).

Figure 4.6. EPR spectra for CoII-APditBu complex (7) and CoIII-APditBu complex (8). Left: EPR
spectrum of CoII-APditBu complex (7) exposed to air. Concentration: 1 mM cobalt complex in
dichloromethane. The sample was prepared inside a N2 filled glovebox. The spectrum was taken
immediately after the sample was exposed to air then frozen in liquid N2. Spectrum measured at
77K. Right: EPR spectrum of CoIII-APditBu (8). Concentration: 1 mM cobalt complex in
dichloromethane. The sample was prepared inside a N2 filled glovebox and properly sealed. The
spectrum was taken under N2 at 77K.
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4.2.4.

Aerobic

Oxidation

of

CoII(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-

butylphenol)2 in solution
Next, the oxidation behavior of the isolated CoII complex 7 in solution was investigated. A
sample of the CoII complex and dimethyl sulfone as an internal standard were placed in a J. Young
NMR tube, then air was introduced into the headspace of the same tube. A 1:1 mixture of
deuterated DMSO and chloroform was employed as the solvent system due to the extreme
difference in polarity between the low-valent CoII complex and the oxidized intermediate. The insitu oxidation was monitored with 1H NMR spectroscopy. Upon oxidation, we observed the ligand
dissociation shown in the Figure 4.7, which was accompanied with the generation of a
diamagnetic intermediate. The presence of an internal standard confirmed that the oxidation of the
low-valent CoII-APditBu to the intermediate accomplished within a few hours. The spectrum
indicated an asymmetric structure for the diamagnetic intermediate, which includes 6 distinct
aromatic protons and 6 different tert-butyl groups from the oxidized cobalt intermediate along with
6 exchangeable protons associated with NH group. Also found were the protons belonging to the
dissociated 2-amino-4,6-di-tertbutyl ligand, and the ratio between the two species was exactly 1:1
according to the calculation based on the internal standard in solution.

Figure 4.7. Aerobic oxidation of the CoII-APditBu complex with dissociation of a ligand monitored
by 1H NMR spectroscopy.
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The exchangeability of NH protons associated with the diamagnetic cobalt intermediate
was further confirmed by the in-situ deuterium-exchange experiment (Figure 4.8). The peaks
between 6.5ppm and 5.0ppm all disappeared when the same sample was treated with a few drops
of D2O.

Figure 4.8. Deuterium exchange experiment of the oxidized cobalt intermediate. Standard
spectrum of the ligand was included for reference.

4.2.5. Reactivity of CoII and CoIII Complexes in the Standard Aerobic Oxidative Coupling
Systems

4.2.5.1. Catalytic and Stoichiometric Reactivity of CoII-APditBu complex (7) in the Oxidative
Cyclization Reactions
In order to test for the catalytic competency of the isolated CoII complex 7, the CoII(2amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-butylphenol)2, 10 mol% of catalyst was
employed in the experiments shown in Scheme 4.10. In the first control experiment (a), 2-amino4,6-di-tert-butyl phenol was employed as both the substrate and the ligand for the CoII complex.
The reaction was carried out in acetonitrile for 24 hours with air as the source of stoichiometric
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oxidant and delivered exclusively the desired benzoxazole 3w in 90% yield. However, the
formation of two distinct benzoxazoles were observed in the control experiment (b) when
unsubstituted 2-aminophenol was used as a substrate. With the same reaction conditions, product
3a from the oxidative cyclization with 2-amionphenol was observed with 55% yield along with
the other product 3w in 32% yield, which derived from 2-amino-4,6-di-tert-butyl phenolate ligand
for the CoII complex. These experiments demonstrated 1) the isolated CoII-APditBu complex is
catalytically competent; 2) the ligand 2-amino-4,6-di-tertbutyl phenol can dissociate from the
cobalt center in solution and engage in the oxidative cyclization reactions with the isocyanide.

Scheme 4.10. Catalytic control experiments of CoII-APditBu complex (7) in the aerobic oxidative
cyclization reactions.

The experiment was repeated using stoichiometric amounts of CoII complex (7) under an
anaerobic atmosphere shown in the Scheme 4.11. In this case, product 3w was not observed from
the oxidative cyclization. We attribute this observation to the incompetency of the low valent CoII
for this transformation, which is in agreement with the findings in Chapter 2. In a stoichiometric
control experiment where 1 equiv of Co(OAc)2 was employed to mediate the oxidative cyclization
of 2-aminophenol and tert-butyl isocyanide under inert atmoshphere, only 10% of the desired
product was generated. This result reconfirmed the requirement of an oxidant to initiate the
cyclization reactions and stoichiometric amount of CoII is insufficient in this transformation.
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Scheme 4.11. Stoichiometric control experiments of CoII-APditBu complex (7) under anaerobic
reaction conditions.

4.2.5.2. Catalytic and Stoichiometric Reactivity of CoIII Complex (8) in the Oxidative Cyclization
Reactions

The reactivity of the CoIII-APditBu Complex (8) in both catalytic and stoichiometric reaction
systems was also evaluated. Catalytic competency of this compound was initially investigated
under the aerobic reaction conditions (Scheme 4.12). When 2-amino-4,6-di-tert-butylphenol was
employed as a substrate under the standard condition, only 43% of the compound 3w was
generated as the major product. In the cross-over control experiment shown in Scheme 4.12b,
unsubstituted o-aminophenol was employed to couple with tert-butyl isocyanide and generated 3a
in 55% yield as the only product. This distinct observation compared to the catalytic control with
CoII complex 7 demonstrated a significantly different behavior of the CoIII complex in terms of the
ligand dissociation. When the tert-butyl isocyanide is replaced with cyclohexyl isocyanide in the
standard reaction, the desired product 3x was generated in 53% yield. While in these three catalytic
reactions the yields are moderate compared to the reactivity of CoII, these results still demonstrate
the catalytic competency of the CoIII complex with 4~5 turnovers, albeit the reaction pathway
might be completely different. The slightly diminished yields could be attributed to the slow ligand
dissociation and reassociation for CoIII complex in the presence of O2. Upon dissociation, the 2amino-4,6-di-tert-butylphenol ligand may be decomposed via an oxidative ring opening pathway
as described in the introduction section, which explains the reason that in control experiment (b),
the formation of the cross-over product was not observed.
118

Scheme 4.12. Catalytic control experiments of CoIII-APditBu complex (8) under aerobic oxidative
cyclization conditions.

The stoichiometric reactivity of the CoIII was also evaluated. Control experiments were
carried out by standard Schlenk line operation under both N2 and O2 atmosphere with 1 equivalent
of the coupling partner, tert-butyl isocyanide (Scheme 4.13). As no desired product 3w was
observed in either case, the reaction vessel was reinvestigated to reduce the potential loss of the
volatile isocyanide through the Schlenk line. When the same reaction was carried out in a pressure
tube under inert atmosphere, 3w was still not detected. Of note, the three control experiments,
regardless of the aerobic or anaerobic conditions, gave very comparable results. While no expected
product was generated, these reactions yielded identical mixtures as indicated by 1H NMR
spectroscopy. These species may be related to one or multiple unknown cobalt complexes bearing
2-amino-4,6-di-tert-butylphenol derived ligands, as illustrated by multiple tert-butyl groups in the
aliphatic range. Under such reaction conditions, cyclized product of 3w not being observed may
be attributed to 1) slow rate of ligand dissociation from the cobalt metal center and 2) the
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concentration of tert-butyl isocyanide is too low to trap any phenoxyl radical and then form the
cyclized products.

Scheme 4.13. Stoichiometric control experiments with CoIII-APditBu complex (8) under both
aerobic and anaerobic atmosphere.

Moving forward, the ability of CoIII complex in mediating the oxidative cyclization
reactions under anaerobic atmosphere was also investigated. Both 2-amino-4,6-di-tert-butylphenol
and tert-butyl isocyanide were present in this set of experiments with the catalyst loading as the
only variation under the N2 atmosphere (Scheme 4.14). It was interesting to find that the yields of
the desired product 3w in this transformation were nearly proportional to the loading of the CoIII
catalyst (8). The reactions carried out with 0.5, 0.7 and 1.0 equivalent of CoIII catalyst afforded the
product with the yields 42%, 64% and 93% respectively. These results indicated CoIII might be the
active species in mediating the oxidative cyclization reactions. Combined with the results from the
above control experiments in the absence of 2-amino-4,6-di-tertbutyl phenol substrate (Scheme
4.13), it was assumed that the dissociated ligand from the CoIII complex is not able to reversibly
bind to the cobalt center, therefore, in the case where no aminophenol substrate was present, a new
cobalt complex from ligand exchange will not be formed thus cannot undergo the transition-metal
mediated interaction with tert-butyl isocyanide to form the cyclized product. Unfortunately, the
fate of the dissociated ligand cannot be confirmed at the current stage, although some type of
decomposition is highly suspected.
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Scheme 4.14. Reactivity of CoIII-APditBu complex in oxidative cyclization reactions under N2
atmosphere.

4.3. Conclusive Summary
In summary, the work in this chapter is focused on the synthesis and reactivity studies of
cobalt complexes bearing bisnucleophile-derived ligands as potentially active intermediates for
aerobic oxidative cyclization transformations developed in the previous two chapters. 2-amino4,6-di-tert-butyl phenol was employed as a model ligand in the metal complex synthesis for
solubility and stability considerations. Two unprecedented cobalt complexes were isolated with
unique coordinating environments, CoII(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tertbutylphenol)2 and Co2III(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tert-butylphenol)(μ-2amido-4,6-tert-butylphenolate)2. To date, these two compounds are the first examples of welldefined cobalt complexes that bear ortho-aminophenol ligands with unsubstituted NH2 groups.
Notably, the bulky N-substitutions on the most commonly used aminophenol-derived ligands play
a critical role in stabilizing cobalt complexes in the presence of O2. Preliminary studies on their
abilities to mediate oxidative cyclization reactions have demonstrated the catalytic and
stoichiometric competencies of both the CoII and CoIII complexes. Both complexes are capable of
participating in O2 activation. Under the catalytic reaction conditions, the ligand on CoII complex
can reversibly bind to the metal center and engage in the aerobic oxidative cyclization. The
interaction of the ligand with the metal center in these CoIII complexes is irreversible upon O2
activation, as suggested by cross-over experiments in the context. In this regard, the CoII and the
CoIII complexes mediate the reaction via different pathways. Although the fate of the dissociated
aminophenol ligands is still not clear at the current stage, these data combined support our earlier
proposed mechanistic pathways in Chapter 2. Our study convinced the dual functionality of the
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bis-nucleophile as both a substrate and a redox-active ligand. The isolated complexes bearing 2amino-4,6-di-tert-butylphenol ligand are capable of activating molecular oxygen and mediating
the oxidative cyclization reactions. We believe these studies on the cobalt complexes derived from
our reaction system will shed a light on deeper insights for future relevant works.

4.4. Experimental Section
4.4.1. General Considerations
1

H, and 13C{1H} NMR spectra were recorded on an Agilent 400 MHz spectrometer or a

JEOL 400 MHz spectrometer. Chemical shifts are given in parts per million and referenced to the
residual solvent signal;135 all coupling constants are reported in Hz. High resolution mass spectra
were obtained on a Thermo Finnigan Linear Trapping Quadrupole mass spectrometer. IR spectra
were recorded on a PerkinElmer (Spectrum 100) FT-IR spectrometer. Column chromatography
was performed using Silicycle SiliaFlash P60 silica gel.
Dry solvents were taken from a solvent system which passes the solvent through a column
of activated molecular sieves. All deuterated solvents were purchased from Cambridge Isotope
Laboratories. All other chemicals were purchased from commercial sources and used without
further purification unless otherwise noted. Air to fill air balloons was obtained from a house
compressed air system. O2 used in control reactions was purchased from Airgas. Both air and O2
sources were used as received without drying tubes or additional precautions to remove trace water.
IR spectra were recorded on a Perkin Elmer (Spectrum 100) FT-IR spectrometer. High resolution
mass spectra were obtained on a Thermofisher Scientific Q Exactive Mass Spectrometer.
Elemental analyses were performed by Atlantic Microlab, Inc., Norcross, GA.

4.4.2. Synthesis of 2-amino-4,6-di-tert-butyl phenol ligand
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The synthesis was based on the modified literature procedure.166 In a 500 mL round bottom
flask, 3,5-di-tertbutyl-1,2-benzoquinone (7.91g, 35.9 mmol, 1.0 equiv) was dissolved in a mixture
of methanol and concentrated ammonium hydroxide (200 mL/80mL) and stirred for 10 min. Upon
dissolution, sodium borohydride (3.23g, 85.4 mmol, 2.2. equiv) was added as solid portion by
portion over a period of 60 min. The mixture was allowed to stir at room temperature for another
1 hour. Upon completion, the reaction mixture was quenched by pouring slowly into 1L of ice
water, then exacted three times with ethyl acetate (3×150 mL). The combined organic phase was
washed with brine, separated, dried over anhydrous sodium sulfate and filtered. The solvent was
removed via the rotary evaporation to yield the crude compound. High purity 2-amino-4,6-ditertbutyl phenol 1w was generated by repetitive washing and decant with hexane, giving the
desired product as a pale-yellow powder (5.65g, 25.5 mmol, 71%). Elemental Analysis: calculated
C14H23NO, C: 75.97; H: 10.47; N: 6.33; found: C: 76.18; H: 10.58; N: 6.32. 1H-NMR (400 MHz,
DMSO-D6) δ 6.54 (d, J = 2.3 Hz, 1H), 6.44 (d, J = 2.3 Hz, 1H), 4.41 (s, 2H), 1.29 (s, 9H), 1.15 (s,
9H).

4.4.3. Synthesis of 5,7-di-tert-butyl-2-(tert-butylamino)benzoxazole (3w) by Aerobic
Oxidative Cyclization Reaction

2-amino-4,6-di-tertbutyl phenol (66.4 mg, 0.300 mmol) and cobalt(II) acetate (5.31 mg,
0.0300 mmol) were combined in a 6-inch test tube inside a N2 filled glovebox, and dissolved in
dry CH3CN (3 mL). tert-Butyl isocyanide (35.2 L, 0.300 mmol) was added to the same test tube
after which it was sealed with a septum and removed from the glovebox. The reaction mixture was
then stirred in an oil bath at 65 °C for 24 hours with an air balloon attached to a syringe with a
needle inserted through the septum. Upon completion, the reaction mixture was cooled to room
temperature and filtered through a Pasteur pipette silica gel plug and washed with ethyl acetate
(~15 mL). The resulting filtrate was concentrated by rotary evaporation and the resulting solid was
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purified by silica column flash chromatography (gradient elution from the pure hexanes to hexane:
ethyl acetate = 8:1, Rf = 0.4 in 5:1 hexanes : ethyl acetate), to give the title compound as a light
pink microcrystalline solid in 78 % yield (70.9 mg, 0.234 mmol). 1H-NMR (400 MHz, CDCl3) δ
7.30 (s, 1H), 6.98 (s, 1H), 5.33 (s, 1H), 1.51 (s, 9H), 1.44 (s, 11H), 1.34 (s, 10H). 13C-NMR (100
MHz, CDCl3) δ160.87, 146.71, 144.09, 143.11, 131.77, 115.21, 111.43, 51.97, 35.05, 34.20, 32.00,
30.10, 29.43. FTIR (ATR, cm-1): 3156 (w), 3056 (w), 2960 (m), 2868 (w), 1666 (s), 1616 (m),
1589 (s), 1492 (m), 1409 (s), 1362 (s), 1302 (m), 1265 (w), 1047.59 (s), 1016 (s), 981 (w), 919 (s),
854 (s), 736 (s), 661 (m), 612 (w).

4.4.4. Synthesis of CoII-APditBu Complex CoII(2-amino-4,6-tert-butylphenolate)2(2-amino4,6-tert-butylphenol)2 and CoIII-APditBu Complex Co2III(2-amino-4,6-tert-butylphenolate)2(2amino-4,6-tert-butylphenol)(μ-2-amido-4,6-tert-butylphenolate)2

In a N2-filled glovebox, a 50 mL Erlenmeyer flask equipped with a stir bar was charged
with 2-amino-4,6-di-tert-butyl phenol ligand (885.4mg, 4.0 mmol, 1.0 equiv) and anhydrous cobalt
(II) chloride (128.8mg, 1.0 mmol, 1 equiv) in dry acetonitrile (40 mL). The resulting mixture was
allowed to stir at room temperature for 10 mins to yield a persistent dark green color. It was then
filtered and the filtrate was transferred into another clean 50 ml Erlenmeyer flask. Triethylamine
(404.8 mg, 4.0 mmol, 4.0 equiv) pre-diluted with 2 mL acetonitrile was added dropwise into the
filtrate and the mixture was stirred under room temperature for another three hours. Upon
completion, beige to light grey precipitate crushed out from the solution, leaving the solution a
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violet supernatant. The precipitate was filtered, washed a couple of times with dry acetonitrile
under vacuum to generate the desired CoII complex with up to 93% yield. The complex was further
dried under high vacuum to remove excess solvent that binding around, leading to slight color
change to light greyish green with a golden sheen. Elemental Analysis: calculated
C56H90CoN4O4·2CH3CN, C: 70.35; H: 9.45; N: 8.20; found, C: 70.13; H: 9.52; N: 7.94.
Solid-state oxidation to CoIII: The dry CoII-APditBu complex was exposed to air up to 12 hours,
yielding the corresponding CoIII-APditBu as microcrystalline dark violet solid with a golden sheen.
Elemental Analysis: calculated C42H66CoN3O3, C: 70.07; H: 9.24; N: 5.84; found, C: 70.33; H:
9.08; N: 5.70.

4.4.5. Reactivity Studies of CoII-APditBu Complex (7) and CoII-APditBu Complex (8)
Synthetic Procedure for Catalytic Experiment with CoII-APditBu Complex (7)

In a 6-inch test tube inside a N2 filled glovebox, CoII-APditBu complex (7) (28.27 mg, 0.03
mmol, 0.1 equiv) and 2-amino-4,6-di-tert-butyl phenol (66.40mg, 0.3 mmol, 1.0 equiv) or 2aminophenol (32.74mg, 0.3 mmol, 1.0 equiv) were combined and dissolved in in dry CH3CN (3
mL). tert-Butyl isocyanide (35.2 L, 0.300 mmol) was added to the same test tube before it was
sealed with a septum and removed from the glovebox. The reaction mixture was stirred in an oil
bath at 65 °C for 24 hours with an air balloon attached to a syringe with a needle inserted through
the septum. Upon completion, the reaction mixture was cooled to room temperature, partitioned
into 30mL ethyl acetate and stirred with 100 mL of 1.0 M EDTA solution for 1 hour. The resulting
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mixture was separated, and the aqueous layer was washed another two times with ethyl acetate
(2×30 mL). The combined organic phase was washed again with saturated sodium chloride
solution, separated, dried over anhydrous sodium sulfate, filtered, concentrated to 10mL solution,
and eventually passed through a Pasteur pipette silica gel plug. The resulting filtrate was
concentrated by rotary evaporation to yield the crude product. The crude yield was determined by
1

H NMR spectroscopy with dimethylsulfone (0.0300 mg, 0.0318 mmol) as the internal standard.

Synthetic Procedure for Stoichiometric Control Experiments of CoII-APditBu complex (7)
under Anaerobic Reaction Conditions

In a 20mL pressure tube inside a N2 filled glovebox, CoII-APditBu complex (7) (188.5 mg,
0.2 mmol, 1.0 equiv) and 2-amino-4,6-di-tert-butyl phenol (44.27mg, 0.2 mmol, 1.0 equiv) were
combined and dissolved in 5 mL mixture of dry CH3CN and DMSO (1:1). tert-Butyl isocyanide
(23.5 L, 0.2 mmol, 1.0 equiv) was added to the same pressure tube before it was sealed and
removed from the glovebox. The reaction mixture was stirred in an oil bath at 65 °C for 24 hours
under N2. Upon completion, the reaction mixture was cooled to room temperature, then CH3CN
was removed via rotary evaporation. The resulting mixture in DMSO was partitioned into 30 mL
ethyl acetate and stirred with 100 mL of 1.0M EDTA solution for 1 hour. The resulting mixture
was separated, and the aqueous layer was washed twice with ethyl acetate (2×30 mL). The
combined organic phase was washed again with saturated sodium chloride solution, separated,
dried over anhydrous sodium sulfate, filtered, concentrated to 10mL solution, and eventually
passed through a Pasteur pipette silica gel plug. The resulting filtrate was concentrated by rotary
evaporation to yield the crude product as a brown solid. No desired product was generated during
this reaction by 1H NMR spectroscopy.
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Synthetic Procedure for Catalytic Reactivity of CoIII-APditBu Complex (8) in the Oxidative
Cyclization Reactions

Representative procedure for the synthesis of 3w: In a 6-inch test tube inside a N2 filled glovebox,
CoIII-APditBu complex (8) (21.6 mg, 0.03 mmol, 0.1 equiv) and 2-amino-4,6-di-tert-butyl phenol
(66.40 mg, 0.3 mmol, 1.0 equiv) were combined and dissolved in 5 mL mixture of dry CH3CN.
tert-Butyl isocyanide (35.2 L, 0.3 mmol) was added to the same test tube before it was sealed
with a septum and removed from the glovebox. The reaction mixture was stirred in an oil bath at
65 °C for 24 hours with an air balloon attached to a syringe with a needle inserted through the
septum. Upon completion, the reaction mixture was cooled to room temperature, partitioned into
30 mL ethyl acetate and stirred with 100 mL of 1.0M EDTA solution for 1 hour. The resulting
mixture was separated, and the aqueous layer was washed twice with ethyl acetate (2×30 mL). The
combined organic phase was extracted again with saturated sodium chloride solution, separated,
dried over anhydrous sodium sulfate, filtered, concentrated to 10mL solution, and eventually
passed through a Pasteur pipette silica gel plug. The resulting filtrate was concentrated by rotary
evaporation to yield the crude product which was later quantified using 1H-NMR spectroscopy
with dimethyl sulfone (0.0300 mg, 0.0318 mmol) internal standard.
Synthesis of 3a: In a 6-inch test tube inside a N2 filled glovebox, CoIII-APditBu complex (8) (21.6
mg, 0.03 mmol, 0.1 equiv) and 2-aminophenol (32.74 mg, 0.3 mmol, 1.0 equiv) were combined
and dissolved in 5 mL mixture of dry CH3CN. tert-Butyl isocyanide (35.2 L, 0.3 mmol) was
added to the same test tube before it was sealed with a septum and removed from the glovebox.
The rest of procedures follow the synthesis of 3w.
Synthesis of 3x: In a 6-inch test tube inside a N2 filled glovebox, CoIII-APditBu complex (8) (21.6
mg, 0.03 mmol, 0.1 equiv) and 2-amino-4,6-di-tert-butyl phenol (66.40 mg, 0.3 mmol, 1.0 equiv)
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were combined and dissolved in 5 mL mixture of dry CH3CN. Cyclohexyl isocyanide (37.3 L,
0.3 mmol) was added to the same test tube before it was sealed with a septum and removed from
the glovebox. The rest of procedures follow the synthesis of 3w.
Synthetic Procedure for Stoichiometric Reactivity of CoIII-APditBu Complex (8) in the
Oxidative Cyclization Reactions

Schlenk Tube Reaction under N2 (Presentative Procedure): To a 25 mL Schlenk tube inside a N2
filled glovebox, CoIII-APditBu complex (8) (71.9 mg, 0.1 mmol, 1.0 equiv) was dissolved in 5 mL
of dry CH3CN. tert-Butyl isocyanide (11.8 L, 0.1 mmol) was added to the same Schlenk tube
before it was sealed with a septum and removed from the glovebox. The tube was connected to the
Schlenk line via the side arm, and tubing was evacuated and backfilled with N2 three times before
the valve on the side arm was opened. The reaction mixture was stirred in an oil bath at 65 °C for
24 hours under N2 atmosphere. Upon completion, the reaction mixture was cooled to room
temperature, partitioned into 30 mL ethyl acetate and stirred with 100 mL of 1.0M EDTA solution
for 1 hour. The resulting mixture was separated, and the aqueous layer was washed twice with
ethyl acetate (2×30 mL). The combined organic phase was extracted again with saturated sodium
chloride solution, separated, dried over anhydrous sodium sulfate, filtered, concentrated to 10mL
solution, and eventually passed through a Pasteur pipette silica gel plug. The resulting filtrate was
concentrated by rotary evaporation to yield the crude product which was later quantified using 1HNMR spectroscopy with dimethyl sulfone (0.0300 mg, 0.0318 mmol) internal standard.
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Schlenk Tube Reaction under O2: In a 25 mL Schlenk tube, CoIII-APditBu complex (8) (71.9 mg,
0.1 mmol, 1.0 equiv) was added. The tube was sealed with a septum and was connected to the
Schlenk line via the side arm. The tube was then evacuated and backfilled with O2 by inserting a
O2 balloon through the septum for three times. Under O2 atmosphere, 5 mL of dry CH3CN was
added to dissolve the CoIII complex, followed by adding the tert-Butyl isocyanide (11.8 L, 0.1
mmol) into the same Schlenk tube. With a O2 balloon attached to a syringe with a needle inserted
through the septum, the reaction mixture was stirred in an oil bath at 65 °C for 24 hours. The rest
procedures follow the above Schlenk Tube Reaction under N2 (Presentative Procedure).
Pressure Tube Reaction under N2: In a 20mL pressure tube inside a N2 filled glovebox, CoIIIAPditBu complex (8) (71.9 mg, 0.1 mmol, 1.0 equiv) was added and dissolved in 5 mL of dry
CH3CN. tert-Butyl isocyanide (11.8 L, 0.1 mmol, 1.0 equiv) was added to the same pressure tube
before it was sealed and removed from the glovebox. The reaction mixture was stirred in an oil
bath at 65 °C for 24 hours under N2. The rest procedures follow the above Schlenk Tube Reaction
under N2 (Presentative Procedure).
Synthetic Procedure for Stoichiometric Reactivity of CoIII-APditBu Complex (8) in the
Presence of Both Aminophenol and Isonitrile Substrates
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Representative Procedure: In a 20mL pressure tube inside a N2 filled glovebox, CoIII-APditBu
complex (8) (144.0 mg, 0.02 mmol, 1.0 equiv) and 2-amino-4,6-di-tert-butyl phenol (44.27mg, 0.2
mmol, 1.0 equiv) were combined and dissolved in 5 mL of dry CH3CN. tert-Butyl isocyanide
(23.5 L, 0.2 mmol, 1.0 equiv) was added to the same pressure tube before it was sealed and
removed from the glovebox. The reaction mixture was stirred in an oil bath at 65 °C for 24 hours
under N2. Upon completion, the reaction mixture was cooled to room temperature, then was
partitioned into 30 mL ethyl acetate and stirred with 100 mL of 1.0M EDTA solution for 1 hour.
The resulting mixture was separated, and the aqueous layer was extracted twice with ethyl acetate
(2×30 mL). The combined organic phase was washed again with saturated sodium chloride
solution, separated, dried over anhydrous sodium sulfate, filtered, concentrated to 10mL solution,
and eventually passed through a Pasteur pipette silica gel plug. The resulting filtrate was
concentrated by rotary evaporation to yield the crude product, which was quantified by 1H NMR
spectroscopy using dimethyl sulfone (0.0300 mg, 0.0318 mmol) internal standard.

4.4.6. Crystallography Data
4.4.6.1. Description of the X-ray Structural Analysis of CoII-APditBu Complex (7)

A green-yellow block shaped crystal measuring 0.34 mm x 0.30 mm x 0.17 mm was
selected under paratone oil using a MiTeGen Micromount and mounted at 100(1) K to a D8-

130

Venture diffractometer equipped with a Mo sealed tube X-ray source, a Triumph monochromator,
and a Photon CMOS area detector. The unit cell was determined from reflections harvested with
a signal to noise ratio (I/σ) of at least 8 from a series of 3 ω scans of 6° with 0.5° frames using
APEX3.1 The data were collected to a resolution of 0.81 Å using 4 ω scans.
The data were integrated using SAINT and corrected for absorption using SADABS.2 The
systematic absences and E-statistics of the data were consistent with the space group Im3̅. The
structure was solved using the intrinsic phasing routine of SHELXT.3 The non-hydrogen atoms
were located from a Fourier difference map of the electron density and anisotropically refined
using the least-squares algorithm of SHELXL.4 The carbon-based hydrogen atoms were then
placed in calculated positions and refined with riding thermal parameters.
The asymmetric unit consists of one half molecule of Co(2-amino-4,6-tertbutylphenolate)2(2-amino-4,6-tert-butylphenol)2 (Figures 1 – 2). The molecule resides on a
crystallographic 2-fold axis and a crystallographic mirror plane. The 2-fold axis is a true symmetry
element of the molecule and passes through the following points: the midpoint of N2 and N2i; Co1;
and the midpoint of N1 and N1i. The molecule is disordered over the mirror plane.
Phenol ligand O2 shows additional positional disorder (major component: 27.8(6)%).
Geometry and thermal parameter restraints were used to ensure a chemically reasonable and
computationally stable refinement.
There was an additional solvent molecule located in the crystal structure. Despite numerous
attempts to model this solvent, a computationally stable refinement was not possible. The
SQUEEZE algorithm of PLATON was used to correct for the solvent electron density. PLATON
calculated that the solvent accessible voids in the structure had a volume of 3077 A3 (16.2% of the
unit cell volume) and consisted of 864 electrons/unit cell. This is consistent with approximately 3
molecules of MeCN per molecule of Co(2-amino-4,6-tert-butylphenolate)2(2-amino-4,6-tertbutylphenol)2 in the structure.
The final structure consisted of 461 parameters refined against 3347 independent
reflections, giving refinement residuals of R1 = 0.0524 (based off F2 for I > 2σ) and wR2 = 0.1617
(based of F2 for all reflections). The final difference Fourier map was featureless.
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Table 4.1. Crystal data and structure refinement for CoII-APditBu Complex (7).
Identification code

CoII-APditBu Complex (7)

Empirical formula

C56H90CoN4O4

Formula weight

942.24

Temperature/K

100.0

Crystal system

cubic

Space group

Im-3

a/Å

26.692(3)

b/Å

26.692(3)

c/Å

26.692(3)

α/°

90

β/°

90

γ/°

90

Volume/Å3

19018(7)

Z

12

ρcalcg/cm3

0.987
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μ/mm-1

0.310

F(000)

6156.0

Crystal size/mm3

0.34 × 0.3 × 0.17

Radiation

MoKα (λ = 0.71073)

2Θ range for data collection/°

6.106 to 52.046

Index ranges

-32 ≤ h ≤ 32, -32 ≤ k ≤ 32, -32 ≤ l ≤ 32

Reflections collected

231435

Independent reflections

3347 [Rint = 0.0988, Rsigma = 0.0146]

Data/restraints/parameters

3347/573/461

Goodness-of-fit on F2

1.181

Final R indexes [I>=2σ (I)]

R1 = 0.0524, wR2 = 0.1322

Final R indexes [all data]

R1 = 0.0757, wR2 = 0.1617

Largest diff. peak/hole / e Å-3

0.42/-0.27

Table 4.2. Fractional atomic coordinates (×104) and equivalent isotropic displacement parameters
(Å2×103) for CoII-APditBu Complex (7). Ueq is defined as 1/3 of of the trace of the orthogonalised
UIJ tensor.
Atom x

y

z

U(eq)

Co1 5000

8024.6(2)

5000

31.9(2)

O1

5176.3(11)

8053.1(11)

4277.8(11)

33.3(7)

N1

5550.0(11)

8619.1(11)

4994(5)

31.7(8)
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C1

5541.7(15)

8821.7(17)

4504.3(15)

29.2(9)

C2

5328.7(15)

8508.2(16)

4144.0(15)

29.0(9)

C3

5296.8(16)

8689.6(18)

3650.7(15)

33.5(10)

C4

5483.3(16)

9157.4(18)

3555.2(16)

33.6(10)

C5

5700.5(18)

9461(2)

3908.1(19)

33.0(11)

C6

5722.4(15)

9280.2(17)

4386.1(15)

30.0(9)

C7

5040(8)

8375.5(17)

3249.1(14)

40(2)

C8

4505(2)

8289(2)

3392.4(18)

46.6(13)

C9

5314(2)

7883(2)

3180(2)

56.2(15)

C10 5055(10)

8642(2)

2741.4(15)

48(3)

C11 5915.5(14)

9966(7)

3790.5(15)

36.4(17)

C12 6484.8(15)

9953(13)

3841(2)

58(4)

C13 5795(2)

10142.6(19)

3258.6(18)

49.9(16)

C14 5716(2)

10372(2)

4145(2)

40.2(12)

O2A 6010(8)

7556(10)

4141(5)

44(3)

N2A 5534(5)

7415(8)

4952(13)

40(3)

C15A 6039(6)

7585(11)

4979(10)

37(2)

C16A 6279(10)

7715(18)

4528(9)

41(3)

C17A 6772(9)

7901(15)

4508(7)

44(2)

C18A 6975(10)

7982(17)

4983(9)

40(2)

C19A 6751(9)

7826(11)

5413(7)

38(2)
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C20A 6274(12)

7650(20)

5418(10)

39(3)

C21A 7071(7)

8091(7)

4052(6)

51(2)

C22A 7056(7)

8651(5)

4034(6)

60(3)

C23A 6842(6)

7886(7)

3572(5)

52(3)

C24A 7606(6)

7884(8)

4082(7)

61(3)

C25A 6961(7)

7844(6)

5940(6)

40(2)

C26A 6641(8)

8201(7)

6265(7)

48(3)

C27A 6958(7)

7330(6)

6191(6)

47(3)

C28A 7484(7)

8083(9)

5928(8)

45(3)

O2

5966(6)

7497(7)

4262(4)

36(2)

N2

5562(4)

7429(6)

5170(6)

35(2)

C15 6066(5)

7595(9)

5128(5)

34(2)

C16 6263(9)

7655(16)

4641(6)

40(2)

C17 6741(8)

7877(14)

4542(7)

44(2)

C18 6998(8)

7956(13)

4992(8)

39(2)

C19 6793(8)

7915(13)

5448(7)

40(2)

C20 6333(7)

7727(11)

5538(6)

38(3)

C21 7026(7)

8072(6)

4079(6)

52(2)

C22 6814(6)

8571(6)

3905(5)

59(3)

C23 6997(6)

7709(6)

3645(5)

56(3)

C24 7598(6)

8111(10)

4161(9)

54(3)
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C25 7030(7)

8009(7)

5957(7)

46(3)

C26 6664(7)

8381(6)

6216(6)

48(3)

C27 7050(7)

7520(6)

6255(6)

49(3)

C28 7523(6)

8281(6)

5861(8)

55(3)

Table 4.3. Anisotropic displacement parameters (Å2×103) for CoII-APditBu Complex (7). The
anisotropic displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…].
Atom U11

U22

U33

U23

U13

U12

Co1 31.4(3)

37.5(4)

26.8(3)

0

0

0

O1

36.4(16)

38.4(16)

25.0(14)

-4.3(12)

-3.2(11)

0.9(12)

N1

31.8(13)

38.5(17)

24.9(15)

-10(10)

1(12)

2.0(13)

C1

24.7(19)

40(2)

22.5(19)

-1.7(17)

-2.5(16)

4.9(17)

C2

23.9(19)

39(2)

24(2)

-3.6(17)

1.7(15)

4.3(17)

C3

33(2)

46(3)

22(2)

-5.3(18)

-0.5(17)

1.9(19)

C4

29(2)

46(3)

26(2)

-1.8(18)

6.5(17)

0.1(19)

C5

25(2)

44(3)

29(3)

-5(2)

8(2)

3(2)

C6

23(2)

41(3)

26(2)

-8.3(19)

0.4(16)

1.4(18)

C7

50(6)

49(2)

22.0(15)

-6.9(15)

1(4)

-14(6)

C8

49(3)

63(3)

28(2)

-2(2)

-7(2)

-17(3)

C9

64(4)

66(4)

39(3)

-23(3)

-6(3)

8(3)

C10 54(9)

69(3)

22.5(17)

-2.9(17)

-10(4)

-9(5)
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C11 27.9(16)

47(5)

33.7(17)

-11(5)

6.6(13)

6(5)

C12 28(2)

68(11)

77(3)

0(6)

13.2(19)

-20(7)

C13 56(3)

58(4)

35(2)

3(2)

10(2)

-10(2)

C14 35(3)

45(3)

41(3)

-4(3)

5(3)

-5(2)

O2A 47(5)

64(6)

21(6)

0(5)

-5(5)

17(4)

N2A 41(4)

42(4)

38(8)

2(7)

-7(7)

1(4)

C15A 35(4)

40(3)

36(6)

3(6)

-10(6)

13(3)

C16A 40(4)

53(5)

31(5)

-3(5)

-10(5)

19(4)

C17A 37(4)

56(4)

39(4)

-2(4)

-10(4)

18(4)

C18A 28(4)

51(5)

40(4)

2(6)

-2(6)

15(4)

C19A 34(4)

44(5)

37(4)

5(5)

-6(5)

20(4)

C20A 38(5)

41(5)

38(6)

9(5)

-1(5)

15(5)

C21A 48(4)

68(4)

38(4)

-3(4)

2(3)

20(4)

C22A 63(6)

69(6)

49(5)

5(5)

0(5)

-1(6)

C23A 53(6)

64(6)

38(5)

0(5)

6(5)

15(5)

C24A 53(5)

83(7)

46(6)

-3(6)

9(5)

25(6)

C25A 42(4)

44(6)

35(4)

2(4)

-4(3)

13(4)

C26A 50(5)

53(8)

40(5)

3(6)

-8(4)

9(6)

C27A 50(6)

50(8)

40(6)

14(6)

-15(5)

9(6)

C28A 54(6)

47(7)

34(5)

6(6)

-6(5)

21(6)

O2

54(5)

13(5)

-5(4)

-1(4)

11(3)

41(4)
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N2

42(4)

40(4)

23(5)

6(5)

-19(4)

5(3)

C15 35(4)

38(3)

30(5)

5(5)

-8(4)

12(3)

C16 40(4)

51(4)

29(5)

-4(5)

-11(4)

16(4)

C17 38(4)

57(4)

38(4)

-3(4)

-7(4)

20(4)

C18 28(3)

49(4)

39(3)

2(6)

-4(6)

17(3)

C19 33(4)

46(5)

41(4)

4(4)

-2(4)

15(4)

C20 41(5)

41(5)

33(5)

6(5)

-11(4)

13(4)

C21 49(4)

68(4)

39(4)

-4(4)

1(3)

22(4)

C22 60(6)

73(6)

44(5)

8(5)

3(5)

16(5)

C23 56(6)

70(7)

42(5)

-4(5)

3(5)

17(5)

C24 51(6)

68(7)

42(6)

-3(6)

6(5)

13(6)

C25 47(4)

55(6)

34(4)

4(5)

-7(4)

21(5)

C26 54(5)

54(8)

35(5)

7(6)

7(4)

2(6)

C27 56(6)

55(7)

37(5)

2(5)

-5(4)

21(6)

C28 55(6)

60(8)

49(6)

-6(7)

-13(5)

15(6)

Table 4.4. Bond Lengths for CoII-APditBu Complex (7).
Atom Atom

Length/Å

Atom

Atom

Length/Å

Co1 O1

1.986(3)

C17A

C21A

1.539(17)

Co1 N1

2.162(3)

C18A

C19A

1.360(17)

Co1 N2A

2.17(2)

C19A

C20A

1.355(16)

Co1 N2

2.231(15)

C19A

C25A

1.516(17)
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O1

C2

1.330(5)

C21A

C22A

1.498(17)

N1

C1

1.415(14)

C21A

C23A

1.521(16)

C1

C2

1.396(6)

C21A

C24A

1.532(16)

C1

C6

1.353(6)

C25A

C26A

1.547(14)

C2

C3

1.405(6)

C25A

C27A

1.526(14)

C3

C4

1.368(6)

C25A

C28A

1.535(16)

C3

C7

1.523(11)

O2

C16

1.351(14)

C4

C5

1.371(7)

N2

C15

1.420(10)

C5

C6

1.365(6)

C15

C16

1.413(14)

C5

C11

1.497(18)

C15

C20

1.353(13)

C7

C8

1.498(19)

C16

C17

1.432(15)

C7

C9

1.515(12)

C17

C18

1.398(16)

C7

C10

1.531(6)

C17

C21

1.544(17)

C11 C12

1.526(6)

C18

C19

1.342(16)

C11 C13

1.531(8)

C19

C20

1.348(15)

C11 C14

1.536(14)

C19

C25

1.518(18)

O2A C16A

1.328(17)

C21

C22

1.521(17)

N2A C15A

1.424(12)

C21

C23

1.512(15)

C15A C16A

1.407(16)

C21

C24

1.545(16)

C15A C20A

1.341(16)

C25

C26

1.554(16)

C16A C17A

1.410(16)

C25

C27

1.529(15)
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C17A C18A

1.394(17)

C25

C28

1.525(18)

Table 4.5. Bond angles for CoII-APditBu complex (7).
Atom Atom Atom Angle/˚

Atom Atom

Atom

Angle/˚

O1

Co1 N1

78.7(4)

C20A C19A

C18A

121.8(16)

O1

Co1 N2

93.7(4)

C20A C19A

C25A

110.4(16)

N1

Co1 N2

93.9(3)

C15A C20A

C19A

118.5(17)

C2

O1

Co1 111.6(2)

C22A C21A

C17A

109.8(18)

C1

N1

Co1 106.1(5)

C22A C21A

C23A

108.8(13)

C2

C1

N1

114.4(4)

C22A C21A

C24A

112.7(15)

C6

C1

N1

123.8(4)

C23A C21A

C17A

109.9(14)

C6

C1

C2

121.8(4)

C23A C21A

C24A

106.9(14)

O1

C2

C1

119.1(4)

C24A C21A

C17A

108.8(16)

O1

C2

C3

123.2(4)

C19A C25A

C26A

109.5(14)

C1

C2

C3

117.6(4)

C19A C25A

C27A

112.2(13)

C2

C3

C7

119.8(4)

C19A C25A

C28A

109.3(13)

C4

C3

C2

117.8(4)

C27A C25A

C26A

107.7(11)

C4

C3

C7

122.3(4)

C27A C25A

C28A

112.8(12)

C3

C4

C5

124.4(4)

C28A C25A

C26A

104.9(13)

C4

C5

C11 123.4(4)

C15 N2

Co1

113.5(13)

C6

C5

C4

116.8(5)

C16 C15

N2

117.4(11)

C6

C5

C11 119.8(5)

C20 C15

N2

121.1(11)
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C1

C6

C5

C3

C7

C8

121.5(4)

C20 C15

C16

121.3(10)

C10 110.9(8)

O2

C16

C15

115.8(11)

C7

C3

109.5(6)

O2

C16

C17

120.9(13)

C8

C7

C9

110.9(7)

C15 C16

C17

123.2(13)

C8

C7

C10 108.8(14)

C16 C17

C21

136.6(15)

C9

C7

C3

C18 C17

C16

110.1(12)

C9

C7

C10 106.4(8)

C18 C17

C21

113.2(13)

C5

C11 C12 110.1(15)

C19 C18

C17

124.5(12)

C5

C11 C13 113.0(7)

C18 C19

C20

124.4(14)

C5

C11 C14 111.9(5)

C18 C19

C25

128.9(14)

C12 C11 C13 107.4(6)

C20 C19

C25

106.4(14)

C12 C11 C14 107.9(12)

C19 C20

C15

115.6(13)

C13 C11 C14 106.3(10)

C17 C21

C24

113.3(14)

C15A N2A Co1 112.4(16)

C22 C21

C17

110.8(17)

C16A C15A N2A 117.8(18)

C22 C21

C24

110.5(15)

C20A C15A N2A 122(2)

C23 C21

C17

111.9(15)

C20A C15A C16A 120.0(12)

C23 C21

C22

108.0(13)

O2A C16A C15A 109.9(16)

C23 C21

C24

101.8(14)

O2A C16A C17A 126.0(19)

C19 C25

C26

104.0(16)

C15A C16A C17A 123.1(15)

C19 C25

C27

109.8(16)

C16A C17A C21A 129.1(16)

C19 C25

C28

106.8(13)

110.3(11)
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C18A C17A C16A 112.5(15)

C27 C25

C26

109.6(12)

C18A C17A C21A 117.8(16)

C28 C25

C26

108.2(13)

C19A C18A C17A 123.3(15)

C28 C25

C27

117.6(14)

C18A C19A C25A 127.7(16)

Table 4.6. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters (Å2×103)
for CoII-APditBu Complex (7).
Atom

x

y

z

U(eq)

H1A

5470

8858

5224

38

H1B

5859

8496

5067

38

H4

5461

9280

3222

40

H6

5868

9481

4641

36

H8A

4491

8123

3720

70

H8B

4343

8077

3140

70

H8C

4329

8611

3411

70

H9A

5668

7948

3108

84

H9B

5164

7698

2900

84

H9C

5286

7683

3487

84

H10A

4877

8962

2766

73

H10B

4894

8431

2488

73

H10C

5404

8703

2645

73
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H12A

6575

9897

4193

86

H12B

6625

10273

3729

86

H12C

6620

9681

3635

86

H13A

5953

9917

3016

75

H13B

5923

10483

3211

75

H13C

5431

10141

3209

75

H14A

5351

10395

4111

60

H14B

5867

10695

4059

60

H14C

5801

10285

4492

60

H2AA

5475

7196

5206

48

H2AB

5487

7249

4657

48

H18A

7285

8155

5007

48

H20A

6112

7575

5725

46

H22A

6711

8766

4084

90

H22B

7177

8767

3708

90

H22C

7270

8788

4300

90

H23A

6809

7521

3598

78

H23B

7059

7969

3288

78

H23C

6510

8035

3521

78

H24A

7764

8000

4393

91

H24B

7800

8004

3794

91
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H24C

7596

7517

4080

91

H26A

6635

8534

6111

71

H26B

6786

8224

6601

71

H26C

6298

8071

6288

71

H27A

6611

7218

6236

70

H27B

7122

7353

6519

70

H27C

7138

7090

5981

70

H28A

7675

7945

5647

67

H28B

7659

8010

6243

67

H28C

7451

8446

5888

67

H2B

5558

7178

4956

42

H2C

5540

7313

5479

42

H18

7342

8046

4972

46

H20

6204

7689

5868

46

H22D

6464

8528

3806

88

H22E

7009

8694

3619

88

H22F

6834

8814

4180

88

H23D

7193

7409

3723

84

H23E

7132

7868

3343

84

H23F

6647

7615

3587

84

H24D

7668

8376

4405

81
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H24E

7762

8191

3843

81

H24F

7726

7791

4288

81

H26D

6622

8678

6004

72

H26E

6802

8481

6541

72

H26F

6339

8218

6265

72

H27D

6708

7403

6321

74

H27E

7223

7578

6573

74

H27F

7231

7266

6061

74

H28D

7756

8055

5690

82

H28E

7668

8387

6181

82

H28F

7461

8575

5650

82

H2A

5740(20)

7760(20)

4170(20)

51(16)

Table 4.7. Atomic occupancy for CoII-APditBu complex (7).
Atom Occupancy

Atom

Occupancy

Atom

Occupancy

O1

0.5

N1

0.5

H1A

0.5

H1B 0.5

C1

0.5

C2

0.5

C3

0.5

C4

0.5

H4

0.5

C5

0.5

C6

0.5

H6

0.5

C7

0.5

C8

0.5

H8A

0.5

H8C

0.5

C9

0.5

H8B 0.5
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H9A 0.5

H9B

0.5

H9C

0.5

C10 0.5

H10A

0.5

H10B

0.5

H10C 0.5

C11

0.5

C12

0.5

H12A 0.5

H12B

0.5

H12C

0.5

C13 0.5

H13A

0.5

H13B

0.5

H13C 0.5

C14

0.5

H14A

0.5

H14B 0.5

H14C

0.5

O2A

0.222(6)

N2A 0.222(6)

H2AA

0.222(6)

H2AB

0.222(6)

C15A 0.222(6)

C16A

0.222(6)

C17A

0.222(6)

C18A 0.222(6)

H18A

0.222(6)

C19A

0.222(6)

C20A 0.222(6)

H20A

0.222(6)

C21A

0.222(6)

C22A 0.222(6)

H22A

0.222(6)

H22B

0.222(6)

H22C 0.222(6)

C23A

0.222(6)

H23A

0.222(6)

H23B 0.222(6)

H23C

0.222(6)

C24A

0.222(6)

H24A 0.222(6)

H24B

0.222(6)

H24C

0.222(6)

C25A 0.222(6)

C26A

0.222(6)

H26A

0.222(6)

H26B 0.222(6)

H26C

0.222(6)

C27A

0.222(6)

H27A 0.222(6)

H27B

0.222(6)

H27C

0.222(6)

C28A 0.222(6)

H28A

0.222(6)

H28B

0.222(6)

H28C 0.222(6)

O2

0.278(6)

N2

0.278(6)

H2B 0.278(6)

H2C

0.278(6)

C15

0.278(6)
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C16 0.278(6)

C17

0.278(6)

C18

0.278(6)

H18 0.278(6)

C19

0.278(6)

C20

0.278(6)

H20 0.278(6)

C21

0.278(6)

C22

0.278(6)

H22D 0.278(6)

H22E

0.278(6)

H22F

0.278(6)

C23 0.278(6)

H23D

0.278(6)

H23E

0.278(6)

H23F 0.278(6)

C24

0.278(6)

H24D

0.278(6)

H24E 0.278(6)

H24F

0.278(6)

C25

0.278(6)

C26 0.278(6)

H26D

0.278(6)

H26E

0.278(6)

H26F 0.278(6)

C27

0.278(6)

H27D

0.278(6)

H27E 0.278(6)

H27F

0.278(6)

C28

0.278(6)

H28D 0.278(6)

H28E

0.278(6)

H28F

0.278(6)

H2A 0.5

4.4.6.2. Description of the X-ray Structural Analysis of CoIII-APditBu Complex (8)
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A green-yellow plate shaped crystal measuring 0.357 mm x 0.279 mm x 0.066 mm was
selected under paratone oil using a MiTeGen Micromount and mounted at 100(1) K to a D8Venture diffractometer equipped with a Mo sealed tube X-ray source, a Triumph monochromator,
and a Photon CMOS area detector. The unit cell was determined from reflections harvested with
a signal to noise ratio (I/σ) of at least 8 from a series of 3 ω scans of 6° with 0.5° frames using
APEX3.1 The data were collected to a resolution of 0.77 Å using 4 ω scans.
The data were integrated using SAINT and corrected for absorption using SADABS.2 The
systematic absences and E-statistics of the data were uniquely consistent with the space group
P21/n. The structure was solved using the intrinsic phasing routine of SHELXT.3 The nonhydrogen atoms were located from a Fourier difference map of the electron density and
anisotropically refined using the least-squares algorithm of SHELXL.4 The carbon-based
hydrogen atoms were then placed in calculated positions and refined with riding thermal
parameters. All hydrogen atoms on heteroatoms were located from the Fourier difference map.
Their positions were allowed to refine freely and their thermal parameters were constrained to be
1.5 times the thermal parameter of their parent atom.
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The

asymmetric

unit

consists

of

one

half

molecule

Co2(2-amino-4,6-tert-

butylphenolate)2(2-amino-4,6-tert-butylphenol)(μ-2-amido-4,6-tert-butylphenolate)2

and

one

molecule of dichloromethane (Figures 1 and 2). The dimer resides on a crystallographic inversion
center. Tert-butyl group C36 was disordered over two positions (major component: 85.6(4)%).
The dichloromethane is also disordered over two positions (major component: 54(3)%). Geometry
and thermal parameter restraints were used to ensure a chemically reasonable and computationally
stable refinement.
The final structure consisted of 564 parameters refined against 10161 independent
reflections, giving refinement residuals of R1 = 0.0380 (based off F2 for I > 2σ) and wR2 = 0.0896
(based of F2 for all reflections). The final difference Fourier map was featureless.

References
1. Bruker-AXS (2016). APEX 3 version 2016.9-0. Madison, Wisconsin, USA
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3. Sheldrick, G. M., Acta Crystallogr. A 2015, A71, 3-8.
4. (a) Sheldrick, G. M., Acta Crystallogr. C 2015, C71, 3-8.; (b) Dolomanov, O. V.; Bourhis, L.
J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H., J. Appl. Crystallogr. 2009, 42, 339-341.

Table 4.8. Crystal data and structure refinement for CoIII-APditBu Complex (8).
Identification code

CoIII-APditBu Complex (8)

Empirical formula

C86H136Cl4Co2N6O6

Formula weight

1609.66

Temperature/K

100(1)

Crystal system

monoclinic
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Space group

P21/n

a/Å

15.0642(4)

b/Å

20.4722(5)

c/Å

15.7982(4)

α/°

90

β/°

115.1256(13)

γ/°

90

Volume/Å3

4411.1(2)

Z

2

ρcalcg/cm3

1.212

μ/mm-1

0.549

F(000)

1728.0

Crystal size/mm3

0.357 × 0.279 × 0.066

Radiation

MoKα (λ = 0.71073)

2Θ range for data collection/°

5.772 to 55.102

Index ranges
Reflections collected
Independent reflections

-19 ≤ h ≤ 19, -26 ≤ k ≤ 26, -20 ≤ l ≤
20
56144
10161 [Rint = 0.0580, Rsigma =
0.0389]

Data/restraints/parameters

10161/259/564

Goodness-of-fit on F2

1.022
150

Final R indexes [I>=2σ (I)]

R1 = 0.0380, wR2 = 0.0812

Final R indexes [all data]

R1 = 0.0573, wR2 = 0.0896

Largest diff. peak/hole / e Å-3

0.47/-0.65

Table 4.9. Fractional atomic coordinates (×104) and equivalent isotropic displacement parameters
(Å2×103) for CoIII-APditBu complex (8). Ueq is defined as 1/3 of of the trace of the orthogonalised
UIJ tensor.
Atom

x

y

z

U(eq)

Co1

4877.3(2)

698.6(2)

5011.0(2)

8.50(6)

O1

3933.5(8)

1263.1(6)

5152.5(8)

10.9(2)

O2

7311.3(9)

845.7(6)

6410.6(9)

13.7(3)

O3

5578.1(8)

665.9(6)

6340.9(8)

10.1(2)

N1

4052.5(10)

755.4(8)

3681.4(10)

11.1(3)

N2

5633.3(11)

1553.5(7)

5131.8(12)

12.3(3)

N3

4226.8(10)

-66.8(7)

5164.5(10)

9.0(3)

C1

3113.5(12)

1033.6(8)

3556.1(12)

11.2(3)

C2

3111.0(12)

1294.9(8)

4368.2(12)

11.0(3)

C3

2218.3(12)

1576.1(8)

4306.3(12)

11.7(3)

C4

1425.0(12)

1570.7(8)

3432.4(13)

13.2(3)

C5

1431.1(13)

1294.1(9)

2621.3(13)

14.1(4)

C6

2305.7(13)

1019.1(8)

2700.2(12)

12.7(3)

C7

528.1(13)

1326.4(9)

1675.8(13)

16.5(4)
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C8

-417.0(14)

1205.3(12) 1795.1(16)

29.3(5)

C9

486.5(15)

2013.5(10) 1272.6(15)

25.4(5)

C10

579.0(17)

825.6(12)

983.8(16)

36.0(6)

C11

2154.2(12)

1851.2(8)

5181.9(12)

12.4(3)

C12

1134.5(13)

2128.7(9)

4967.7(14)

16.9(4)

C13

2367.4(14)

1300.1(9)

5909.0(13)

16.6(4)

C14

2904.4(14)

2401.8(9)

5604.0(14)

17.8(4)

C15

4238.8(12)

-8.4(8)

6078.6(11)

9.6(3)

C16

4995.0(12)

382.6(8)

6700.4(12)

10.2(3)

C17

5136.6(13)

445.7(9)

7634.4(12)

12.7(3)

C18

4452.2(13)

130.2(9)

7875.9(13)

15.1(4)

C19

3662.5(13)

-232.7(8)

7254.0(13)

12.9(3)

C20

3572.4(12)

-312.3(8)

6343.5(12)

11.0(3)

C21

2943.3(14)

-554.2(9)

7588.1(13)

17.5(4)

C22

1988.5(15)

-754.2(12)

6764.3(15)

27.6(5)

C23

2668.7(16)

-73.9(10)

8185.7(15)

24.5(4)

C24

3433.9(17)

-1158.2(10) 8172.1(16)

27.7(5)

C25

5996.7(13)

839.2(9)

8346.0(13)

16.3(4)

C26

5959.6(16)

877.8(11)

9300.5(14)

24.7(4)

C27

6969.6(14)

509.8(11)

8496.1(14)

22.9(4)

C28

5970.3(15)

1543.7(9)

7996.6(14)

21.3(4)
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C29

6613.9(12)

1655.5(8)

5193.3(12)

11.7(3)

C30

7399.1(12)

1281.6(8)

5797.1(12)

11.3(3)

C31

8328.5(12)

1346.8(8)

5784.0(12)

11.8(3)

C32

8435.5(13)

1844.8(9)

5231.7(13)

14.3(4)

C33

7674.7(13)

2255.9(9)

4668.2(13)

16.0(4)

C34

6752.5(13)

2138.9(9)

4639.1(13)

14.9(4)

C35

7868.2(14)

2828.4(10) 4136.2(15)

23.8(4)

C39

9171.7(12)

875.6(9)

6341.6(13)

13.4(3)

C40

9487.6(13)

939.7(10)

7397.7(13)

18.4(4)

C41

8851.9(14)

166.2(9)

6029.7(14)

17.4(4)

C42

10076.7(13)

1008.5(10) 6158.0(14)

19.8(4)

C36

8371.3(18)

2573.1(12) 3505.3(18)

25.5(6)

C37

6934.6(19)

3171.0(15) 3490(2)

32.2(7)

C38

8565(2)

3308.2(12) 4835(2)

31.3(7)

C36A

8813(13)

2979(9)

4347(14)

40(3)

C37A

7081(15)

2868(11)

3220(15)

42(3)

C38A

7533(14)

3520(9)

4693(13)

40(3)

Cl1

3942(4)

2856(2)

3846(3)

23.5(9)

Cl2

4049(7)

2107(3)

2327(5)

42.1(12)

C43

3246(9)

2591(6)

2708(9)

23.7(17)

Cl1A

3850(7)

2835(3)

3717(8)

51.9(16)
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Cl2A

4266(9)

2048(5)

2407(5)

53.9(17)

C43A

3415(11)

2492(8)

2591(11)

28(3)

Table 4.10. Anisotropic displacement parameters (Å2×103) for CoIII-APditBu complex (8). The
anisotropic displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…].
Atom

U11

U22

Co1

6.49(10) 10.11(11)

O1

7.4(5)

O2

U33

U13

U12

8.86(11) 0.30(9)

3.21(8)

0.60(9)

13.1(6)

11.6(6) -0.8(5)

3.5(5)

1.6(5)

7.1(6)

18.2(7)

15.7(6) 5.0(5)

4.9(5)

-0.2(5)

O3

8.8(5)

14.1(6)

8.2(6)

0.1(5)

4.5(5)

-0.4(5)

N1

9.3(7)

13.5(7)

10.7(7) 1.8(6)

4.5(6)

2.1(6)

N2

9.4(7)

12.0(7)

15.6(8) 1.4(6)

5.3(6)

1.6(6)

N3

5.9(6)

12.2(7)

7.5(6)

1.5(6)

-0.5(5)

C1

8.3(8)

10.2(8)

16.3(9) 2.3(7)

6.4(7)

1.7(6)

C2

9.1(8)

9.3(8)

15.0(8) 2.2(7)

5.6(7)

-0.4(6)

C3

10.8(8)

9.5(8)

16.4(9) 2.1(7)

7.2(7)

1.2(6)

C4

8.7(8)

12.2(8)

18.9(9) 3.0(7)

6.1(7)

2.7(7)

C5

10.5(8)

11.6(8)

17.2(9) 4.3(7)

3.0(7)

0.0(7)

C6

13.1(8)

11.4(8)

13.5(8) 1.2(7)

5.6(7)

1.2(7)

C7

11.3(8)

17.2(9)

16.1(9) 2.3(7)

1.0(7)

1.9(7)

C8

11.7(9)

41.1(13)

26.9(11) 8.5(10)

0.3(8)

-5.1(9)
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U23

-0.1(6)

C9

19.5(10) 25.6(11)

22.8(10) 8.4(9)

C10

24.8(11) 40.1(14)

25.5(12) -12.8(10) -6.4(9)

10.5(10)

C11

10.2(8)

12.7(8)

15.9(9) 1.3(7)

7.0(7)

1.9(7)

C12

13.9(8)

17.5(9)

22.8(10) 2.7(8)

11.0(8)

5.1(7)

C13

16.6(9)

17.7(9)

18.4(9) 3.7(7)

10.2(8)

4.5(7)

C14

17.3(9)

16.0(9)

22.9(10) -4.2(8)

11.2(8)

-1.1(7)

C15

10.4(8)

10.4(7)

8.6(7)

1.5(6)

4.6(6)

3.8(6)

C16

8.7(7)

10.5(8)

12.1(8) 2.2(6)

5.0(7)

2.9(6)

C17

14.2(8)

12.2(8)

10.4(8) 0.1(7)

3.9(7)

1.5(7)

C18

18.5(9)

16.7(9)

11.0(8) 0.1(7)

7.2(7)

0.0(7)

C19

15.1(8)

11.8(8)

14.5(8) 2.3(7)

9.0(7)

1.0(7)

C20

10.0(8)

11.1(8)

11.3(8) -0.5(6)

3.7(7)

0.5(6)

C21

22.3(9)

19.0(9)

16.6(9) -1.9(7)

13.7(8)

-5.4(8)

C22

24.3(10) 41.0(13)

23.8(11) -5.9(10)

16.3(9)

-15.7(10)

C23

25.4(11) 29.2(11)

27.6(11) -5.7(9)

19.8(9)

-5.1(9)

C24

39.6(12) 20.7(10)

31.1(12) 4.2(9)

22.9(10)

-2.4(9)

C25

16.0(9)

11.2(8) -3.1(7)

4.6(7)

-3.6(7)

C26

26.7(11) 33.1(11)

13.6(9) -6.9(8)

8.1(8)

-10.1(9)

C27

15.3(9)

16.9(9) -0.8(8)

2.4(8)

-0.4(8)

C28

27.9(10) 18.6(9)

18.6(10) -6.8(8)

11.0(8)

-6.4(8)

C29

8.6(8)

15.1(8) -1.9(7)

4.6(7)

-0.9(6)

20.3(9)

31.8(11)

10.9(8)
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1.1(8)

0.8(8)

C30

12.0(8)

10.0(8)

11.3(8) -1.8(6)

4.4(7)

-1.9(7)

C31

9.9(8)

10.7(8)

12.9(8) -1.3(6)

3.0(7)

-1.4(6)

C32

9.3(8)

16.1(9)

16.5(9) 1.3(7)

4.6(7)

-2.0(7)

C33

13.5(8)

13.0(8)

20.4(9) 4.3(7)

6.1(7)

-1.7(7)

C34

10.9(8)

12.3(8)

18.0(9) 2.3(7)

2.7(7)

1.2(7)

C35

17.6(9)

20.4(10)

28.6(11) 12.7(9)

5.3(9)

-3.5(8)

C39

9.4(8)

13.6(8)

16.4(9) 3.1(7)

4.8(7)

1.6(7)

C40

12.5(8)

22.3(9)

16.5(9) 2.3(8)

2.3(7)

0.9(7)

C41

16.5(9)

13.0(9)

22.3(10) 1.8(7)

7.9(8)

2.9(7)

C42

11.5(8)

21.3(10)

26.5(10) 7.8(8)

8.1(8)

3.3(7)

C36

23.5(12) 29.0(13)

29.0(13) 13.5(11)

15.8(11)

1.8(10)

C37

18.9(12) 30.0(15)

48.2(18) 26.8(14)

14.6(12)

4.5(11)

C38

37.5(15) 20.6(12)

34.1(15) 5.0(11)

13.6(12)

-11.7(11)

C36A

39(5)

43(6)

50(6)

28(5)

31(5)

9(5)

C37A

44(7)

43(7)

49(7)

27(6)

31(6)

15(6)

C38A

53(6)

35(6)

46(6)

13(6)

33(5)

4(6)

Cl1

24.9(11) 26.2(13)

15.1(11) 2.1(9)

4.5(7)

0.9(7)

Cl2

82(3)

24.5(11)

33.5(17) -0.7(12)

38(2)

-10.8(16)

C43

21(4)

21(3)

25(3)

3(2)

6(2)

3(2)

Cl1A

44(2)

62(3)

50(3)

30.9(19)

20(2)

5.3(17)

Cl2A

66(3)

47(3)

35.2(13) 11.0(14)

9.2(17)

-22(2)

156

C43A

20(5)

27(5)

27(4)

13(4)

Table 4.11. Bond lengths for CoIII-APditBu complex (8).
Atom

Atom

Length/Å

Atom

Atom

Length/Å

Co1

Co11

2.8861(5)

C17

C25

1.534(2)

Co1

O1

1.9176(12)

C18

C19

1.393(3)

Co1

O3

1.9104(12)

C19

C20

1.396(2)

Co1

N1

1.9373(15)

C19

C21

1.540(2)

Co1

N2

2.0524(15)

C21

C22

1.530(3)

Co1

N3

1.9172(14)

C21

C23

1.537(3)

Co1

N31

1.9719(14)

C21

C24

1.532(3)

O1

C2

1.331(2)

C25

C26

1.534(3)

O2

C30

1.365(2)

C25

C27

1.538(3)

O3

C16

1.362(2)

C25

C28

1.539(3)

N1

C1

1.458(2)

C29

C30

1.392(2)

N2

C29

1.454(2)

C29

C34

1.395(2)

N3

Co11

1.9720(14)

C30

C31

1.415(2)

N3

C15

1.441(2)

C31

C32

1.395(2)

C1

C2

1.392(2)

C31

C39

1.539(2)

C1

C6

1.383(2)

C32

C33

1.396(3)

C2

C3

1.428(2)

C33

C34

1.391(2)
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-1(3)

-5(4)

C3

C4

1.390(2)

C33

C35

1.541(2)

C3

C11

1.534(2)

C35

C36

1.576(3)

C4

C5

1.405(3)

C35

C37

1.514(3)

C5

C6

1.389(2)

C35

C38

1.517(3)

C5

C7

1.536(2)

C35

C36A

1.353(17)

C7

C8

1.534(3)

C35

C37A

1.43(2)

C7

C9

1.534(3)

C35

C38A

1.846(18)

C7

C10

1.524(3)

C39

C40

1.534(3)

C11

C12

1.535(2)

C39

C41

1.544(2)

C11

C13

1.543(2)

C39

C42

1.534(2)

C11

C14

1.534(2)

Cl1

C43

1.739(13)

C15

C16

1.398(2)

Cl2

C43

1.851(11)

C15

C20

1.388(2)

Cl1A

C43A

1.759(15)

C16

C17

1.404(2)

Cl2A

C43A

1.694(14)

C17

C18

1.400(2)

Table 4.12. Bond angles for CoIII-APditBu complex (8).
Atom Atom

Ato
m

Angle/˚

Atom Atom

Atom

Angle/˚

O1

Co1

Co11 134.73(4)

O3

C16

C15

115.36(15)

O1

Co1

N1

85.65(6)

O3

C16

C17

124.20(15)

O1

Co1

N2

83.39(6)

C15 C16

C17

120.40(15)
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O1

Co1

N31 175.75(6)

C16 C17

C25

121.49(16)

O3

Co1

Co11 87.98(4)

C18 C17

C16

116.30(16)

O3

Co1

O1

89.07(5)

C18 C17

C25

122.21(16)

O3

Co1

N1

174.29(6)

C19 C18

C17

124.14(17)

O3

Co1

N2

84.37(6)

C18 C19

C20

118.00(16)

O3

Co1

N31 92.30(5)

C18 C19

C21

120.05(16)

O3

Co1

N3

84.59(6)

C20 C19

C21

121.91(16)

N1

Co1

Co11 94.19(5)

C15 C20

C19

119.48(16)

N1

Co1

N2

97.16(7)

C22 C21

C19

111.53(15)

N1

Co1

N31 92.82(6)

C22 C21

C23

107.02(17)

N2

Co1

Co11 141.03(4)

C22 C21

C24

109.59(17)

N3

Co1

Co11 42.83(4)

C23 C21

C19

110.43(15)

N31

Co1

Co11 41.37(4)

C24 C21

C19

108.77(16)

N3

Co1

O1

91.93(6)

C24 C21

C23

109.48(17)

N3

Co1

N1

93.40(6)

C17 C25

C26

112.04(15)

N3

Co1

N2

168.07(6)

C17 C25

C27

109.62(15)

N31

Co1

N2

100.75(6)

C17 C25

C28

110.12(15)

N3

Co1

N31 84.20(6)

C26 C25

C27

107.52(16)

C2

O1

Co1 111.36(10)

C26 C25

C28

107.34(16)

C16

O3

Co1 108.70(10)

C27 C25

C28

110.13(16)

C1

N1

Co1 108.02(11)

C30 C29

N2

120.71(16)
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C29

N2

Co1 129.54(11)

C30 C29

C34

120.69(16)

Co1

N3

Co11 95.81(6)

C34 C29

N2

118.60(15)

C15

N3

Co11 118.49(11)

O2

C30

C29

122.41(15)

C15

N3

Co1 105.62(11)

O2

C30

C31

117.84(15)

C2

C1

N1

114.02(15)

C29 C30

C31

119.75(16)

C6

C1

N1

121.63(15)

C30 C31

C39

120.89(15)

C6

C1

C2

124.33(15)

C32 C31

C30

117.13(16)

O1

C2

C1

118.28(15)

C32 C31

C39

121.97(15)

O1

C2

C3

124.12(16)

C31 C32

C33

123.91(16)

C1

C2

C3

117.59(16)

C32 C33

C35

120.82(16)

C2

C3

C11 120.30(15)

C34 C33

C32

117.09(16)

C4

C3

C2

116.89(16)

C34 C33

C35

122.04(16)

C4

C3

C11 122.80(15)

C33 C34

C29

121.00(16)

C3

C4

C5

124.98(16)

C33 C35

C36

110.24(17)

C4

C5

C7

121.58(16)

C33 C35

C38A

99.8(5)

C6

C5

C4

117.07(16)

C37 C35

C33

112.54(17)

C6

C5

C7

121.27(17)

C37 C35

C36

106.6(2)

C1

C6

C5

119.10(17)

C37 C35

C38

110.4(2)

C8

C7

C5

111.00(16)

C38 C35

C33

109.17(18)

C8

C7

C9

108.83(16)

C38 C35

C36

107.77(19)

C9

C7

C5

107.84(15)

C36A C35

C33

117.5(7)
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C10

C7

C5

112.03(15)

C36A C35

C37A

124.7(11)

C10

C7

C8

108.14(18)

C36A C35

C38A

100.4(11)

C10

C7

C9

108.94(18)

C37A C35

C33

109.1(8)

C3

C11

C12 112.18(15)

C37A C35

C38A

99.3(11)

C3

C11

C13 109.26(14)

C31 C39

C41

109.70(14)

C12

C11

C13 107.89(14)

C40 C39

C31

111.62(15)

C14

C11

C3

110.18(14)

C40 C39

C41

109.78(15)

C14

C11

C12 107.91(14)

C42 C39

C31

111.36(15)

C14

C11

C13 109.36(15)

C42 C39

C40

107.47(15)

C16

C15

N3

114.30(15)

C42 C39

C41

106.76(15)

C20

C15

N3

124.18(15)

Cl1

Cl2

108.2(7)

C20

C15

C16 121.52(15)

Cl1A

113.8(9)

C43

Cl2A C43A

Table 4.13. Torsion angles for CoIII-APditBu complex (8).
A

B

C

D

Angle/˚

A

Co1

O1

C2

C1

-11.35(18)

C15 C16 C17 C25

Co1

O1

C2

C3

168.08(13) C16 C15 C20 C19

Co1

O3

C16 C15 21.72(17)

Co1

O3

C16 C17 -160.52(14) C16 C17 C25 C26

176.09(17)

Co1

N1

C1

C2

11.58(18)

-64.6(2)

Co1

N1

C1

C6

-167.20(14) C16 C17 C25 C28

Co1

N2

C29 C30 -46.8(2)

B

C

D

C16 C17 C18 C19

C16 C17 C25 C27

C17 C18 C19 C20

161

Angle/˚
176.39(16)
-0.7(3)
0.1(3)

56.7(2)
3.1(3)

Co1

N2

C29 C34 133.63(15) C17 C18 C19 C21

-179.26(17)

Co11 N3

C15 C16 81.09(16)

C18 C17 C25 C26

-4.0(2)

Co1

N3

C15 C16 -24.65(16)

C18 C17 C25 C27

115.30(19)

Co1

N3

C15 C20 155.87(14) C18 C17 C25 C28

-123.38(18)

Co11 N3

C15 C20 -98.39(17)

-2.7(2)

O1

C2

C3

C4

O1

C2

C3

C11 -1.6(3)

O2

C30 C31 C32 -172.94(16) C18 C19 C21 C24

-75.5(2)

O2

C30 C31 C39 8.4(2)

-178.19(15)

O3

C16 C17 C18 178.80(15) C20 C15 C16 C17

4.0(3)

O3

C16 C17 C25 -1.3(3)

C20 C19 C21 C22

-19.0(2)

N1

C1

C2

O1

-0.4(2)

C20 C19 C21 C23

-137.82(18)

N1

C1

C2

C3

-179.87(15) C20 C19 C21 C24

102.0(2)

N1

C1

C6

C5

-179.74(16) C21 C19 C20 C15

179.68(16)

N2

C29 C30 O2

-5.6(3)

-179.87(17)

N2

C29 C30 C31 174.20(16) C29 C30 C31 C32

7.2(2)

N2

C29 C34 C33 -179.81(17) C29 C30 C31 C39

-171.46(16)

N3

C15 C16 O3

0.6(3)

N3

C15 C16 C17 -175.54(15) C30 C31 C32 C33

-3.0(3)

N3

C15 C20 C19 178.76(15) C30 C31 C39 C40

-64.4(2)

C1

C2

57.5(2)

C3

C4

C18 C19 C20 C15

179.95(16) C18 C19 C21 C22

2.3(2)

-0.6(2)

C18 C19 C21 C23

C20 C15 C16 O3

C25 C17 C18 C19

C30 C29 C34 C33

C30 C31 C39 C41

162

163.48(17)
44.6(2)

C1

C2

C3

C11 177.85(15) C30 C31 C39 C42

175.50(16)

C2

C1

C6

C5

1.6(3)

C31 C32 C33 C34

-2.4(3)

C2

C3

C4

C5

2.0(3)

C31 C32 C33 C35

175.29(18)

C2

C3

C11 C12 -179.84(15) C32 C31 C39 C40

116.98(19)

C2

C3

C11 C13 -60.3(2)

C32 C31 C39 C41

-121.11(18)

C2

C3

C11 C14 59.9(2)

C32 C31 C39 C42

-3.1(2)

C3

C4

C5

C6

-1.5(3)

C32 C33 C34 C29

3.6(3)

C3

C4

C5

C7

-178.29(16) C32 C33 C35 C36

C4

C3

C11 C12 -1.5(2)

C32 C33 C35 C37

174.2(2)

C4

C3

C11 C13 118.12(18) C32 C33 C35 C38

-62.9(3)

C4

C3

C11 C14 -121.70(18) C32 C33 C35 C36A -10.1(11)

C4

C5

C6

C1

-0.3(2)

C32 C33 C35 C37A 139.2(10)

C4

C5

C7

C8

-41.0(2)

C32 C33 C35 C38A -117.3(7)

C4

C5

C7

C9

78.2(2)

C34 C29 C30 O2

C4

C5

C7

C10 -161.97(19) C34 C29 C30 C31

-6.2(3)

C6

C1

C2

O1

178.34(16) C34 C33 C35 C36

-127.2(2)

C6

C1

C2

C3

-1.1(3)

-8.3(3)

C6

C5

C7

C8

142.40(18) C34 C33 C35 C38

C6

C5

C7

C9

-98.5(2)

C6

C5

C7

C10 21.4(3)

C7

C5

C6

C1

C34 C33 C35 C37

55.3(2)

173.95(16)

114.7(2)

C34 C33 C35 C36A 167.5(10)
C34 C33 C35 C37A -43.2(10)

176.49(16) C34 C33 C35 C38A 60.3(7)
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C11

C3

C4

C5

-176.45(16) C35 C33 C34 C29

C15

C16 C17 C18 -3.5(2)

C39 C31 C32 C33

-174.03(18)
175.71(17)

Table 4.14. Hydrogen atom coordinates (Å×104) and isotropic displacement parameters
(Å2×103) for CoIII-APditBu complex (8).
Atom x

y

z

U(eq)

H2

6844(18)

837(12)

6415(17)

21

H1A

3975(16)

372(12)

3472(15)

17

H1B

4292(16)

970(11)

3367(15)

17

H2A

5607(16)

1649(11)

5643(16)

18

H2B

5235(16)

1827(11)

4716(16)

18

H3

3631(16)

-130(10)

4748(15)

13

H4

834

1769

3380

16

H6

2348

824

2173

15

H8A

-376

781

2097

44

H8B

-978

1206

1181

44

H8C

-501

1551

2184

44

H9A

457

2339

1715

38

H9B

-98

2052

679

38

H9C

1074

2088

1167

38

H10A 1135

927

839

54

H10B -30

840

408

54
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H10C 664

388

1259

54

H12A 985

2484

4512

25

H12B 1125

2296

5545

25

H12C 643

1783

4709

25

H13A 1891

947

5639

25

H13B 2315

1472

6465

25

H13C 3031

1131

6085

25

H14A 3567

2230

5781

27

H14B 2853

2576

6159

27

H14C 2773

2751

5142

27

H18

4531

166

8504

18

H20

3059

-572

5909

13

H22A 1699

-373

6368

41

H22B 1529

-925

7000

41

H22C 2126

-1092

6397

41

H23A 3257

41

8747

37

H23B 2188

-278

8369

37

H23C 2385

322

7822

37

H24A 3587

-1472

7784

42

H24B 2988

-1361

8401

42

H24C 4041

-1028

8704

42
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H26A 5346

1087

9228

37

H26B 6517

1134

9732

37

H26C 5991

436

9551

37

H27A 6983

64

8728

34

H27B 7518

760

8954

34

H27C 7028

495

7902

34

H28A 6032

1538

7404

32

H28B 6515

1793

8461

32

H28C 5347

1749

7902

32

H32

9064

1908

5240

17

H34

6209

2392

4236

18

H40A 8931

837

7542

28

H40B 9707

1388

7595

28

H40C 10026

636

7731

28

H41A 8316

45

6194

26

H41B 9408

-128

6345

26

H41C 8629

131

5351

26

H42A 10596

697

6513

30

H42B 10310

1454

6354

30

H42C 9903

959

5489

30

H36A 8983

2348

3897

38
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H36B 8514

2943

3190

38

H36C 7929

2269

3037

38

H37A 6486

2854

3052

48

H37B 7091

3513

3141

48

H37C 6622

3368

3860

48

H38A 8269

3475

5238

47

H38B 8692

3673

4500

47

H38C 9183

3087

5219

47

H36D 9110

2627

4134

60

H36E 9175

3031

5025

60

H36F 8840

3387

4036

60

H37D 7116

2496

2845

63

H37E 7134

3276

2920

63

H37F 6453

2858

3268

63

H38D 6849

3474

4596

61

H38E 7612

3931

4413

61

H38F 7960

3523

5364

61

H43A 2976

2971

2289

28

H43B 2692

2319

2684

28

H43C 2847

2208

2490

34

H43D 3182

2849

2124

34

167

Table 4.15. Atomic occupancy for CoIII-APditBu complex (8).
Atom Occupancy

Atom Occupancy

Atom

Occupancy

C36

H36A 0.856(4)

H36B

0.856(4)

H36C 0.856(4)

C37

H37A

0.856(4)

H37B 0.856(4)

H37C 0.856(4)

C38

0.856(4)

H38A 0.856(4)

H38B 0.856(4)

H38C

0.856(4)

C36A 0.144(4)

H36D 0.144(4)

H36E

0.144(4)

H36F 0.144(4)

C37A 0.144(4)

H37D

0.144(4)

H37E 0.144(4)

H37F 0.144(4)

C38A

0.144(4)

H38D 0.144(4)

H38E 0.144(4)

H38F

0.144(4)

Cl1

Cl2

C43

0.54(3)

0.856(4)

0.54(3)

0.856(4)

0.54(3)

H43A 0.54(3)

H43B 0.54(3)

Cl1A

0.46(3)

Cl2A 0.46(3)

C43A 0.46(3)

H43C

0.46(3)

H43D 0.46(3)
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Appendix
NMR Characterization of Aminobenzoxazoles and
Aminobenzimidazoles
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1H

and 13C NMR Spectra of 2-Aminobenzoxazoles

Figure A1. 1H NMR spectrum of 2-(tert-butylamino)benzoxazole (3a) in CDCl3 at 400 MHz.

Figure A2. 13C NMR spectrum of 2-(tert-butylamino)benzoxazole (3a) in CDCl3 at 100 MHz.
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Figure A3. 1H NMR spectrum of 4-methyl-2-(tert-butylamino)benzoxazole (3b) in CDCl3 at
400 MHz.

Figure A4. 13C NMR spectrum of 4-methyl-2-(tert-butylamino)benzoxazole (3b) in CDCl3 at
100 MHz.
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Figure A5. 1H-NMR spectrum of 5-phenyl-2-(tert-butylamino) benzoxazole (3c) in CDCl3 at
400 MHz.

Figure A6. 13C NMR spectrum of 5-phenyl-2-(tert-butylamino)benzoxazole (3c) in CDCl3 at
100 MHz.
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Figure A7. 1H NMR spectrum of 5-methyl-2-(tert-butylamino)benzoxazole (3d) in CDCl3 at
400 MHz.

Figure A8. 13C NMR spectrum of 5-methyl-2-(tert-butylamino) benzoxazole (3d) in CDCl3 at
100 MHz.
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Figure A9. 1H NMR spectrum of 5-methoxy-2-(tert-butylamino)benzoxazole (3e) in CDCl3
at 400 MHz.

Figure A10. 13C NMR spectrum of 5-methoxy-2-(tert-butylamino)benzoxazole (3e) in CDCl3 at
100 MHz.
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Figure A11. 1H NMR spectrum of 5-nitro-2-(tert-butylamino)benzoxazole (3f) in CDCl3 at
400 MHz.

Figure A12. 13C NMR spectrum of 5-nitro-2-(tert-butylamino)benzoxazole (3f) in CDCl3 at
100 MHz.
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Figure A13. 1H NMR spectrum of 5-bromo-2-(tert-butylamino)benzoxazole (3g) in CDCl3 at
400 MHz.

Figure A14. 13C NMR spectrum of 5-bromo-2-(tert-butylamino)benzoxazole (3g) in CDCl3 at
100 MHz.
188

Figure A15. 1H NMR spectrum of 5-tert-butyl-2-(tert-butylamino)benzoxazole (3h) in CDCl3 at
400 MHz.

Figure A16. 13C NMR spectrum of 5-tert-butyl-2-(tert-butylamino)benzoxazole (3h) in CDCl3
at 100 MHz.
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Figure A17. 1H NMR spectrum of 6-methyl-2-(tert-butylamino)benzoxazole (3i) in CDCl3 at
400 MHz.

Figure A18. 13C NMR spectrum of 6-methyl-2-(tert-butylamino) benzoxazole(3i) in CDCl3 at
100 MHz.
190

Figure A19. 1H NMR spectrum of 6-methoxy-2-(tert-butylamino)benzoxazole (3j) in CDCl3
at 400 MHz.

Figure A20. 13C NMR spectrum of 6-methoxy-2-(tert-butylamino)benzoxazole (3j) in CDCl3 at
100 MHz.
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Figure A21. 1H NMR spectrum of 6-nitro-2-(tert-butylamino)benzoxazole (3k) in CDCl3 at
400 MHz.

Figure A22. 13C NMR spectrum of 6-nitro-2-(tert-butylamino)benzoxazole (3k) in CDCl3 at
100 MHz.
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Figure A23. 1H NMR spectrum of 7-methyl-2-(tert-butylamino)benzoxazole (3l) in CDCl3 at
400 MHz.

Figure A24. 13C NMR spectrum of 7-methyl-2-(tert-butylamino)benzoxazole (3l) in CDCl3
at 100 MHz.
193

Figure A25. 1H NMR spectrum of 6-nitro-5-chloro-2-(tert-butylamino)benzoxazole (3m) in CDCl3
at 400 MHz.

Figure A26. 13C NMR spectrum of 6-nitro-5-chloro-2-(tert-butylamino)benzoxazole (3m) in CDCl3
at 100 MHz.
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Figure A27. 1H NMR spectrum of 2-(cyclohexylamino)benzoxazole (3n) in CDCl3 at 400 MHz.

Figure A28.
MHz.

13C

NMR spectrum of 2-(cyclohexylamino)benzoxazole (3n) in CDCl3 at 100
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Figure A29. 1H NMR spectrum of 2-(1-admantylamino)benzoxazole (3o) in CDCl3 at 400
MHz.

Figure A30. 13C-NMR spectrum of 2-(1-admantylamino)benzoxazole (3o) in CDCl3 at 100
MHz.
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Figure A31. 1H NMR spectrum of 2-(1,1,3,3-tetramethylbutylamino)benzoxazole (3p) in CDCl3
at 400 MHz.

Figure A32. 13C NMR spectrum of 2-(1,1,3,3-tetramethylbutylamino)benzoxazole (3p) in CDCl3 at
100 MHz.
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Figure A33. 1H NMR spectrum of 2-(isopropylamino)benzoxazole (3q) in CDCl3 at 400 MHz.

Figure A34. 13C NMR spectrum of 2-(isopropylamino)benzoxazole (3q) in CDCl3 at 100 MHz.
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Figure A35. 1H NMR spectrum of 2-(4-methoxyphenylamino)benzoxazole (3r) in CDCl3 at
400 MHz.

Figure A36. 13C NMR spectrum of 2-(4-methoxyphenylamino)benzoxazole (3r) in CDCl3 at
100 MHz.
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Figure A37. 1H NMR spectrum of 2-(6-chloro-2-methylphenylamino)benzoxazole (3s) in
CDCl3 at 400 MHz.

Figure A38. 13C NMR spectrum of 2-(6-chloro-2-methylphenylamino)benzoxazole (3s) in
CDCl3 at 100 MHz.
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Figure A39. 1H NMR spectrum of 2-(2,6-dimethylphenylamino)benzoxazole (3t) in CDCl3
at 400 MHz.

Figure A40. 13C NMR spectrum of 2-(2,6-dimethylphenylamino)benzoxazole (3t) in CDCl3
at 100 MHz.
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Figure A41. 1H NMR spectrum of N-(phenylmethyl)-2-benzoxazolamine (3u) in CDCl3 at 400
MHz.

Figure A42. 13C NMR spectrum of N-(phenylmethyl)-2-benzoxazolamine (3u) in CDCl3 at
100 MHz.
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Figure A43. 1H NMR spectrum of 2-(4-fluorophenylamino)benzoxazole (3v) in CDCl3 at 400
MHz.

Figure A44. 13C NMR spectrum of 2-(4-fluorophenylamino)benzoxazole (3v) in CDCl3 at
100 MHz.
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Figure A45. 19F NMR spectrum of 2-(4-fluorophenylamino)benzoxazole (3v) in CDCl3 at
376 MHz.
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Figure A46. 1H NMR spectrum of 5,7-di-tertbutyl -2-(tert-butylamino)benzoxazole (3w) in
CDCl3 at 400 MHz.

Figure A47. 13C NMR spectrum of 5,7-di-tertbutyl -2-(tert-butylamino)benzoxazole (3w) in
CDCl3 at 400 MHz.
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1H

and 13C NMR Spectra of 2-Aminobenzimidazoles

Figure A48. 1H NMR spectrum of 2-(tert-butylamino)benzimidazole (5a) in DMSO-d6 at 400
MHz.

Figure A49. 13C NMR spectrum of 2-(tert-butylamino)benzimidazole (5a) in DMSO-d6 at 100
MHz.
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Figure A50. 1H NMR spectrum of 2-(tert-butylamino)-5-methylbenzimidazole (5b) in CDCl3
at 400 MHz.

Figure A51. 13C NMR spectrum of 2-(tert-butylamino) benzimidazole (5b) in CDCl3 at 100
MHz.
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Figure A52. 1H NMR spectrum of 2-(tert-butylamino)-5-tert-butylbenzimidazole (5c) in
CDCl3 at 400 MHz.

Figure A53. 13C NMR spectrum of 2-(tert-butylamino)-5-tert-butylbenzimidazole (5c) in CDCl3 at
100 MHz.
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Figure A54. 1H NMR spectrum of 2-(tert-butylamino)-5-methoxybutylbenzimidazole (5d) in
CDCl3 at 400 MHz.

Figure A55. 13C NMR spectrum of 2-(tert-butylamino)-5-methoxybenzimidazole (5d) in
CDCl3 at 100 MHz.
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Figure A56. 1H NMR spectrum of 2-(tert-butylamino)-5-bromobenzimidazole (5e) in CDCl3
at 400 MHz.

Figure A57. 13C NMR spectrum of 2-(tert-butylamino)-5-bromobenzimidazole (5e) in CDCl3
at 100 MHz.
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Figure A58. 1H NMR spectrum of 2-(tert-butylamino)-5-chlorobenzimidazole (5f) in
DMSO-d6 at 400 MHz.

Figure A59. 13C NMR spectrum of 2-(tert-butylamino)-5-chlorobenzimidazole (5f) in DMSO-d6
at 100 MHz.
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Figure A60. 1H NMR spectrum of 2-(tert-butylamino)-5-fluorobenzimidazole (5g) in DMSOd6 at 400 MHz.

Figure A61. 13C NMR spectrum of 2-(tert-butylamino)-5-fluorobenzimidazole (5g) in DMSOd6 at 100 MHz.
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Figure A62. 19F NMR spectrum of 2-(tert-butylamino)-5-fluorobenzimidazole (5g) in DMSOd6 at 376 MHz.
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Figure A63. 1H NMR spectrum of 2-(tert-butylamino)-5-trifluoromethylbenzimidazole (5h)
in CD3OD at 400 MHz.

Figure A64. 13H NMR spectrum of 2-(tert-butylamino)-5-trifluoromethylbenzimidazole (5h)
in CD3OD at 100 MHz.
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Figure A65. 19F NMR spectrum of 2-(tert-butylamino)-5-trifluoromethylbenzimidazole (5h)
in CD3OD at 376 MHz.
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Figure A66. 1H NMR spectrum of 2-(tert-butylamino)-5-nitrobenzimidazole (5i) in CD3OD
at 400 MHz.

Figure A67. 13C NMR spectrum of 2-(tert-butylamino)-5-nitrobenzimidazole (5i) in CD3OD
at 100 MHz.
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Figure A68. 1H NMR spectrum of 2-(tert-butylamino)-5-cyanobenzimidazole (5j) in CD3OD
at 400 MHz.

Figure A69. 13C NMR spectrum of 2-(tert-butylamino)-5-cyanobenzimidazole (5j) in CD3OD
at 100 MHz.
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Figure A70. 1H NMR spectrum of 2-(tert-butylamino)-7-methylbenzimidazole (5k) in CDCl3
at 400 MHz.

Figure A71. 13C NMR spectrum of 2-(tert-butylamino)-7-methylbenzimidazole (5k) in CDCl3
at 100 MHz.
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Figure A72. 1H NMR spectrum of 2-(tert-butylamino)-7-bromobenzimidazole (5l) in CDCl3
at 400 MHz.

Figure A73. 13C NMR spectrum of 2-(tert-butylamino)-7-bromobenzimidazole (5l) in CDCl3
at 100 MHz.
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Figure A74. 1H NMR spectrum of 2-(tert-butylamino)naphtho[2,3-d]imidazole (5m) in
CDCl3 at 400 MHz.

Figure A75. 13C NMR spectrum of 2-(tert-butylamino)naphtho[2,3-d]imidazole (5m) in
CDCl3 at 100 MHz.
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Figure A76. 1H NMR spectrum of 2-(1,1,3,3-tetramethylbutylamino)benzimidazole (5n) in
CDCl3 at 400 MHz.

Figure A77. 13C NMR spectrum of 2-(1,1,3,3-tetramethylbutylamino)benzimidazole (5n) in
CDCl3 at 100 MHz.
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Figure A78. 1H NMR spectrum of 2-(1-adamantylamino)benzimidazole (5o) in DMSO-d6 at
400 MHz.

Figure A79. 13C NMR spectrum of 2-(1-adamantylamino)benzimidazole (5o) in DMSO-d6 at
100 MHz.
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Figure A80. 1H NMR spectrum of 2-(cyclohexylamino)benzimidazole (5p) in DMSO-d6 at 400
MHz.

Figure A81.
100 MHz.

13C

NMR spectrum of 2-(cyclohexylamino)benzimidazole (5p) in DMSO-d6 at
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Figure A82. 1H NMR spectrum of 2-amino-5-benzoyl-1H-benzimidazole (5t) in DMSO-d6 at
400 MHz.

Figure A83. 13C NMR spectrum of 2-amino-5-benzoyl-1H-benzimidazole (5t) in DMSO-d6 at
100 MHz.
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Figure A84. 1H NMR spectrum of N2,N3-dipentylquinoxaline-2,3-diamine (6) in CDCl3 at 400
MHz.

Figure A85. 13C NMR spectrum of N2,N3-dipentylquinoxaline-2,3-diamine (6) in CDCl3 at
100 MHz.
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